
<html lang="en"     class="pb-page"  data-request-id="0cc436e8-cc23-4931-9c0b-e5f575f4ae1d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.1c00510;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Mapping Chromone-3-Phenylcarboxamide Pharmacophore: Quid Est Veritas?" /></meta><meta name="dc.Creator" content="Francesco  Mesiti" /></meta><meta name="dc.Creator" content="Alexandra  Gaspar" /></meta><meta name="dc.Creator" content="Daniel  Chavarria" /></meta><meta name="dc.Creator" content="Annalisa  Maruca" /></meta><meta name="dc.Creator" content="Roberta  Rocca" /></meta><meta name="dc.Creator" content="Eva  Gil Martins" /></meta><meta name="dc.Creator" content="Sandra  Barreiro" /></meta><meta name="dc.Creator" content="Renata  Silva" /></meta><meta name="dc.Creator" content="Carlos  Fernandes" /></meta><meta name="dc.Creator" content="Sheraz  Gul" /></meta><meta name="dc.Creator" content="Oliver  Keminer" /></meta><meta name="dc.Creator" content="Stefano  Alcaro" /></meta><meta name="dc.Creator" content="Fernanda  Borges" /></meta><meta name="dc.Description" content="Chromone-3-phenylcarboxamides (Crom-1 and Crom-2) were identified as potent, selective, and reversible inhibitors of human monoamine oxidase B (hMAO-B). Since they exhibit some absorption, distribu..." /></meta><meta name="Description" content="Chromone-3-phenylcarboxamides (Crom-1 and Crom-2) were identified as potent, selective, and reversible inhibitors of human monoamine oxidase B (hMAO-B). Since they exhibit some absorption, distribu..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 16, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00510" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00510" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00510" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00510" /></link>
        
    
    

<title>Mapping Chromone-3-Phenylcarboxamide Pharmacophore: Quid Est Veritas? | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00510" /></meta><meta property="og:title" content="Mapping Chromone-3-Phenylcarboxamide Pharmacophore: Quid Est Veritas?" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0012.jpeg" /></meta><meta property="og:description" content="Chromone-3-phenylcarboxamides (Crom-1 and Crom-2) were identified as potent, selective, and reversible inhibitors of human monoamine oxidase B (hMAO-B). Since they exhibit some absorption, distribution, metabolism, and excretion (ADME)-toxicity liabilities, new derivatives were synthesized to map the chemical structural features that compose the pharmacophore, a process vital for lead optimization. Structure–activity relationship data, supported by molecular docking studies, provided a rationale for the contribution of the heterocycle’s rigidity, the carbonyl group, and the benzopyran heteroatom for hMAO-B inhibitory activity. From the study, N-(3-chlorophenyl)-4H-thiochromone-3-carboxamide (31) (hMAO-B IC50 = 1.52 ± 0.15 nM) emerged as a reversible tight binding inhibitor with an improved pharmacological profile. In in vitro ADME-toxicity studies, compound 31 showed a safe cytotoxicity profile in Caco-2, SH-SY5Y, HUVEC, HEK-293, and MCF-7 cells, did not present cardiotoxic effects, and did not affect P-gp transport activity. Compound 31 also protected SH-SY5Y cells from iron(III)-induced damage. Collectively, these studies highlighted compound 31 as the first-in-class and a suitable candidate for in vivo preclinical investigation." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00510"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00510">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00510&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00510&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00510&amp;href=/doi/10.1021/acs.jmedchem.1c00510" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, XXXX</span><span class="cit-fg-issue">, XXX</span><span class="cit-fg-pageRange">, XXX-XXX</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/0/0" title="Return to Articles ASAP" id="returnToASAP" class="content-navigation__btn--return"><span>RETURN TO ARTICLES ASAP</span></a><a href="/doi/10.1021/acs.jmedchem.1c00472" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.1c00596" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Mapping Chromone-3-Phenylcarboxamide Pharmacophore: <i>Quid Est Veritas</i>?</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Francesco Mesiti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Francesco Mesiti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Scienze della Salute, Università “Magna Græcia” di Catanzaro, Campus “Salvatore Venuta”, Catanzaro 88100, Italy</div><div class="loa-info-affiliations-info">Net4Science srl, Academic Spinoff, Università “Magna Græcia” di Catanzaro, Campus “Salvatore Venuta”, Catanzaro 88100, Italy</div><div class="loa-info-affiliations-info">CIQUP/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto 4169-007, Portugal</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Francesco++Mesiti">Francesco Mesiti</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alexandra Gaspar</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alexandra Gaspar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CIQUP/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto 4169-007, Portugal</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#6908050c1108070d1b08470e081a19081b290f0a471c1947191d"><span class="__cf_email__" data-cfemail="751419100d141b1107145b1214060514073513165b00055b0501">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alexandra++Gaspar">Alexandra Gaspar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel Chavarria</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel Chavarria</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CIQUP/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto 4169-007, Portugal</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Chavarria">Daniel Chavarria</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Annalisa Maruca</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Annalisa Maruca</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Scienze della Salute, Università “Magna Græcia” di Catanzaro, Campus “Salvatore Venuta”, Catanzaro 88100, Italy</div><div class="loa-info-affiliations-info">Net4Science srl, Academic Spinoff, Università “Magna Græcia” di Catanzaro, Campus “Salvatore Venuta”, Catanzaro 88100, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Annalisa++Maruca">Annalisa Maruca</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Roberta Rocca</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Roberta Rocca</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Net4Science srl, Academic Spinoff, Università “Magna Græcia” di Catanzaro, Campus “Salvatore Venuta”, Catanzaro 88100, Italy</div><div class="loa-info-affiliations-info">Department of Experimental and Clinical Medicine, “Magna Græcia” University of Catanzaro, Campus “S. Venuta”, Viale Europa, Germaneto, Catanzaro 88100, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Roberta++Rocca">Roberta Rocca</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-0680-7097" title="Orcid link">https://orcid.org/0000-0002-0680-7097</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eva Gil Martins</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eva Gil Martins</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UCIBIO-REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto 4050-313, Portugal</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eva++Gil+Martins">Eva Gil Martins</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sandra Barreiro</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sandra Barreiro</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UCIBIO-REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto 4050-313, Portugal</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sandra++Barreiro">Sandra Barreiro</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Renata Silva</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Renata Silva</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UCIBIO-REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto 4050-313, Portugal</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Renata++Silva">Renata Silva</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0001-9962-7548" title="Orcid link">https://orcid.org/0000-0001-9962-7548</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carlos Fernandes</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carlos Fernandes</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CIQUP/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto 4169-007, Portugal</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carlos++Fernandes">Carlos Fernandes</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-0102-0703" title="Orcid link">https://orcid.org/0000-0002-0102-0703</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sheraz Gul</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sheraz Gul</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Fraunhofer Institute for Translational Medicine and Pharmacology, Hamburg 22525, Germany</div><div class="loa-info-affiliations-info">Fraunhofer Cluster of Excellence for Immune-Mediated Diseases CIMD, Hamburg Site, Hamburg 22525, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sheraz++Gul">Sheraz Gul</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Oliver Keminer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Oliver Keminer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Fraunhofer Institute for Translational Medicine and Pharmacology, Hamburg 22525, Germany</div><div class="loa-info-affiliations-info">Fraunhofer Cluster of Excellence for Immune-Mediated Diseases CIMD, Hamburg Site, Hamburg 22525, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Oliver++Keminer">Oliver Keminer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stefano Alcaro</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stefano Alcaro</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Scienze della Salute, Università “Magna Græcia” di Catanzaro, Campus “Salvatore Venuta”, Catanzaro 88100, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stefano++Alcaro">Stefano Alcaro</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Fernanda Borges</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fernanda Borges</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CIQUP/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto 4169-007, Portugal</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#4224202d302527310224216c37326c3236"><span class="__cf_email__" data-cfemail="c9afaba6bbaeacba89afaae7bcb9e7b9bd">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fernanda++Borges">Fernanda Borges</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0003-1050-2402" title="Orcid link">https://orcid.org/0000-0003-1050-2402</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00510&amp;href=/doi/10.1021%2Facs.jmedchem.1c00510" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, XXXX</span><span class="cit-issue">, XXX</span><span class="cit-pageRange">, XXX-XXX</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 16, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 March 2021</li><li><span class="item_label"><b>Published</b> online</span>16 July 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00510" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00510</a></div><div class="article_header-article-copyright"><strong>© 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFrancesco%2BMesiti%252C%2BAlexandra%2BGaspar%252C%2BDaniel%2BChavarria%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D0%26issueNum%3D0%26contentID%3Dacs.jmedchem.1c00510%26title%3DMapping%2BChromone-3-Phenylcarboxamide%2BPharmacophore%253A%2BQuid%2BEst%2BVeritas%253F%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D14%26publicationDate%3DJuly%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00510"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">246</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00510" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Mapping Chromone-3-Phenylcarboxamide Pharmacophore: Quid Est Veritas?&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Francesco&quot;,&quot;last_name&quot;:&quot;Mesiti&quot;},{&quot;first_name&quot;:&quot;Alexandra&quot;,&quot;last_name&quot;:&quot;Gaspar&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Chavarria&quot;},{&quot;first_name&quot;:&quot;Annalisa&quot;,&quot;last_name&quot;:&quot;Maruca&quot;},{&quot;first_name&quot;:&quot;Roberta&quot;,&quot;last_name&quot;:&quot;Rocca&quot;},{&quot;first_name&quot;:&quot;Eva&quot;,&quot;last_name&quot;:&quot;Gil Martins&quot;},{&quot;first_name&quot;:&quot;Sandra&quot;,&quot;last_name&quot;:&quot;Barreiro&quot;},{&quot;first_name&quot;:&quot;Renata&quot;,&quot;last_name&quot;:&quot;Silva&quot;},{&quot;first_name&quot;:&quot;Carlos&quot;,&quot;last_name&quot;:&quot;Fernandes&quot;},{&quot;first_name&quot;:&quot;Sheraz&quot;,&quot;last_name&quot;:&quot;Gul&quot;},{&quot;first_name&quot;:&quot;Oliver&quot;,&quot;last_name&quot;:&quot;Keminer&quot;},{&quot;first_name&quot;:&quot;Stefano&quot;,&quot;last_name&quot;:&quot;Alcaro&quot;},{&quot;first_name&quot;:&quot;Fernanda&quot;,&quot;last_name&quot;:&quot;Borges&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;0&quot;,&quot;volume&quot;:&quot;0&quot;,&quot;pages&quot;:&quot;&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00510&quot;},&quot;abstract&quot;:&quot;Chromone-3-phenylcarboxamides (Crom-1 and Crom-2) were identified as potent, selective, and reversible inhibitors of human monoamine oxidase B (hMAO-B). Since they exhibit some absorption, distribution, metabolism, and excretion (ADME)-toxicity liabilities, new derivatives were synthesized to map the chemical structural features that compose the pharmacophore, a process vital for lead optimization. Structure–activity relationship data, supported by molecular docking studies, provided a rationale for the contribution of the heterocycle’s rigidity, the carbonyl group, and the benzopyran heteroatom for hMAO-B inhibitory activity. From the study, N-(3-chlorophenyl)-4H-thiochromone-3-carboxamide (31) (hMAO-B IC50 = 1.52 ± 0.15 nM) emerged as a reversible tight binding inhibitor with an improved pharmacological profile. In in vitro ADME-toxicity studies, compound 31 showed a safe cytotoxicity profile in Caco-2, SH-SY5Y, HUVEC, HEK-293, and MCF-7 cells, did not present cardiotoxic effects, and did not affect P-gp tr&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00510&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00510" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00510&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00510" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00510&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00510" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00510&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00510&amp;href=/doi/10.1021/acs.jmedchem.1c00510" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00510" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00510" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00510%26sid%3Dliteratum%253Aachs%26pmid%3D34269579%26genre%3Darticle%26aulast%3DMesiti%26date%3D2021%26atitle%3DMapping%2BChromone-3-Phenylcarboxamide%2BPharmacophore%253A%2BQuid%2BEst%2BVeritas%253F%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D0%26issue%3D0%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/0/0" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/medium/jm1c00510_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00510&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Chromone-3-phenylcarboxamides (<b>Crom-1</b> and <b>Crom-2</b>) were identified as potent, selective, and reversible inhibitors of human monoamine oxidase B (<i>h</i>MAO-B). Since they exhibit some absorption, distribution, metabolism, and excretion (ADME)-toxicity liabilities, new derivatives were synthesized to map the chemical structural features that compose the pharmacophore, a process vital for lead optimization. Structure–activity relationship data, supported by molecular docking studies, provided a rationale for the contribution of the heterocycle’s rigidity, the carbonyl group, and the benzopyran heteroatom for <i>h</i>MAO-B inhibitory activity. From the study, <i>N</i>-(3-chlorophenyl)-4<i>H</i>-thiochromone-3-carboxamide (<b>31</b>) (<i>h</i>MAO-B IC<sub>50</sub> = 1.52 ± 0.15 nM) emerged as a reversible tight binding inhibitor with an improved pharmacological profile. In <i>in vitro</i> ADME-toxicity studies, compound <b>31</b> showed a safe cytotoxicity profile in Caco-2, SH-SY5Y, HUVEC, HEK-293, and MCF-7 cells, did not present cardiotoxic effects, and did not affect P-gp transport activity. Compound <b>31</b> also protected SH-SY5Y cells from iron(III)-induced damage. Collectively, these studies highlighted compound <b>31</b> as the first-in-class and a suitable candidate for <i>in vivo</i> preclinical investigation.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85131" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85131" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Human monoamine oxidases A and B (<i>h</i>MAO-A and <i>h</i>MAO-B, respectively) are mitochondrial flavoenzymes expressed in the brain and peripheral tissues.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> They catalyze the oxidative deamination of endogenous and dietary monoamines having a pivotal role in regulating the levels of monoamine neurotransmitters.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Since <i>h</i>MAO-A and <i>h</i>MAO-B isoforms exhibit different affinities for specific neurotransmitters, their selective inhibition is considered an attractive approach for the therapy of several neurological disorders.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a><i>h</i>MAO-B is a pharmacological target for the treatment of Parkinson’s disease (PD)<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and has also been described as a potential target for Alzheimer’s disease.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> During aging, the activity and expression of <i>h</i>MAO-B are enhanced approximately 4-fold in most of the brain regions.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> This <i>h</i>MAO-B overexpression boosts dopamine (DA) catabolism, with subsequent DA deficiency and generation of hydrogen peroxide and toxic aldehydes, which contribute to increased oxidative stress and neurodegeneration.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> As such, the use of selective <i>h</i>MAO-B inhibitors (i-<i>h</i>MAO-B) not only decreases DA catabolism, prolonging its action in the basal ganglia,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> but also prevents the formation of neurotoxic dopamine-derived oxidative products.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The i-<i>h</i>MAO-B selegiline and rasagiline are currently used as monotherapy or as add-on therapy to L-DOPA in PD.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> However, they present adverse effects and safety issues often associated with their irreversible inhibition.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Considerable efforts have been made to overcome these drawbacks, which culminated in safinamide approval, the only reversible i-<i>h</i>MAO-B in the market.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> As a result, the discovery of novel reversible i-<i>h</i>MAO-B is an active research area in drug discovery, and we report here novel outcomes based on a new scaffold.</div><div class="NLM_p">Benzopyrones, such as coumarins and chromones, are considered valid scaffolds for the development of new i-<i>h</i>MAO-B.<a onclick="showRef(event, 'ref3 ref8'); return false;" href="javascript:void(0);" class="ref ref3 ref8">(3,8)</a> Within this framework, benzopyrone-based libraries were developed and screened toward <i>h</i>MAOs, and relevant structure–activity relationships (SAR) were established.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9−11)</a> From our preliminary studies, we observed that the location and type of substituent at position C3 of the γ-pyrone nucleus were crucial to obtain potent and selective i-<i>h</i>MAO-B.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> As a result, <i>N</i>-(3′,4′-dimethyl phenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>Crom-1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) and <i>N</i>-(3′-chlorophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>Crom-2</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) were identified as the most potent, selective, and reversible i-<i>h</i>MAO-B.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Notably, the presence of the amide spacer and its direct linkage to the pyrone ring were found to be crucial for <i>h</i>MAO-B inhibitory activity. Moreover, the presence of 3,4-dimethyl and 3-chloro substituents at the exocyclic aromatic ring had remarkable effects on the compounds’ inhibitory potency against <i>h</i>MAO-B.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> Focusing on the lead optimization, we evaluated the effect of substituents located on the aromatic ring of benzopyrone (chromone and its bioisoster coumarin).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> From this study, we validated chromone-3-phenyl carboxamide as a lead to develop new and reversible i-<i>h</i>MAO-B. Then, crystallographic ligand–enzyme studies showed that both <b>Crom-1</b> and <b>Crom-2</b> occupied the hydrophobic active site of <i>h</i>MAO-B.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> However, despite the promising <i>h</i>MAO-B inhibition activity, these compounds presented cytotoxic effects in differentiated SH-SY5Y cells.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/medium/jm1c00510_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Rational design followed for the mapping of the chromone-3-phenylcarboxamide pharmacophore.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00510&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The data obtained gave us the rationale to develop selective and potent i-<i>h</i>MAO-B based on the chromone-3-phenylcarboxamide pharmacophore with improved absorption, distribution, metabolism, and excretion (ADME)-toxicity properties. To achieve this goal, the first step includes the evaluation of the chemical features that are part of the chromone-3-phenylcarboxamide pharmacophore. We investigated the relevance of key structural features of the benzopyrone moiety on bioactivity, namely, heterocycle rigidity, the presence/absence of a carbonyl group, and the type of heteroatom. Modifications of the substituents at the aromatic exocyclic ring were also explored. Thus, following a rational design strategy (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), here, we report the synthesis of a novel library and new SAR studies guided by <i>in silico</i> and experimental studies. The results were then rationalized using docking studies with crystal structures of <i>h</i>MAO-A and <i>h</i>MAO-B. The most promising i-<i>h</i>MAO-B followed through with preliminary preclinical <i>in vitro</i> ADME-toxicity studies, in order to evaluate its cytotoxicity against SH-SY5Y, Caco-2, HEK-293, and MCF-7 cells, cardiotoxicity (<i>h</i>ERG inhibition), P-gp modulation, and protection against iron(III)-induced oxidative stress in differentiated neuroblastoma cells. Collectively, these studies allowed the selection of i-<i>h</i>MAO-B with the best ADME-toxicity profile suitable for progression to animal studies.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74105" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74105" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">Benzopyran-inspired libraries were obtained following the synthetic strategies depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. In accordance with our rational design strategy (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), compounds lacking the carbonyl group and/or the double bond at the benzopyran ring were synthesized. To assess the relevance of the benzopyran oxygen on the compounds’ bioactivity, isosteric replacements by nitrogen and sulfur were also performed. The new derivatives were designed with the same types of substitution patterns of <b>Crom-1</b> and <b>Crom-2</b> at the phenyl carboxamide ring (3,4-dimethyl and 3-chloro groups, respectively).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Additionally, 3,4-dimethoxy and 3,4-dichloro substituents were incorporated at the phenyl exocyclic ring to gather additional SAR data.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/medium/jm1c00510_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Strategy Pursued for Synthesis of (A) Chromane-3-phenylcarboxamides (<b>2</b>–<b>5</b>), (B) Chromene-3-phenylcarboxamides (<b>7</b>–<b>10</b>), (C) Coumarin-3-phenylcarboxamides (<b>14</b>–<b>17</b>), (D) 2-Oxoquinoline-3-phenylcarboxamides (<b>20</b>–<b>22</b>) and <i>N</i>-Methyl-2-oxoquinoline-3-phenylcarboxamides (<b>23</b>–<b>25</b>), and (E) Thiochromone-3-phenylcarboxamides (<b>30</b> and <b>31</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00510&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (A,B) (a) POCl<sub>3</sub>, DMF, appropriate arylamine, rt, 24 h; (C) (a) diethyl malonate, EtOH, pyrimidine, reflux, overnight; (b) NaOH (ethanolic solution), reflux, 1 h; (c) POCl<sub>3</sub>, DMF, appropriate arylamine, rt, 24 h; (D) (a) CH<sub>3</sub>I, K<sub>2</sub>CO<sub>3</sub>, 60 °C, argon, 1 h; (b) DIPEA, TBTU, appropriate arylamine, rt, 24 h; (E) (a) <i>N</i>,<i>N</i>-dimethylformamide dimethyl acetal, 115 °C, 1 h; (b) H<sub>2</sub>S, −30 °C, 4 h, argon; (c) HCl, AcOH, reflux, 4 h; (d) POCl<sub>3</sub>, appropriate arylamine, rt, 24 h.</p></p></figure><div class="NLM_p">Chromane and chromene derivatives (<b>2</b>–<b>5</b> and <b>7</b>–<b>10</b>, respectively) were synthetized by a one-pot reaction using chromane-3-carboxylic (<b>1</b>) or chromene-3-carboxylic acids (<b>6</b>) as starting materials. The amides were synthesized by an acyl nucleophilic substitution reaction between the appropriate arylamine and the corresponding acyl chloride intermediate, which is generated <i>in situ</i> by the addition of phosphoryl chloride (POCl<sub>3</sub>) (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B,A).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">Coumarin derivatives (<b>14</b>–<b>17</b>) were obtained using a three-step synthetic strategy (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>C). The reaction of salicylaldehyde (<b>11</b>) with diethyl malonate afforded coumarin-3-ethyl carboxylate (<b>12</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>C, step a), which, after alkaline hydrolysis, yielded coumarin-3-carboxylic acid (<b>13</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>C, step b).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Finally, the POCl<sub>3</sub>-mediated coupling reaction of <b>13</b> with the appropriate arylamine led to the synthesis of coumarin carboxamides (<b>14</b>–<b>17</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>C, step c).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">The synthetic route used to obtain 2-oxoquinoline derivatives (<b>20</b>–<b>22</b>) and their <i>N</i>-methyl counterparts (<b>23</b>–<b>25</b>) is outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>D. First, <i>N</i>-methyl-2-oxoquinoline-3-carboxylic acid (<b>19</b>) was obtained <i>via N</i>-methylation of <b>18</b> with methyl iodide under alkaline conditions (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>D, step a).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Then, carboxylic acids (<b>18</b> or <b>19</b>) reacted with the appropriate arylamine, using 2-(1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethylaminium tetrafluoroborate (TBTU) as a coupling agent (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>D, step b).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> In this case, the use of POCl<sub>3</sub> was not suitable for the synthesis of these amides due to the formation of several byproducts.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a></div><div class="NLM_p last">Thiochromone derivatives (<b>30</b> and <b>31</b>) were obtained using the synthetic strategy shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>E. The synthesis started with the reaction of ethyl 3-(2-fluorophenyl)-3-oxopropanoate (<b>26</b>) with <i>N</i>,<i>N</i>-dimethylformamide dimethyl acetal affording the intermediate <b>27</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>E, step a), which in turn was reacted with hydrogen sulfide (H<sub>2</sub>S) to yield a thiochromone ester (<b>28</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>E, step b).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Then, 4-oxothiochromone-3-carboxylic acid (<b>29</b>) was synthesized from the hydrolysis of <b>28</b> with HCl and acetic acid<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>E, step c). A coupling reaction of <b>29</b> with the appropriate arylamine, in the presence of POCl<sub>3</sub>, provided thiochromone carboxamides (<b>30</b> and <b>31</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>E, step d).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Monoamine Oxidase Inhibition Studies</h3><div class="NLM_p">The evaluation of i-<i>h</i>MAOs (<b>2</b>–<b>5</b>, <b>7</b>–<b>10</b>, <b>14</b>–<b>17</b>, <b>20</b>–<b>25</b>, and <b>30</b> and <b>31</b>) was performed using a spectrophotometric assay using kynuramine as a substrate and recombinant <i>h</i>MAO-A and <i>h</i>MAO-B isoforms.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> Since IC<sub>50</sub> values of <b>Crom-1</b> and <b>Crom-2</b> reported by Reis <i>et al</i>. were determined using the Amplex Red assay,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> their activity was reassessed under our experimental conditions. The <i>h</i>MAO inhibition potencies (IC<sub>50</sub> values) and the selectivity index (SI) of the compounds under study and reference inhibitors (rasagiline and safinamide for <i>h</i>MAO-B and clorgyline for <i>h</i>MAO-A) are presented in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. The results obtained indicate that the novel compounds that exhibited <i>h</i>MAO inhibitory activity were more selective toward the isoform B. The <i>h</i>MAO-B inhibitory activities of compounds bearing 3-chloro (<b>3</b>, <b>8</b>, <b>15</b>, and <b>31</b>) and 3,4-dichloro (<b>5</b> and <b>10</b>) groups at the exocyclic aromatic ring were, in general, higher than their 3,4-dimethyl counterparts (<b>2</b>, <b>7</b>, <b>14</b>, and <b>30</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). In contrast, the presence of 3,4-dimethoxy substituents decreased (<b>9</b>) or even abolished (<b>4</b>) <i>h</i>MAO-B inhibition at the highest concentration tested (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. <i>h</i>MAO Inhibitory Activities of Chromane (<b>2</b>–<b>5</b>), Chromene (<b>7</b>–<b>10</b>), Coumarin (<b>14</b>–<b>17</b>), 2-Oxoquinoline (<b>20</b>–<b>22</b>), <i>N</i>-Methyl-2-oxoquinoline (<b>23</b>–<b>25</b>), Thiochromone (<b>30</b> and <b>31</b>), and Chromone (<b>Crom-1</b> and <b>Crom-2</b>) Derivatives and Reference Inhibitors<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/medium/jm1c00510_0011.gif" alt="" id="gr10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">SI: <i>h</i>MAO-B selectivity index [IC<sub>50</sub> (<i>h</i>MAO-A)/IC<sub>50</sub> (<i>h</i>MAO-B)].</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Percentage of inhibition at 10 μM (highest concentration tested).</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Values obtained under the assumption that the corresponding IC<sub>50</sub> against <i>h</i>MAO-A is the highest concentration tested (10 μM).</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Asterisks (*) indicate not soluble in phosphate buffer at concentrations higher than 10 μM.</p></div></div><div></div></div><div class="NLM_p">With the exception of <b>4</b>, chromane derivatives (<b>2</b>, <b>3</b>, and <b>5</b>) acted as moderate i-<i>h</i>MAO-B (<b>2</b>, <i>h</i>MAO-B IC<sub>50</sub> = 1779 ± 130 nM; <b>3</b>, <i>h</i>MAO-B IC<sub>50</sub> = 957 ± 40 nM; <b>5</b>, <i>h</i>MAO-B IC<sub>50</sub> = 78.8 ± 6.3 nM). Since they are considerably less potent than <b>Crom-1</b> (<i>h</i>MAO-B IC<sub>50</sub> = 2.82 ± 0.34 nM) and <b>Crom-2</b> (<i>h</i>MAO-B IC<sub>50</sub> = 2.50 ± 0.30 nM), we concluded that the absence of the carbonyl group and the double carbon bond led to a remarkable decrease in MAO-B inhibitory activity. In marked contrast, the chromene derivatives (<b>7</b>–<b>10</b>) were more active toward <i>h</i>MAO-B than the chromane counterparts (<b>7</b>, <i>h</i>MAO-B IC<sub>50</sub> = 45.7 ± 3.0 nM; <b>8</b>, <i>h</i>MAO-B IC<sub>50</sub> = 26.4 ± 2.8 nM; <b>9</b>, <i>h</i>MAO-B IC<sub>50</sub> = 2869 ± 350 nM; <b>10</b>, <i>h</i>MAO-B IC<sub>50</sub> = 3.16 ± 0.2 nM), demonstrating that benzopyran rigidity is an essential chemical feature for <i>h</i>MAO-B inhibition. The compound lacking the carbonyl group but with two chloro substituents in the exocyclic aromatic ring (<b>10</b>) was the most potent i-<i>h</i>MAO-B of the series.</div><div class="NLM_p">Subsequently, the effect of the position of the carbonyl group on the pyrone ring (<b>14</b>–<b>17</b>) on MAOs inhibitory activity was investigated. Coumarins <b>14</b> (<i>h</i>MAO-B IC<sub>50</sub> = 18.8 ± 1.3 nM) and <b>15</b> (<i>h</i>MAO-B IC<sub>50</sub> = 10.2 ± 1.1 nM) were potent and selective i-<i>h</i>MAO-B. Although they were less active than the chromone counterparts (<b>Crom-1</b> and <b>Crom-2</b>, respectively), they exhibited similar, or even lower, IC<sub>50</sub> values than the reference i-<i>h</i>MAO-Bs safinamide and rasagiline. When compared with chromene derivatives (<b>7</b> and <b>8</b>), we can conclude that the presence of a carbonyl group at positions C2 (coumarin) or C4 (chromone) improved potency and selectivity. Since the presence of 3,4-dimethoxy substituents was not required for <i>h</i>MAO-B inhibition and was associated with poor solubility, this substitution pattern was not considered when designing additional compounds for further studies.</div><div class="NLM_p">In order to investigate the influence of different heteroatoms on <i>h</i>MAO inhibition, 2-oxoquinoline derivatives (<b>20</b>–<b>25</b>) and thiochromones (<b>30</b> and <b>31</b>) were synthesized and screened. The 2-oxoquinolines (<b>20</b>–<b>22</b>) and the <i>N-</i>methyl analogues (<b>23</b>–<b>25</b>) were inactive toward <i>h</i>MAOs. The thiochromones (<b>30</b> and <b>31</b>) displayed <i>h</i>MAO-B IC<sub>50</sub> values within the same concentration range as <b>Crom-1</b> and <b>Crom-2</b> (<b>30</b>, <i>h</i>MAO-B IC<sub>50</sub> = 3.35 ± 0.64 nM; <b>31</b>, <i>h</i>MAO-B IC<sub>50</sub> = 1.52 ± 0.15 nM). Overall, the data show that the bioisosteric replacement of O by NH or N–CH<sub>3</sub> atoms at the benzopyrone core results in complete loss of activity and that the amidic tautomerism, which can occur in the 2-oxoquinoline-based compounds, does not influence the <i>h</i>MAOs inhibition properties. A recent work on 4-hydroxyquinoline and <i>h</i>MAOs reveals important findings that also supported the data.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In marked contrast, O to S isosteric replacement was well-tolerated leading to potent and selective i-<i>h</i>MAO-B. Of note, the thiochromone amide (<b>31</b>) was the most potent i-<i>h</i>MAO-B, showing an IC<sub>50</sub> value lower than safinamide and the parent chromones (<b>Crom-1</b> and <b>Crom-2</b>). Taking these data together, the results obtained enabled the establishment of robust SAR that is summarized in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/medium/jm1c00510_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Synopsis of the SAR data obtained in the present work.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00510&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Evaluation of the Enzyme–Ligand Inhibition Mechanism</h3><div class="NLM_p">To further evaluate the type of binding between <i>h</i>MAO-B and the most potent i-<i>h</i>MAO-B (<b>31</b>), time-dependent inhibition studies were performed. The reference irreversible (rasagiline) and reversible (safinamide) i-<i>h</i>MAO-Bs were also included in these experiments (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The data obtained with rasagiline showed a decay in the residual enzyme activity after 30 min incubation, which is consistent with irreversible <i>h</i>MAO-B inhibition. In contrast, the results obtained with safinamide showed an increase in <i>h</i>MAO-B activity over time indicating reversible inhibition. Compound <b>31</b> exhibited an inhibition profile similar to safinamide, suggesting that it acts as a reversible i-<i>h</i>MAO-B. The reversible inhibition mechanism could minimize the adverse effects and safety issues often associated to irreversible i-<i>h</i>MAO-B.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/medium/jm1c00510_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Time-dependent enzyme inhibition studies for rasagiline, safinamide, and compound <b>31</b>. Enzymatic activity is expressed in the amount of 4-hydroxyquinoline (4-HQ, nmol). Data are the mean ± SD of three different experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00510&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Moreover, to clarify the inhibition mechanism of the most potent i-<i>h</i>MAO-B (<b>31</b>), kinetic experiments were performed. The assay was carried out by measuring the initial rates of the <i>h</i>MAO-B activity at six different concentrations of kynuramine (substrate) in the absence or presence of three different concentrations of compound <b>31</b>. The kinetic parameters of the Michaelis–Menten reaction were analyzed using a double reciprocal Lineweaver–Burk plot, which provides a better visual assessment of enzyme inhibition data. As reported in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A, the data were fitted to lines intersecting in the upper-left quadrant of the Lineweaver–Burk plot indicating a mixed-type inhibition mechanism.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/medium/jm1c00510_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Double reciprocal plot of the initial velocity of <i>h</i>MAO-B at increasing substrate concentrations (10–100 μM) in the absence or the presence of compound <b>31</b>. (B) Effect of total enzyme concentration on <i>h</i>MAO-B inhibition by compound <b>31</b> (Ackermann–Potter plot).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00510&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Since this type of behavior can be indicative of “tight binding inhibition”,<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> the kinetics was additionally investigated by using seven different <i>h</i>MAO-B concentrations in the absence or presence of three different concentrations of compound <b>31</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_003.pdf" class="ext-link">SI</a>). The Ackermann–Potter plot (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B) clearly resulted in asymptotic concave curves showing that compound <b>31</b> is a tight binding inhibitor.</div><div class="NLM_p last">These results were in line with our previous findings and strengthen the concept that mixed-type inhibition behavior may occur when compounds bind to the enzyme active site in a “tight binding inhibition” manner.<a onclick="showRef(event, 'ref10 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref13">(10,13)</a></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Molecular Ligand–Enzyme Studies</h3><div class="NLM_p">Following the <i>in vitro</i> studies, molecular modeling studies were carried out for the best benzopyran-based i-<i>h</i>MAO-B to better explore the <i>in silico</i> ligand–target interactions. Moreover, the binding mode of the selected compounds on <i>h</i>MAO-A was studied to define their strong <i>h</i>MAO-B selectivity. In the case of the chromane derivatives (<b>2</b>, <b>3</b>, and <b>5</b>), both enantiomers <i>R</i> and <i>S</i> were explored. The best thermodynamic complex, provided by the application of the XP Glide protocol and by further thermodynamic characterization through the MM-GBSA (Δ<i>G</i><sub>bind</sub>), was analyzed. Coulomb (coul) and van der Waals (vdW) components were also examined to evaluate the nonbonded interaction energy contribution (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_003.pdf" class="ext-link">Table S1, SI</a>).</div><div class="NLM_p">In general, the data analysis showed good target–ligand interactions. However, the theoretical binding energies, considered as Δ<i>G</i><sub>bind</sub>, did not perfectly match with the IC<sub>50</sub> values obtained since in these calculations, translational, rotational, and vibrational entropy changes were ignored. However, it is interesting to observe that for each series, the most active compound also showed the best Δ<i>G</i><sub>bind</sub>. Overall, the <i>in silico</i> prediction studies are in line with the selectivity of the compounds toward the <i>h</i>MAO-B isoform than <i>h</i>MAO-A (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_003.pdf" class="ext-link">Table S1, SI</a>). In particular, the vdW component strongly favored <i>h</i>MAO-B binding when compared to <i>h</i>MAO-A (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_003.pdf" class="ext-link">Table S1, SI</a>). Chromane (<b>2</b>, <b>3</b>, and <b>5</b>), chromene (<b>7</b>–<b>10</b>), coumarin (<b>14</b> and <b>15</b>), and thiochromone (<b>30</b> and <b>31</b>) derivatives shared a similar docking profile into the <i>h</i>MAO-B binding pocket, with their heterocycle facing FAD. The binding mode of the most potent compounds for each series (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) is characterized by the establishment of an H-bond with the side chain of Tyr435 and several hydrophobic interactions with Tyr398, Tyr60, Gln206, Leu171, Ile199, Leu164, Leu167, and Phe168, as observed in the crystal structure of <b>Crom-2</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_003.pdf" class="ext-link">Figure S1B</a>). For the chromane enantiomers <i>R</i>/<i>S</i>, an overlapping binding mode toward <i>h</i>MAO-B was observed (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A,B and <a href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_003.pdf" class="ext-link">Figure S2, SI</a>), except for the enantiomer <i>S</i> of <b>2</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_003.pdf" class="ext-link">Figure S2C, SI</a>), which showed the flipped chromane ring by preventing the H-bond with Tyr435. Interestingly, both enantiomers of the most active chromane derivative (<b>5</b>) engage an additional halogen bond with Pro102 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A,B).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/medium/jm1c00510_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Best docking pose of the most active compounds for each series (A) <b>5<i>R</i></b>, (B) <b>5<i>S</i></b>, (C) <b>10</b>, (D) <b>15</b>, and (E) <b>31</b> against <i>h</i>MAO-B. Ligands are shown in green carbon ball-and-sticks, while the protein is represented as a gray surface and FAD in CPK. H-bonds, halogen, and π–π interactions are displayed as dashed purple, violet, and cyan lines, respectively. Amino acid residues involved in the molecular interactions are shown as gray carbon sticks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00510&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In accordance with the biological results, chromene derivatives showed several favorable interactions due to the double bond present at C3-C4, endowing them with higher planarity and leading to a better orientation in the <i>h</i>MAO-B binding site (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C and <a href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_003.pdf" class="ext-link">Figure S3, SI</a>). Moreover, <b>7</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_003.pdf" class="ext-link">Figure S3A, SI</a>) and <b>9</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_003.pdf" class="ext-link">Figure S3C, SI</a>), the two low-potency molecules of the series, lose the H-bond with Tyr435 due to the inverted position of the chromene ring. Interestingly, the binding mode of <b>10</b>, the most active compound of this series, is favored by the presence of the chlorine in <i>meta</i>, which establishes a halogen bond with Pro102 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C) as observed for <b>5</b>.</div><div class="NLM_p">Regarding the coumarin series, the best docking poses of <b>15</b> established a further π–π interaction with Phe343, by means of the aromatic portion of the coumarin ring (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D). Moreover, it was observed that the two methyl groups of derivative <b>14</b> interact with the hydrophobic pocket created by several residues, such as Phe168, Leu167, Ile316, Trp119, Leu164, Pro104, Phe103, Pro102, Ile199, and Ile198 (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_003.pdf" class="ext-link">Figure S4A, SI</a>), while <b>15</b> places the <i>meta</i>-chlorine similarly to <b>Crom-2</b> in its crystal structure (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D and <a href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_003.pdf" class="ext-link">Figure S1B</a>).</div><div class="NLM_p">Finally, the thiochromone derivatives, <b>30</b> and <b>31</b>, perfectly fit the hydrophobic flat active site of the <i>h</i>MAO-B. Both complexes exhibited an H-bond between the carbonyl group of the thiochromone ring and the side chain of Tyr435, and the most active compound <b>31</b> engages a further π–π interaction with Tyr326 and places the <i>meta</i>-chlorine similarly to <b>Crom-2</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>E and <a href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_003.pdf" class="ext-link">Figure S1B, SI</a>). As previously reported, docking results on <i>h</i>MAO-A are reported in the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_003.pdf" class="ext-link">Supporting Information (Figures S5–S8, SI)</a>.</div><div class="NLM_p">Furthermore, the pan-assay interference compound (PAINS) <i>in silico</i> assay was run for the compounds studied, using two different methods, namely, ZINC PAINS Pattern Identifier and False Positive Remover tools. The analysis of the results obtained indicated that the chromone (<b>2</b>, <b>3</b>, and <b>5</b>) chromene (<b>7</b>–<b>10</b>), coumarin (<b>14</b> and <b>15</b>), and thiochromone (<b>30</b> and <b>31</b>) derivatives were not potential PAINS.</div><div class="NLM_p last">Furthermore, we estimated the drug-like properties of <b>Crom-1</b>, <b>Crom-2</b>, and the most potent derivatives (<b>10</b>, <b>15</b>, <b>30</b>, and <b>31</b>) to predict their capability to reach the central nervous system (CNS). The drug-like properties were studied by estimating some important physicochemical parameters including the molecular weight (MW), topological polar surface area (tPSA in Å<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a>), number of hydrogen bond acceptors (HBA), number of hydrogen bond donors (HBD), and number of rotatable bonds (RB). Overall, the values obtained were in line with the general drug-likeness requirements of the CNS-active drugs (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_003.pdf" class="ext-link">Table S2, SI</a>). An important physicochemical parameter used to estimate the ability of a compound to cross the blood–brain barrier (BBB) by passive diffusion is the logarithm of the ratio of the compound concentration in the brain and in blood (log BB). It was reported that compounds with log BB < −1 are unlikely to act as CNS drugs due to their low distribution into the brain.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The compounds under study showed log BB values suggesting > −1, indicating that these derivatives may cross the BBB and reach the CNS (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_003.pdf" class="ext-link">Table S2, SI</a>). It is important to note that based on the predicted tPSA and log BB values, the thiochromone <b>31</b> is more likely to cross the BBB than <b>Crom-2</b>.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Preliminary <i>In Vitro</i> Preclinical ADME-Toxicity Studies</h3><div class="NLM_p last">Following the discovery of novel, potent, and selective benzopyran-based i-<i>h</i>MAO-B, preliminary <i>in vitro</i> preclinical ADME-toxicity studies were performed. These included the evaluation of the compounds’ cytotoxicity against SH-SY5Y, Caco-2, HUVEC, HEK-293, and MCF-7 cells, cardiotoxicity (<i>h</i>ERG inhibition), P-gp modulation, and protection against iron(III)-induced oxidative stress.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Cytotoxicity Studies in SH-SY5Y and Caco-2 Cells</h3><div class="NLM_p">The cytotoxicity profile of the most promising i-<i>h</i>MAO-B (<i>h</i>MAO-B IC<sub>50</sub> < 80 nM) was assessed in differentiated neuroblastoma (SH-SY5Y) and in colon adenocarcinoma (Caco-2) cells, two cell lines extensively used to assess the safety of drug candidates.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> Prior to conducting the cytotoxicity experiments with the test compounds, SH-SY5Y cells were treated with differentiation-inducing agents to obtain cells morphologically similar to dopaminergic neurons.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Since the clinical symptoms of PD result mainly from the loss of dopaminergic neurons, differentiated SH-SY5Y cells are a suitable cellular model to evaluate the neurotoxicity profile of drug candidates for PD.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p">Differentiated SH-SY5Y cells and Caco-2 cells were treated with two different concentrations (1 and 10 μM) of compounds <b>5</b>, <b>7</b>, <b>8</b>, <b>10</b>, <b>14</b>, <b>15</b>, <b>30</b>, and <b>31</b> for 24 h. <b>Crom-1</b> and <b>Crom-2</b> were also included in these experiments for the establishment of structure–toxicity relationships (STR). Cellular cytotoxicity was determined using the methylthiazolyldiphenyltetrazolium bromide (MTT) reduction assay and the neutral red (NR) uptake assay. The MTT assay is based on the reduction of MTT into the respective formazan by metabolically active cells,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> while the NR uptake assay is based on the lysosomal accumulation of the NR dye in living cells.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The results obtained showed that treatment of differentiated SH-SY5Y cells with <b>Crom-1</b>, <b>Crom-2</b>, and compound <b>14</b> at 10 μM led to a marked decrease in MTT reduction (% MTT reduction was <85%) (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). Compound <b>15</b> also significantly decreased MTT reduction in neuroblastoma cells at 1 (79.5%) and 10 μM (71.8%) (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). In contrast, incubation of differentiated SH-SY5Y cells for 24 h with compounds at both concentrations did not significantly affect NR uptake (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). In Caco-2 cells, only compounds <b>8</b> (88.3%) and <b>15</b> (93.5%), at 10 μM, slightly decreased the cellular metabolic activity (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C) without any effect on lysosomal activity. The treatment with the other compounds did not affect MTT reduction (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C) and NR uptake (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D) when compared with control cells.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/medium/jm1c00510_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cellular viability of differentiated SH-SY5Y (A,B) and Caco-2 cells (C,D) following treatment with <b>Crom-1</b>, <b>Crom-2</b>, and compounds <b>5</b>, <b>7</b>, <b>8</b>, <b>10</b>, <b>14</b>, <b>15</b>, <b>30</b>, and <b>31</b> at 1 (black) and 10 μM (orange) for 24 h. Cytotoxicity was evaluated by measuring metabolic (A,C) and lysosomal activities (B,D) using MTT reduction and NR uptake assays, respectively. Results are expressed as mean ± SEM from at least three independent experiments, performed in triplicate. Statistical comparisons were performed by one-way ANOVA (A,B) and by Kruskal–Wallis test (C,D). In all cases, <i>p</i> values lower than 0.05 were considered significant (*<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001, and ****<i>p</i> < 0.0001 vs untreated cells).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00510&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Overall, the data obtained indicate that chromones <b>Crom-1</b> and <b>Crom-2</b> and coumarins <b>14</b> and <b>15</b> negatively affected cellular metabolic activity of differentiated SH-SY5Y cells. In contrast, chromane derivative <b>5</b>, chromene derivatives <b>7</b>, <b>8</b>, and <b>10</b>, and thiochromones <b>30</b> and <b>31</b> did not induce significant cytotoxic effects in both differentiated SH-SY5Y cells and Caco-2 cells, exhibiting a broader safety window than <b>Crom-1</b> and <b>Crom-2</b>. Based on these preliminary results, we can conclude that despite the slight improvement of <i>h</i>MAO-B inhibition properties, the presence of a carbonyl group in the benzopyran scaffold at positions C4 (chromones) or C2 (coumarins) of the heterocyclic ring was associated with increased cytotoxicity. However, thiochromones <b>30</b> and <b>31</b> with a carbonyl group at position C4 did not show significant cytotoxicity effects in both cellular models.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Cytotoxicity Studies in HUVEC, HEK-293, and MCF-7 Cells and Cardiotoxicity (<i>h</i>ERG Inhibition)</h3><div class="NLM_p">The two most active compounds (<b>10</b>, <i>h</i>MAO-B IC<sub>50</sub> = 3.16 ± 0.2 nM and <b>31</b>, <i>h</i>MAO-B IC<sub>50</sub> = 1.52 ± 0.15 nM) and the parent chromones (<b>Crom-1</b> and <b>Crom-2</b>) were then selected for the evaluation of their cytotoxicity in a panel of cell lines (HUVEC, HEK-293, and MCF-7). Cells were treated with the test compounds at 10 μM for 24 h exposure, and the cellular cytotoxicity was evaluated using previously described methods.<a onclick="showRef(event, 'ref26 ref32'); return false;" href="javascript:void(0);" class="ref ref26 ref32">(26,32)</a> Briefly, cellular cytotoxicity was determined in triplicate using a highly sensitive luminescence-based commercial kit that measures intracellular ATP levels (Promega). In general, negligible cytotoxic effects were observed in all cell lines (<10% inhibition at 10 μM) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The only exception was compound <b>10</b>, which was associated with moderate toxicity in HUVEC cells (cellular cytotoxicity at 10 μM, 64.4 ± 10%; cytotoxicity IC<sub>50</sub>, 8.4 ± 2.5 μM).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Preliminary Preclinical <i>In Vitro</i> ADME-Toxicity Studies: Cytotoxicity in a Panel of Cell Lines (HUVEC, HEK-293, and MCF-7) for 24 h and Cardiotoxicity (<i>h</i>ERG Inhibition) for <b>Crom-1</b>, <b>Crom-2</b>, <b>10</b>, and <b>31</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">% cytotoxicity at 10 μM</th><th class="rowsep1 colsep0" colspan="3" align="center">cytotoxicity IC<sub>50</sub> (μM)</th><th class="rowsep1 colsep0" align="center">% inhibition at 10 μM</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">HUVEC</th><th class="colsep0 rowsep0" align="center">HEK-293</th><th class="colsep0 rowsep0" align="center">MCF-7</th><th class="colsep0 rowsep0" align="center">HUVEC</th><th class="colsep0 rowsep0" align="center">HEK-293</th><th class="colsep0 rowsep0" align="center">MCF-7</th><th class="colsep0 rowsep0" align="center"><i>h</i>ERG</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">64.4 ± 10</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">8.4 ± 2.5</td><td class="colsep0 rowsep0" align="left">inactive</td><td class="colsep0 rowsep0" align="left">inactive</td><td class="colsep0 rowsep0" align="left"><10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">inactive</td><td class="colsep0 rowsep0" align="left">inactive</td><td class="colsep0 rowsep0" align="left">inactive</td><td class="colsep0 rowsep0" align="left"><10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Crom</b><b>-1</b></td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">inactive</td><td class="colsep0 rowsep0" align="left">inactive</td><td class="colsep0 rowsep0" align="left">inactive</td><td class="colsep0 rowsep0" align="left"><10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Crom-2</b></td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">inactive</td><td class="colsep0 rowsep0" align="left">inactive</td><td class="colsep0 rowsep0" align="left">inactive</td><td class="colsep0 rowsep0" align="left"><10</td></tr></tbody></table></div></div><div class="NLM_p last">Compounds were also tested for potential cardiotoxicity using the predictor <i>h</i>ERG fluorescence polarization (FP) binding assay (Thermo). The assay relies on the use of a homogenized membrane solution containing <i>h</i>ERG, which, in the presence of a fluorescent tracer, yields a high FP signal. If compounds displace the fluorescent tracer, then a reduction in the FP signal indicating <i>h</i>ERG inhibition is observed. In the case of <b>Crom-1</b>, <b>Crom-2</b>, <b>10</b>, and <b>31</b>, negligible <i>h</i>ERG inhibition at 10 μM was observed (<10% inhibition) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Evaluation of P-glycoprotein (P-gp) Transport Activity</h3><div class="NLM_p">One of the main challenges for an effective drug transport to the brain is the blood–brain barrier (BBB), the main interface between the brain and the circulatory system.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The BBB restricts the permeability of CNS drugs,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> a problem that is partially linked to the presence of efflux pumps such as the P-gp at the luminal membrane of brain capillary endothelial cells.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The P-gp uses adenosine triphosphate (ATP) to actively extrude a wide variety of lipophilic drugs against their concentration gradient,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> contributing to the high attrition observed for CNS drugs and drug candidates.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Caco-2 cells have been accepted as a useful <i>in vitro</i> model to evaluate BBB drug permeability and P-gp-mediated transport.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Therefore, in this study, we evaluated the P-gp modulatory activity of compounds <b>10</b> and <b>31</b> and the reference chromones <b>Crom-1</b> and <b>Crom-2</b>. The assay was performed in Caco-2 cells using Rhodamine 123 (RHO 123), a P-gp substrate, and zosuquidar, a specific third-generation P-gp inhibitor.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Overall, the pretreatment of Caco-2 cells with the selected i-<i>h</i>MAO-B at 10 μM did not significantly affect P-gp transport activity (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/medium/jm1c00510_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Evaluation of P-gp activity by fluorescence spectroscopy in Caco-2 cells exposed to <b>Crom-1</b>, <b>Crom-2</b>, and compounds <b>10</b> and <b>31</b> (10 μM) during the incubation period with the fluorescent substrate (RHO 123, 5 μM). Results are presented as mean ± SEM from at least three independent experiments, performed in triplicate. Statistical comparisons were performed by one-way ANOVA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00510&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Protection against Iron(III)-Induced Damage in Neuroblastoma Cells</h3><div class="NLM_p">The association between iron and PD is long-standing since daily exposure to elevated iron levels is a risk factor for the development of this neurodegenerative disease.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> In fact, the development of new multitarget compounds that can chelate iron and prevent ferroptosis is one of the strategies currently used to develop new drug candidates for PD. With this in mind, we evaluated whether <b>Crom-1</b>, <b>Crom-2</b>, and compounds <b>10</b> and <b>31</b> can protect differentiated SH-SY5Y cells against iron(III)-induced damage. After a pretreatment with the test compounds at 1 and 10 μM for 30 min, cells were treated with iron(III) at 1000 and 1500 μM for 24 h. Cellular cytotoxicity was measured using the NR uptake assay. The results obtained are shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/medium/jm1c00510_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Evaluation of the protective effect of i-<i>h</i>MAO-B in differentiated SH-SY5Y cells against iron(III) (1000 and 1500 μM). The dashed line is the control data obtained from nontreated cells, while solid and squared bars are related with the data from cells exposed to iron(III) at 1000 and 1500 μM, respectively. The data are expressed as the means of three independent experiments together with the standard deviation (mean ± SD). Statistical comparisons were made using two-way ANOVA. In all cases, <i>p</i> values lower than 0.05 were considered significant (<sup>####</sup><i>p</i> < 0.0001 vs the control data; **<i>p</i> < 0.01 vs iron(III) values).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00510&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compared with nontreated cells, the 24 h treatments with only iron(III) at 1000 and 1500 μM reduced 55.7 ± 5.8% and 44.9 ± 4.4% of cellular lysosomal activity, respectively. As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>, when cells were coincubated with iron(III) at 1000 μM, no significant protection was observed for the compounds <b>Crom-1</b>, <b>Crom-2</b>, and <b>10</b>. Remarkably, a moderate but significant increase in lysosomal activity was observed in cells pretreated with compound <b>31</b> at 10 μM (63.0 ± 7.0%, <i>p</i> < 0.01). No significant protection was observed when cells were coincubated with i-<i>h</i>MAO-B and iron(III) at 1500 μM. Together with the data obtained from <i>h</i>MAOs inhibition studies, these results indicate that compound <b>31</b> can act as a multitarget agent able to prevent dopamine depletion and iron(III)-induced damage.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56220" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56220" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A new library of benzopyran-based compounds was synthesized, and relevant SAR and STR data were obtained. In general, the derivatives bearing chloro substituents at the exocyclic ring presented lower <i>h</i>MAO-B IC<sub>50</sub> values than the 3,4-dimethyl counterparts, while compounds bearing 3,4-dimethoxy groups lacked or exhibited reduced inhibitory activity toward <i>h</i>MAO-B. These observations reinforce the data obtained so far in our previous works. Globally, our data showed for the first time the importance of the ring rigidity for <i>h</i>MAO-B inhibition and that the presence of a double bound and a carbonyl group at positions C2 or C4 of the heterocyclic ring improves <i>h</i>MAO-B inhibitory activity. We also demonstrated for the first time that while the O to N isosteric replacement abolished <i>h</i>MAO-B inhibitory activity, the O to S replacement in the chromone moiety preserved the <i>h</i>MAO-B inhibition profile of compounds. All the studies performed so far reinforce the superiority of the chemical features of the previously reported i-<i>h</i>MAO-Bs <i>N</i>-(3′,4′-dimethyl phenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>Crom-1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) and <i>N</i>-(3′-chlorophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>Crom-2</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). However, for the first time, relevant data related with thiochromones emerged. They were identified as potent and selective i-<i>h</i>MAO-Bs, with IC<sub>50</sub> values within the low nM range. All the conclusions were supported by <i>in silico</i> studies that provided a rationale for the interactions of the active compounds toward <i>h</i>MAO-B and <i>h</i>MAO-A, which are consistent with the observations from the outputs of the <i>in vitro</i> biological assays.</div><div class="NLM_p">Cytotoxicity studies showed that chromenes are safer than the related carbonyl-containing benzopyran compounds (coumarins and chromones) and that thiochromones <b>30</b> and <b>31</b> with a carbonyl group at C4 did not display remarkable cytotoxicity effects. Of particular note is <i>N</i>-(3-chlorophenyl)-4<i>H</i>-thiochromone-3-carboxamide (<b>31</b>), which exhibited potent and selective <i>h</i>MAO-B inhibition with an IC<sub>50</sub> value within the low nanomolar range (<i>h</i>MAO-B IC<sub>50</sub> = 1.52 ± 0.15 nM). The selected i-<i>h</i>MAO-B did not significantly affect P-gp transport activity at 10 μM. The preliminary preclinical <i>in vitro</i> ADME-toxicity studies (cytotoxicity in HUVEC, HEK-293, and MCF-7 cell lines) and cardiotoxicity (<i>h</i>ERG inhibition) indicated that compound <b>31</b> has no obvious ADME-toxicity liability.</div><div class="NLM_p last">From the gathered data, <i>N</i>-(3-chlorophenyl)-4<i>H</i>-thiochromone-3-carboxamide <b>31</b> stands out as the best potent and selective “tight binding” i-<i>h</i>MAO-B, showing a safe cytotoxicity profile in SH-SY5Y, Caco-2, HUVEC, HEK-293, and MCF-7 cells. Furthermore, compound <b>31</b> did not significantly affect P-gp activity and protected differentiated neuroblastoma cells against iron(III)-induced cell death. As such, compound <b>31</b> is a valid candidate for <i>in vivo</i> pharmacological studies.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63660" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63660" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry</h3><div class="NLM_p last">Details on reagents, materials, and apparatuses are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_003.pdf" class="ext-link">SI</a>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Synthesis</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Synthesis of 2-Oxo-2<i>H</i>-chromene-2-carboxylic Acid (<b>13</b>)</h4><div class="NLM_p last">Salicylaldehyde (<b>11</b>) (16.37 mmol), diethyl malonate (16.37 mmol), and catalytic amounts of piperidine (0.5 mL) were refluxed in ethanol (163.7 mL) overnight. After cooling to rt, the suspension was filtered off, and ethyl-coumarin-3-caboxylate (<b>12</b>) was obtained without further purification. <b>12</b> was refluxed in a 150 mL ethanolic solution of 0.5% NaOH (<i>m</i>/<i>v</i>) for 1 h. Then, the reaction mixture was acidified with 12 M HCl. The solid formed was isolated by filtration under reduced pressure and washed with H<sub>2</sub>O to provide 2-oxo-2<i>H</i>-chromene-2-carboxylic acid (<b>13</b>). Yield = 61%. <sup>1</sup>H NMR (400 MHz, DMSO) δ (ppm): 7.36 (1H, d, <i>J</i> = 7.7 Hz, H5), 7.10 (1H, s, H4), 6.98 (1H, dd, <i>J</i> = 7.3, 6.9 Hz, H7), 6.71 (1H, d, <i>J</i> = 8.1 Hz, H8), 6.64 (1H, dd, <i>J</i> = 7.8, 6.8 Hz, H6).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Synthesis of 1-Methyl-2-oxo-1,2-dihydroquinoline-3-carboxylic Acid (<b>19</b>)</h4><div class="NLM_p last">To a solution of 2-oxo-1,2-dihydroquinoline-3-carboxylic acid (<b>18</b>) (4.56 mmol) in DMF (10 mL), K<sub>2</sub>CO<sub>3</sub> (6.84 mmol) was added, and the reaction mixture was stirred at rt in an argon atmosphere for 20 min. Then, CH<sub>3</sub>–I (9.12 mmol) was added dropwise, and the mixture was stirred at 60 °C for 1 h. Upon completion, water (15 mL) was added, and the mixture was extracted with DCM (3 × 15 mL). The organic layers were combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was recrystallized from DCM/ethyl ether. Yield = 70%. <sup>1</sup>H NMR (400 MHz, DMSO) δ (ppm): 14.67 (1H, s, COOH), 8.97 (1H, s, H4), 8.11 (1H, dd, <i>J</i> = 7.9, 1.5 Hz, H8), 7.89 (1H, ddd, <i>J</i> = 8.6, 7.1, 1.5 Hz, H7) 7.78 (1H, dd, <i>J</i> = 8.6, 1.5 Hz, H5), 7.49 (1H, ddd, <i>J</i> = 7.9, 7.1, 1.2 Hz, H6), 3.80 (3H, s, NCH<sub>3</sub>).</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Synthesis of Ethyl-3-(dimethylamino)-2-(2-fluorobenzoyl)acrylate (<b>27</b>)</h4><div class="NLM_p last"><i>N</i>,<i>N</i>-Dimethylformamide dimethyl acetal (5.94 mmol) was added to a solution of ethyl-(2-fluorobenzoyl)acetate (<b>26</b>) (2.73 mmol) in dry toluene (13 mL). The reaction mixture was stirred at 115 °C for 1 h. Then, the mixture was concentrated under reduced pressure. Purification by flash column chromatography (DCM/ethyl acetate 1:1) yielded compound <b>27</b>. Yield = 90%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 7.76 (1H, s, CH), 7.59 (1H, ddd, <i>J</i> = 7.5, 7.5, 1.8 Hz, H5), 7.38 (1H, dddd, <i>J</i> = 8.2, 7.1, 5.1, 1.9 Hz, H6), 7.16 (1H, ddd, <i>J</i> = 7.5, 7.5, 1.0 Hz, H4), 7.01 (1H, ddd, <i>J</i> = 10.4, 8.2, 1.1 Hz, H3), 3.96 (2H, q, <i>J</i> = 7.1 Hz, CH<sub>2</sub>), 3.39–2.80 (6H, m, CH<sub>3</sub>NCH<sub>3</sub>), 0.89 (3H, t, <i>J</i> = 7.1 Hz, CH<sub>3</sub>).</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Synthesis of Ethyl 4-Oxo-4<i>H</i>-thiochromene-3-carboxylate (<b>28</b>)</h4><div class="NLM_p last">Hydrogen sulfide (H<sub>2</sub>S) was bubbled into a solution of ethyl-3-(dimethylamino)-2-(2-fluorobenzoyl)acrylate (<b>27</b>) (3.20 mmol) in THF (60 mL) at −30 °C for 4 h. The mixture was concentrated, and the crude product was purified by chromatography to afford compound <b>28</b>. Yield = 80%. <sup>1</sup>H NMR (400 MHz, DMSO) δ (ppm): 7.70 (1H, s, H2), 7.50–7.38 (2H, m, H5, H7), 7.23–7.19 (1H, m, H8), 7.16 (ddd, <i>J</i> = 10.7, 8.3, 1.1 Hz, H6), 3.84 (2H, q, <i>J</i> = 7.1 Hz, CH<sub>2</sub>), 0.84 (3H, t, <i>J</i> = 7.1 Hz, CH<sub>3</sub>).</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Synthesis of 4-Oxo-4<i>H</i>-thiochromene-3-carboxylic Acid (<b>29</b>)</h4><div class="NLM_p last">A mixture of ethyl 4-oxo-4<i>H</i>-thiochromene-3-carboxylate (<b>28</b>) (2.13 mmol), acetic acid (54 mL), H<sub>2</sub>O (15 mL), and HCl (1.5 mL) was heated on a steam bath for 4 h. The reaction mixture was concentrated under reduced pressure, and the product obtained was recrystallized from DCM/petroleum ether to give the compound <b>29</b>. Yield = 40%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 15.12 (1H, s, COOH), 8.07 (1H, s, H2), 8.25 (1H, ddd, <i>J</i> = 8.5, 1.3, 0.6 Hz, H5), 7.90 (1H, ddd, <i>J</i> = 8.5, 6.9, 1.3 Hz, H7), 7.70 (1H, ddd, <i>J</i> = 8.5, 1.3, 0.6 Hz, H8), 7.62 (1H, ddd, <i>J</i> = 8.5, 6.9, 1.3 Hz, H6).</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Procedure A: Synthesis of Chromane (<b>2</b>–<b>5</b>), Chromene (<b>7</b>–<b>10</b>), Coumarin (<b>14</b>–<b>17</b>), and Thiochromone (<b>30</b> and <b>31</b>) Derivatives</h3><div class="NLM_p">A solution of the appropriate heterocyclic carboxylic acid (chromane-3-carboxylic acid (<b>1</b>), chromene-3-carboxylic acid (<b>6</b>), 2-oxo-2<i>H</i>-chromene-3-carboxylic acid (<b>13</b>), or thiochromone-3-carboxylic acid (<b>29</b>)) (2.8 mmol) and POCl<sub>3</sub> (4.2 mmol) in DMF (4.2 mL) was stirred at rt for 15 min. Then, the appropriate amine (5.61 mmol) was added, and the mixture was stirred at rt overnight. Following the addition of DCM (50 mL), the mixture was extracted with H<sub>2</sub>O (3 × 15 mL), 1 M HCl (3 × 15 mL) and saturated aqueous solution of NaHCO<sub>3</sub> (3 × 5 mL). The organic layers were combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by recrystallization.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>N</i>-(3,4-Dimethylphenyl)chromane-3-carboxamide (<b>2</b>)</h4><div class="NLM_p last">Compound <b>2</b> was recrystallized from DCM/ethyl ether. Yield = 56%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 7.53 (1H, s, CONH), 7.28 (1H, d, <i>J</i> = 2.3 Hz, H2′), 7.19 (1H, dd, <i>J</i> = 8.1, 2.4 Hz, H6′), 7.15–7.10 (1H, m, H6), 7.08 (1H, dd, <i>J</i> = 7.7, 1.3 Hz, H5), 7.05 (1H, d, <i>J</i> = 8.1 Hz, H5′), 6.90 (1H, dd, <i>J</i> = 7.4, 1.3 Hz, H8), 6.87–6.84 (1H, m, H7), 4.48–4.17 (2H, m, H2), 3.22 (1H, dd, <i>J</i> = 16.4, 9.4 Hz, H3), 3.04–2.85 (2H, m, H4), 2.22 (3H, s, 3′CH<sub>3</sub>), 2.21 (3H, s, 4′CH<sub>3</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ (ppm): 170.2, 153.8, 137.3, 135.1, 133.1, <u class="uu">130.0</u>, <u class="uu">129.9</u>, <u class="uu">127.7</u>, <u class="uu">121.5</u>, <u class="uu">121.0</u>, 120.4, <u class="uu">117.6</u>, <u class="uu">116.8</u>, <u class="uu">67.2</u>, <u class="uu">40.8</u>, <u class="uu">28.4</u>, <u class="uu">19.8</u>, <u class="uu">19.1</u>. EI/MS <i>m</i>/<i>z</i> (%): 55 (12), 77 (24), 79 (12) 105 (22), 106 (16), 120 (16), 121 (92), 131 (13), 133 (13), 237 (12), 281 (M<sup>·</sup><sup>+</sup>, 100), 282 (M<sup>·</sup><sup>+</sup> + 1, 19).</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>N</i>-(3-Chlorophenyl)chromane-3-carboxamide (<b>3</b>)</h4><div class="NLM_p last">Compound <b>3</b> was recrystallized from DCM/ethyl ether. Yield = 54%. <sup>1</sup>H NMR (400 MHz, DMSO) δ (ppm): 10.37 (1H, s, CONH), 7.84 (1H, dd, <i>J</i> = 2.1, 2.1 Hz, H2′), 7.48 (1H, ddd, <i>J</i> = 8.2, 2.1, 1.0 Hz, H6′), 7.35 (1H, dd, <i>J</i> = 8.0, 8.0 Hz, H5′), 7.17–7.06 (3, m, H5, H6, H4′), 6.86 (1H, ddd, <i>J</i> = 7.4, 7.4, 1.2 Hz, H7), 6.79 (1H, dd, <i>J</i> = 8.2, 1.2 Hz, H8), 4.49–3.96 (2H, m, H2), 3.11–2.91 (3H, m, H3, H4). <sup>13</sup>C NMR (100 MHz, DMSO) δ (ppm): 170.6, 153.6, 140.3, 133.0, <u class="uu">130.4</u>, <u class="uu">129.7</u>, <u class="uu">127.1</u>, <u class="uu">123.0</u>, 121.0, <u class="uu">120.3</u>, <u class="uu">118.6</u>, <u class="uu">117.5</u>, <u class="uu">116.1</u>, <u class="uu">66.8</u>, <u class="uu">39.2</u>, <u class="uu">27.3</u>. EI/MS <i>m</i>/<i>z</i> (%): 51 (19), 55 (39), 77 (44), 79 (22), 103 (23), 129 (26), 131 (59), 132 (60), 133 (74), 134 (18), 243 (16), 287 (M<sup>·</sup><sup>+</sup>, 100), 288 (M<sup>·</sup><sup>+</sup> + 1, 18), 289 (M<sup>·</sup><sup>+</sup> + 2, 33).</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-(3,4-Dimethoxyphenyl)chromane-3-carboxamide (<b>4</b>)</h4><div class="NLM_p last">Compound <b>4</b> was recrystallized from ethyl acetate/<i>n</i>-hexane. Yield = 45%. <sup>1</sup>H NMR (400 MHz, DMSO) δ (ppm): 10.04 (1H, s, CONH), 7.34 (1H, d, <i>J</i> = 2.4 Hz, H2′), 7.14 (1H, dd, J = 7.6, 1.6 Hz, H6′), 7.14–7.04 (2H, m, H5, H6), 6.89 (1H, d, <i>J</i> = 8.7 Hz, H5′), 6.86 (1H, ddd, <i>J</i> = 7.40, 7.39, 1.26 Hz, H7), 6.78 (1H, dd, <i>J</i> = 8.1, 1.2 Hz, H8), 4.50–3.93 (2H, m, H2), 3.73 (3H, s, 3′OCH<sub>3</sub>), 3.72 (3H, s, 4′OCH<sub>3</sub>), 3.07–2.90 (3H, m, H4, H3). <sup>13</sup>C NMR (100 MHz, DMSO) δ (ppm): 170.3, 154.2, 149.0, 145.4, 133.1, <u class="uu">130.3</u>, <u class="uu">127.6</u>, 121.7, <u class="uu">120.8</u>, <u class="uu">116.6</u>, <u class="uu">112.5</u>, <u class="uu">111.6</u>, <u class="uu">104.9</u>, <u class="uu">67.5</u>, <u class="uu">56.2</u>, <u class="uu">55.8</u>, <u class="uu">39.6</u>, <u class="uu">28.0</u>. EI/MS <i>m</i>/<i>z</i> (%): 77 (11), 105 (17), 133 (14), 138 (52), 151 (11), 153 (57), 313 (M<sup>·</sup><sup>+</sup>, 100), 314 (21).</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>-(3,4-Dichlorophenyl)chromane-3-carboxamide (<b>5</b>)</h4><div class="NLM_p last">Compound <b>5</b> was recrystallized from DCM/ethyl ether. Yield = 36%. <sup>1</sup>H NMR (400 MHz, DMSO) δ (ppm): 10.47 (1H, s, CONH), 8.01 (1H, d, <i>J</i> = 2.4 Hz, H2′), 7.58 (1H, d, <i>J</i> = 8.8 Hz, H5′), 7.51 (1H, dd, <i>J</i> = 8.8, 2.4 Hz, H6′), 7.14 (1H, dd, <i>J</i> = 7.6, 1.6 Hz, H5), 7.09 (1H, ddd, <i>J</i> = 8.1, 7.3, 1.7 Hz, H6), 6.86 (1H, ddd, <i>J</i> = 7.4, 7.4, 1.2 Hz, H7), 6.79 (1H, dd, <i>J</i> = 8.1, 1.3 Hz, H8), 4.48–3.98 (2H, m, H2), 3.06–2.93 (3H, m, H3, H4). <sup>13</sup>C NMR (100 MHz, DMSO) δ (ppm): 170.7, 153.6, 138.9, 130.9, <u class="uu">130.6</u>, <u class="uu">129.7</u>, <u class="uu">127.1</u>, 124.7, 121.0, <u class="uu">120.3 (2 ×</u><sup><u class="uu">13</u></sup><u class="uu">C)</u>, <u class="uu">119.2</u>, <u class="uu">116.1</u>, <u class="uu">66.7</u>, <u class="uu">39.3</u>, <u class="uu">27.2</u>. EI/MS <i>m</i>/<i>z</i> (%): 77 (54), 78 (18), 79 (27), 103 (24), 105 (83), 131 (49), 132 (51), 133 (98), 134 (18), 160 (20), 161 (88), 163 (48), 277 (18), 321 (100), 322 (M<sup>·</sup><sup>+</sup>, 18), 323 (M<sup>·</sup><sup>+</sup> + 1, 63), 324 (M<sup>·</sup><sup>+</sup> + 2, 12).</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>-(3,4-Dimethylphenyl)-2<i>H</i>-chromene-3-carboxamide (<b>7</b>)</h4><div class="NLM_p last">Compound <b>7</b> was recrystallized from DCM/ethyl ether. Yield = 43%. <sup>1</sup>H NMR (400 MHz, CDCl3) δ (ppm): 7.54 (1H, s, CONH), 7.35 (1H, d, <i>J</i> = 2.3 Hz, H2′), 7.27 (1H, dd, <i>J</i> = 8.0, 2.3 Hz, H5), 7.22 (1H, ddd, <i>J</i> = 8.1, 7.4, 1.7 Hz, H7), 7.13–7.05 (2H, m, H6′, H8), 7.05 (1H, s, H4), 6.92 (1H, ddd, <i>J</i> = 7.4, 7.4, 1.1 Hz, H6), 6.86 (1H, d, <i>J</i> = 8.1 Hz, H5′), 5.06 (2H, d, <i>J</i> = 1.3 Hz, H2), 2.24 (3H, s, 3′CH3), 2.22 (3H, s, 4′CH3). <sup>13</sup>C NMR (100 MHz, CDCl3) δ (ppm): 163.2, 154.9, 137.4, 135.1, 133.1, <u class="uu">131.5</u>, <u class="uu">130.1</u>, <u class="uu">128.4</u>, 127.4, <u class="uu">127.2, 121.8</u>, <u class="uu">121.6</u>, 120.8, <u class="uu">117.7</u>, <u class="uu">116.2</u>, <u class="uu">64.9</u>, <u class="uu">19.9</u>, <u class="uu">19.2</u>. EI/MS <i>m</i>/<i>z</i> (%): 77 (23), 115 (28), 131 (22), 159 (100), 278 (15), 279 (M<sup>·</sup><sup>+</sup>, 90), 280 (M<sup>·</sup><sup>+</sup> + 1, 18).</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>-(3-Chlorophenyl)-2<i>H</i>-chromene-3-carboxamide (<b>8</b>)</h4><div class="NLM_p last">Compound <b>8</b> was recrystallized from ethyl acetate/<i>n</i>-hexane. Yield = 28%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 7.69 (1H, dd, <i>J</i> = 2.1, 2.1 Hz, H2′), 7.59 (1H, s, CONH), 7.42 (1H, ddd, <i>J</i> = 8.2, 2.1, 1.0 Hz, H6′), 7.28 (1H, ddd, <i>J</i> = 8.2, 1.5, 1.5 Hz, H4′), 7.24 (1H, dd, <i>J</i> = 6.05, 1.78, H5), 7.14–7.10 (2H, m, H7, H5′), 7.08 (1H, s, H4), 6.94 (1H, ddd, <i>J</i> = 7.5, 7.5, 1.1 Hz, H6), 6.88 (1H, d, <i>J</i> = 8.1 Hz, H8), 5.06 (2H, d, <i>J</i> = 1.3 Hz, H2). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ (ppm): 163.2, 155.0, 138.6, 134.8, <u class="uu">131.9</u>, <u class="uu">130.1</u>, <u class="uu">128.5</u>, <u class="uu">127.9</u>, 126.8, <u class="uu">124.7</u>, <u class="uu">121.9</u>, 120.6, <u class="uu">120.2</u>, <u class="uu">118.0</u>, <u class="uu">116.3</u>, <u class="uu">64.7</u>. EI/MS <i>m</i>/<i>z</i> (%): 51 (10), 77 (22), 115 (26), 131 (17), 159 (100), 160 (11), 285 (M<sup>·</sup><sup>+</sup>, 45), 286 (M<sup>·</sup><sup>+</sup> + 1, 9), 287 (M<sup>·</sup><sup>+</sup> + 2, 15).</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>N</i>-(3,4-Dimethoxyphenyl)-2<i>H</i>-chromene-3-carboxamide (<b>9</b>)</h4><div class="NLM_p last">Compound <b>9</b> was recrystallized from ethyl acetate/<i>n</i>-hexane. Yield = 25%. <sup>1</sup>H NMR (400 MHz, DMSO) δ (ppm): 9.91 (1H, s, CONH), 7.44 (1H, s, H4), 7.39 (1H, d, <i>J</i> = 2.4 Hz, H2′), 7.31–7.24 (2H, m, H5, H7), 7.25 (1H, dd, <i>J</i> = 8.8, 2.1 Hz, H6′), 6.99 (1H, ddd, <i>J</i> = 7.4, 7.4, 1.1 Hz, H6), 6.92 (1H, d, <i>J</i> = 8.8 Hz, H5′), 6.88 (1H, dd, <i>J</i> = 7.8, 1.0 Hz, H8), 4.98 (2H, d, <i>J</i> = 1.4 Hz, H2), 3.74 (3H, s, 3′OCH<sub>3</sub>), 3.73 (3H, s, 4′OCH<sub>3</sub>). <sup>13</sup>C NMR (100 MHz, DMSO) δ (ppm): 163.4, 154.7, 148.9, 145.6, 132.8, <u class="uu">131.6</u>, <u class="uu">129.0</u>, <u class="uu">127.9</u>, 127.5, <u class="uu">122.4</u>, 121.7, <u class="uu">116.2</u>, <u class="uu">112.6</u>, <u class="uu">112.4</u>, <u class="uu">105.7</u>, <u class="uu">64.9</u>, <u class="uu">56.2</u>, <u class="uu">55.8</u>. EI/MS <i>m</i>/<i>z</i> (%): 77 (17), 115 (33), 131 (20), 159 (100), 292 (13), 311 (M<sup>·</sup><sup>+</sup>, 80), 312 (15).</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>-(3,4-Dichlorophenyl)-2<i>H</i>-chromene-3-carboxamide (<b>10</b>)</h4><div class="NLM_p last">Compound <b>10</b> was recrystallized from DCM/ethyl ether. Yield = 21%. <sup>1</sup>H NMR (400 MHz, DMSO) δ (ppm): 10.29 (1H, s, CONH), 8.07 (1H, d, <i>J</i> = 2.4 Hz, H2′), 7.68 (1H, dd, <i>J</i> = 8.8, 2.4 Hz, H6′), 7.60 (1H, d, <i>J</i> = 8.8 Hz, H5′), 7.50 (1H, s, H4), 7.32–7.25 (2H, m, H7, H5), 7.00 (1H, ddd, <i>J</i> = 7.4, 7.4, 1.1 Hz, H6), 6.89 (1H, dd, <i>J</i> = 7.4, 1.1 Hz, H8), 4.98 (2H, d, <i>J</i> = 1.3 Hz, H2). <sup>13</sup>C NMR (100 MHz, DMSO) δ (ppm): 164.1, 154.8, 139.5, <u class="uu">132.0</u>, 131.3, <u class="uu">131.1</u>, <u class="uu">129.2</u>, <u class="uu">129.1</u>, 126.8, 125.5, <u class="uu">122.4</u>, <u class="uu">121.6</u>, 121.4, <u class="uu">120.4</u>, <u class="uu">116.3</u>, <u class="uu">64.7</u>. EI/MS <i>m</i>/<i>z</i> (%): 77 (24), 102 (9), 103 (10), 115 (34), 131 (17), 159 (100), 160 (11), 319 (16), 320 (M<sup>·</sup><sup>+</sup>, 3), 321 (M<sup>·</sup><sup>+</sup> + 1, 10), 322 (M<sup>·</sup><sup>+</sup> + 2, 2).</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>-(3,4-Dimethylphenyl)-2-oxo-2<i>H</i>-chromene-3-carboxamide (<b>14</b>)</h4><div class="NLM_p last">Compound <b>14</b> was recrystallized from ethyl acetate/<i>n</i>-hexane. Yield = 45%. <sup>1</sup>H NMR (400 MHz, DMSO) δ (ppm): 10.55 (1H, s, CONH), 8.91 (1H, s, H4), 8.01 (1H, dd, <i>J</i> = 7.7, 1.6 Hz, H5), 7.78 (1H, ddd, <i>J</i> = 8.8, 7.4, 1.6 Hz, H7), 7.55 (1H, dd, <i>J</i> = 8.4, 2.2 Hz, H6′), 7.52–7.47 (2H, m, H2′, H8), 7.46–7.44 (1H, m, H6), 7.13 (1H, d, <i>J</i> = 8.1 Hz, H5′), 2.23 (3H, s, 3′CH<sub>3</sub>), 2.20 (3H, s, 4′CH<sub>3</sub>). <sup>13</sup>C NMR (100 MHz, DMSO) δ (ppm): 160.5, 159.4, 153.8, <u class="uu">147.2</u>, 136.7, 135.6, <u class="uu">134.1</u>, 132.1, <u class="uu">130.2</u>, <u class="uu">129.8</u>, <u class="uu">125.2</u>, <u class="uu">120.9</u>, 119.8, 118.4, <u class="uu">117.2</u>, <u class="uu">116.1</u>, <u class="uu">19.4</u>, <u class="uu">18.7</u>. EI/MS <i>m</i>/<i>z</i> (%): 89 (13), 101 (16), 173 (100), 174 (11), 264 (10), 265 (14), 293 (M<sup>·</sup><sup>+</sup>, 79), 294 (M<sup>·</sup><sup>+</sup> + 1, 16).</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>-(3-Chlorophenyl)-2-oxo-2<i>H</i>-chromene-3-carboxamide (<b>15</b>)</h4><div class="NLM_p last">Compound <b>15</b> was recrystallized from ethyl acetate/<i>n</i>-hexane. Yield = 42%. <sup>1</sup>H NMR (400 MHz, DMSO) δ (ppm): 10.76 (1H, s, CONH), 8.91 (1H, s, H4), 8.02 (1H, dd, <i>J</i> = 7.8, 1.6 Hz, H5), 7.98 (1H, dd, <i>J</i> = 2.0, 2.0 Hz, H2′), 7.79 (1H, ddd, <i>J</i> = 8.9, 7.4, 1.6 Hz, H7), 7.60–7.54 (2H, m, H4′, H6′), 7.48 (1H, ddd, <i>J</i> = 7.5, 7,52, 1.1 Hz, H6), 7.42 (1H, dd, <i>J</i> = 8.1, 8.0 Hz, H5′), 7.22 (1H, ddd, <i>J</i> = 7.9, 2.1, 0.9 Hz, H8). <sup>13</sup>C NMR (100 MHz, DMSO) δ (ppm): 160.3, 160.0, 153.8, <u class="uu">147.4</u>, 139.3, <u class="uu">134.3</u>, 133.2, <u class="uu">130.6</u>, <u class="uu">130.2</u>, <u class="uu">125.2</u>, <u class="uu">124.0</u>, 119.8, <u class="uu">119.4</u>, <u class="uu">118.4</u>, 118.3, <u class="uu">116.2</u>. EI/MS <i>m</i>/<i>z</i> (%): 63 (8), 89 (14), 101 (14), 173 (100), 174 (11), 299 (M<sup>·</sup><sup>+</sup>, 26), 301 (M<sup>·</sup><sup>+</sup> + 2, 9).</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>-(3,4-Dimethoxyphenyl)-2-oxo-2<i>H</i>-chromene-3-carboxamide (<b>16</b>)</h4><div class="NLM_p last">Compound <b>16</b> was recrystallized from ethyl acetate/<i>n</i>-hexane. Yield = 53%. <sup>1</sup>H NMR (400 MHz, DMSO) δ (ppm): 10.53 (1H, s, CONH), 8.91 (1H, s, H4), 8.01 (1H, dd, <i>J</i> = 7.8, 1.6 Hz, H5), 7.78 (1H, ddd, <i>J</i> = 8.4, 7.3, 1.6 Hz, H7), 7.56 (1H, d, <i>J</i> = 8.4 Hz, H5′), 7.48 (1H, ddd, <i>J</i> = 7.7, 7.7, 1.1 Hz, H6), 7.39 (1H, d, <i>J</i> = 2.4 Hz, H2′), 7.29 (1H, dd, <i>J</i> = 8.4, 2.4 Hz, H6′), 6.96 (1H, dd, <i>J</i> = 7.8, 1.6, Hz, H8), 3.78 (3H, s, 3′OCH<sub>3</sub>), 3.75 (3H, s, 4′OCH<sub>3</sub>). <sup>13</sup>C NMR (100 MHz, DMSO) δ (ppm): 160.4, 159.3, 153.8, 148.6, <u class="uu">147.2</u>, 145.5, <u class="uu">134.1</u>, 131.3, <u class="uu">130.2</u>, <u class="uu">125.2</u>, 119.8, 118.4, <u class="uu">116.1</u>, <u class="uu">112.0</u>, <u class="uu">111.9</u>, <u class="uu">104.9</u>, <u class="uu">55.6</u>, <u class="uu">55.4</u>. EI/MS <i>m</i>/<i>z</i> (%): 89 (10), 101 (11), 173 (100), 174 (11), 310 (24), 325 (M<sup>·</sup><sup>+</sup>, 82), 326 (17).</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>N</i>-(3,4-Dichlorophenyl)-2-oxo-2<i>H</i>-chromene-3-carboxamide (<b>17</b>)</h4><div class="NLM_p last">Compound <b>17</b> was recrystallized from ethyl acetate/<i>n</i>-hexane. Yield = 25%. <sup>1</sup>H NMR (400 MHz, MeOD) δ (ppm): 9.20 (1H, s, H4), 8.22 (1H, d, <i>J</i> = 2.4 Hz, H2′), 7.99 (1H, dd, <i>J</i> = 7.7, 1.6 Hz, H5), 7.95 (1H, ddd, <i>J</i> = 8.8, 7.3, 1.6 Hz, H7), 7.72 (1H, dd, <i>J</i> = 8.7, 2.5 Hz, H6′), 7.68–7.67 (1H, m, H5′), 7.66–7.64 (2H, m, H8, H6). <sup>13</sup>C NMR and DEPT 135 data (*). MS/EI <i>m</i>/<i>z</i> (%): 63 (12), 89 (22), 101 (21), 173 (100), 174 (11), 333 (15), 334 (M<sup>·</sup><sup>+</sup>, 3), 335 (M<sup>·</sup><sup>+</sup> + 1, 10), 336 (M<sup>·</sup><sup>+</sup> + 2, 1).</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-(3,4-Dimethylphenyl)-4-oxo-4<i>H</i>-thiochromene-3-carboxamide (<b>30</b>)</h4><div class="NLM_p last">Compound <b>30</b> was recrystallized from DCM/ethyl ether. Yield = 25%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 11.28 (1H, s, CONH), 9.07 (1H, s, H2), 8.34 (1H, dd, <i>J</i> = 8.0, 1.7 Hz, H5), 7.79 (1H, ddd, <i>J</i> = 8.7, 7.1, 1.7 Hz, H7), 7.59 (1H, dd, <i>J</i> = 8.6, 1.1 Hz, H8), 7.56–7.53 (1H, m, H6), 7.52 (1H, d, <i>J</i> = 1.2 Hz, H2′), 7.48 (1H, dd, <i>J</i> = 8.1, 2.4 Hz, H6′), 7.12 (1H, d, <i>J</i> = 8.1 Hz, H5′), 2.28 (3H, s, 3′CH<sub>3</sub>), 2.24 (3H, s, 4′CH<sub>3</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ (ppm): 177.4, <u class="uu">162.7</u>, 160.5, 156.2, 137.2, 135.7, <u class="uu">134.8</u>, 132.8, <u class="uu">130.0</u>, <u class="uu">126.4</u>, <u class="uu">126.2</u>, 124.1, <u class="uu">121.8</u>, <u class="uu">118.5</u>, <u class="uu">118.0</u>, 116.1, <u class="uu">19.9</u>, <u class="uu">19.2</u>. EI/MS <i>m</i>/<i>z</i> (%): 53 (15), 77 (9), 121 (63), 122 (9), 145 (9), 173 (100), 174 (11), 293 (91), 294 (18).</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>-(3-Chlorophenyl)-4-oxo-4<i>H</i>-thiochromene-3-carboxamide (<b>31</b>)</h4><div class="NLM_p last">Compound <b>31</b> was recrystallized from DCM/ethyl ether. Yield = 20%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 11.49 (1H, s, CONH), 9.07 (1H, s, H2), 8.34 (1H, ddd, <i>J</i> = 6.4, 1.3, 0.4 Hz, H5), 7.90 (1H, dd, <i>J</i> = 2.04, 2.04 Hz, H2′), 7.81 (1H, ddd, <i>J</i> = 8.7, 7.1, 1.7 Hz, H7), 7.61 (1H, dd, <i>J</i> = 7.8, 1.8 Hz, H8), 7.58–7.53 (2H, m, H6, H6′), 7.29 (1H, dd, <i>J</i> = 8.13, 8.13 Hz, H5′), 7.12 (1H, ddd, <i>J</i> = 7.9, 2.0, 1.0 Hz, H4′). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ (ppm): 177.4, <u class="uu">163.0</u>, 160.9 (CONH), 156.2 (C8a), 139.1, <u class="uu">135.0</u>, 134.6, <u class="uu">129.9</u>, <u class="uu">126.6</u>, <u class="uu">126.3</u>, <u class="uu">124.5</u>, 124.0, <u class="uu">120.6</u>, <u class="uu">118.6</u>, <u class="uu">118.5</u>, 115.7. EI/MS <i>m</i>/<i>z</i> (%): 53 (17), 89 (9), 120 (4), 121 (58), 123 (7), 145 (3), 172 (3), 173 (100), 174 (11), 299 (51), 300 (9), 301 (17), 315 (M<sup>·</sup><sup>+</sup>, 2).</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> General Procedure B: Synthesis of 2-Oxo-1,2-dihydroquinoline-3-carboxamide (<b>20</b>–<b>22</b>) and <i>N</i>-1-Methyl-2-oxo-1,2-dihydroquinoline-3-carboxamide (<b>23</b>–<b>25</b>) Derivatives</h3><div class="NLM_p">A solution of the appropriate heterocyclic carboxylic acid (2-oxo-1,2-dihydroquinoline-3-carboxylic acid (<b>18</b>) or <i>N-</i>1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid (<b>19</b>)) (1.05 mmol), TBTU (1.05 mmol), and DIPEA (2.1 mmol) in DMF (10 mL) was stirred at rt for 15 min. Then, the appropriate amine (1.26 mmol) was added, and the mixture was stirred at room temperature overnight. Then, DCM (50 mL) was added, and the mixture was extracted with H<sub>2</sub>O (3 × 5 mL), 1 M HCl (3 × 5 mL), and saturated aqueous solution of NaHCO<sub>3</sub> (3 × 5 mL). The organic layers were combined, washed with aqueous solution of 10% NaOH (<i>m</i>/<i>v</i>), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude product was purified by recrystallization.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-(3,4-Dimethylphenyl)-2-oxo-1,2-dihydroquinoline-3-carboxamide (<b>20</b>)</h4><div class="NLM_p last">Compound <b>20</b> recrystallized from MeOH/<i>n</i>-hexane. Yield = 40%. <sup>1</sup>H NMR (400 MHz, DMSO) δ (ppm): 12.63 (1H, s, CONH), 12.01 (1H, s, NH), 8.96 (1H, s, H4), 8.00 (1H, dd, <i>J</i> = 6.7, 1.1 Hz, H8), 7.70 (1H, ddd, <i>J</i> = 7.1, 6.0, 1.5 Hz, H7), 7.52 (1H, dd, <i>J</i> = 8.3, 2.1 Hz, H5), 7.48 (1H, dd, <i>J</i> = 8.2, 2.2 Hz, H6′), 7.45 (1H, d, <i>J</i> = 2.2 Hz, H2′), 7.34 (1H, ddd, <i>J</i> = 7.0, 6.2, 1.5 Hz, H6), 7.13 (1H, d, <i>J</i> = 8.1 Hz, H5′), 2.24 (3H, s, 3′CH<sub>3</sub>), 2.20 (3H, s, 4′CH<sub>3</sub>). <sup>13</sup>C NMR (100 MHz, DMSO) δ (ppm): 162.1, 160.6, <u class="uu">144.2</u>, 141.00, 139.4, 136.7, 135.9, <u class="uu">132.9</u> (2 × <sup>13</sup>C), 131.7, <u class="uu">129.8</u>, 127.5, <u class="uu">123.0</u>, <u class="uu">120.8</u>, <u class="uu">117.1</u>, <u class="uu">115.4</u>, <u class="uu">19.4</u>, <u class="uu">18.7</u>. EI/MS <i>m</i>/<i>z</i> (%): 57 (15), 89 (30), 116 (48), 121 (87), 128 (12), 172 (92), 173 (11), 292 (M<sup>·</sup><sup>+</sup>, 100), 293 (22).</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-(3-Chlorophenyl)-2-oxo-1,2-dihydroquinoline-3-carboxamide (<b>21</b>)</h4><div class="NLM_p last">Compound <b>21</b> was recrystallized from ethyl acetate/<i>n</i>-hexane. Yield = 50%. <sup>1</sup>H NMR (400 MHz, DMSO) δ (ppm): 12.68 (1H, s, CONH), 12.27 (1H, s, NH), 8.98 (1H, s, H4), 8.03–8.00 (2H, m, H8, H2′), 7.72 (1H, ddd, <i>J</i> = 8.5, 7.1, 1.4 Hz, H7), 7.54 (1H, ddd, <i>J</i> = 8.2, 2.1, 1.0 Hz, H6′), 7.49 (1H, dd, <i>J</i> = 8.3, 1.3 Hz, H5), 7.41 (1H, dd, <i>J</i> = 8.0, 8.0 Hz, H5′), 7.35 (1H, ddd, <i>J</i> = 8.1, 7.1, 1.1 Hz, H6), 7.20 (1H, ddd, <i>J</i> = 8.0, 2.2, 1.0 Hz, H4′). <sup>13</sup>C NMR (100 MHz, DMSO) δ (ppm): 162.6, 161.9, <u class="uu">145.3</u>, 140.1, 140.0, 133.8, <u class="uu">133.7</u>, <u class="uu">131.2</u>, <u class="uu">130.5</u>, <u class="uu">124.2</u>, <u class="uu">123.6</u>, 121.5, <u class="uu">119.8</u>, 119.2, <u class="uu">118.8</u>, <u class="uu">116.0</u>. EI/MS <i>m</i>/<i>z</i> (%): 63 (8), 89 (23), 116 (46), 117 (8), 128 (11), 144 (3), 172 (100), 173 (11), 298 (M<sup>·</sup><sup>+</sup>, 33), 299 (M<sup>·</sup><sup>+</sup> + 1, 7), 300 (M<sup>·</sup><sup>+</sup> + 2, 12).</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-(3,4-Dichlorophenyl)-2-oxo-1,2-dihydroquinoline-3-carboxamide (<b>22</b>)</h4><div class="NLM_p last">Compound <b>22</b> was recrystallized from MeOH/ethyl ether. Yield = 40%. <sup>1</sup>H NMR (400, MHz, DMSO) δ (ppm): 12.60 (1H, s, CONH), 12.05 (1H, s, NH), 8.45 (1H, s, H4), 7.90 (1H, d, <i>J</i> = 2.4 Hz, H2′), 7.83 (1H, dd, <i>J</i> = 7.5, 1.7 Hz, H5), 7.75 (1H, dd, <i>J</i> = 7.1, 2.4 Hz, H6′), 7.60 (1H, d, <i>J</i> = 7.1 Hz, H5′), 7.50 (1H, dd, <i>J</i> = 7.5, 1.5 Hz, H8), 7.30–7.26 (2H, m, H7, H6). <sup>13</sup>C NMR and DEPT 135 data (*). EI/MS <i>m</i>/<i>z</i> (%): 89 (23), 116 (40), 128 (10), 172 (100), 173 (11), 332 (29), 333 (M<sup>·</sup><sup>+</sup>, 6), 334 (M<sup>·</sup><sup>+</sup> + 1, 19), 335 (M<sup>·</sup><sup>+</sup> + 2, 3), 337 (M<sup>·</sup><sup>+</sup> + 4, 6).</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-(3,4-Dimethylphenyl)-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamide (<b>23</b>)</h4><div class="NLM_p last">Compound <b>23</b> was recrystallized from ethyl acetate/<i>n</i>-hexane. Yield = 35%. <sup>1</sup>H NMR (400 MHz, DMSO) δ (ppm): 12.00 (1H, s, CONH) 8.95 (1H, s, H4), 8.07 (1H, dd, <i>J</i> = 7.8, 1.5 Hz, H8), 7.82 (1H, ddd, <i>J</i> = 8.6, 7.1, 1.5 Hz, H7), 7.71 (1H, dd, <i>J</i> = 8.5 Hz, 1.5 Hz, H5), 7.53 (1H, dd, <i>J</i> = 8.1, 2.0 Hz, H6′), 7.46 (1H, d, <i>J</i> = 2.0 Hz, H2′), 7.43 (1H, ddd, <i>J</i> = 7.9, 7.1, 1.2 Hz, H6), 7.13 (1H, d, <i>J</i> = 8.1 Hz, H5′), 3.79 (3H, s, NCH<sub>3</sub>), 2.24 (3H, s, 3′CH<sub>3</sub>), 2.20 (3H, s, 4′CH<sub>3</sub>). <sup>13</sup>C NMR (100 MHz, DMSO) δ (ppm): 161.4, 160.5, <u class="uu">143.4</u>, 140.2, 136.7, 135.9, <u class="uu">133.3</u>, 131.8, <u class="uu">130.8</u>, <u class="uu">129.8</u>, <u class="uu">123.1</u>, 120.9, <u class="uu">120.8</u>, 119.2, <u class="uu">117.1</u>, <u class="uu">115.3</u>, <u class="uu">29.9</u>, <u class="uu">19.4</u>, <u class="uu">18.7</u>. EI/MS <i>m</i>/<i>z</i> (%): 89 (19), 91 (5), 186 (100), 277 (11), 278 (10), 306 (M<sup>·</sup><sup>+</sup>, 99), 307 (M<sup>·</sup><sup>+</sup> + 1, 19).</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-(3-Chlorophenyl)-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamide (<b>24</b>)</h4><div class="NLM_p last">Compound <b>24</b> was recrystallized from MeOH/<i>n</i>-hexane. Yield = 22%. <sup>1</sup>H NMR (400 MHz, DMSO) δ (ppm): 12.22 (1H, s, CONH), 8.97 (1H, s, H4), 8.07 (1H, dd, <i>J</i> = 7.9, 1.3 Hz, H8), 8.03 (1H, dd, <i>J</i> = 2.0, 2.0 Hz, H2′), 7.83 (1H, ddd, <i>J</i> = 8.6, 7.1, 1.5 Hz, H7), 7.72 (1H, d, <i>J</i> = 8.6 Hz, H5), 7.55 (1H, ddd, <i>J</i> = 8.1, 1.9, 1.5 Hz, H6′), 7.43 (1H, ddd, <i>J</i> = 7.5, 7.5, 1.8 Hz, H6), 7.40 (1H, d, <i>J</i> = 8.1 Hz, H5′), 7.20 (1H, ddd, <i>J</i> = 8.0, 2.0, 1.5 Hz, H4′), 3.80 (3H, s, NCH<sub>3</sub>). <sup>13</sup>C NMR and DEPT 135 data (a). MS/EI <i>m</i>/<i>z</i> (%): 89 (13), 128 (3), 130 (4), 185 (3), 186 (100), 312 (M<sup>·</sup><sup>+</sup>, 35), 313 (M<sup>·</sup><sup>+</sup> + 1, 6), 314 (M<sup>·</sup><sup>+</sup> + 2, 12).</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>N</i>-(3,4-Dichlorophenyl)-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamide (<b>25</b>)</h4><div class="NLM_p">Compound <b>25</b> was recrystallized from MeOH/<i>n</i>-hexane. Yield = 20%. <sup>1</sup>H NMR (400 MHz, DMSO) δ (ppm): 12.14 (1H, s, CONH), 8.93 (1H, s, H4), 8.15 (1H, dd, <i>J</i> = 8.1, 2.0 Hz, H6′), 8.07 (1H, dd, <i>J</i> = 7.8, 1.5 Hz, H8), 7.82 (1H, dd, <i>J</i> = 7.9, 7.9 Hz, H7), 7.70 (1H, dd, <i>J</i> = 8.5 Hz, 1.5 Hz H5), 7.61 (1H, d, <i>J</i> = 6.08 Hz, H5′), 7.50–7.43 (2H, m, H6, H2′), 3.80 (3H, s, NCH<sub>3</sub>). <sup>13</sup>C NMR and DEPT 135 data (*). EI/MS <i>m</i>/<i>z</i> (%): 55 (19), 57 (20), 89 (22), 128 (9), 186 (100), 187 (14), 346 (36), 348 (M<sup>·</sup><sup>+</sup> + 1, 21).</div><div class="NLM_p">(*) <sup>13</sup>C NMR was not acquired due to solubility constraints.</div><div class="NLM_p last">The purity of the final products (>98%) was verified by high-performance liquid chromatography (HPLC) equipped with a DAD detector (Figures S9–S26).</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Pharmacology</h3><div class="NLM_p last">The details about monoamine oxidase inhibitory assays, cytotoxicity studies, and computational simulations are provided in the SI.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48"><a href="/doi/suppl/10.1021/acs.jmedchem.1c00510" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83467" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83467" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.1c00510?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00510</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">PDB files of homology (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_002.zip" class="ext-link">ZIP</a>)</p></li><li><p class="inline">Enzymatic assays, <i>in vitro</i> toxicology, computational studies, supplementary tables, and figures (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_003.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_001.csv">jm1c00510_si_001.csv (1.64 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_002.zip">jm1c00510_si_002.zip (937.18 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_003.pdf">jm1c00510_si_003.pdf (2.22 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.1c00510" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71164" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71164" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexandra Gaspar</span> - <span class="hlFld-Affiliation affiliation">CIQUP/Department
of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto 4169-007, Portugal</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b0d1dcd5c8d1ded4c2d19ed7d1c3c0d1c2f0d6d39ec5c09ec0c4"><span class="__cf_email__" data-cfemail="7d1c1118051c13190f1c531a1c0e0d1c0f3d1b1e53080d530d09">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fernanda Borges</span> - <span class="hlFld-Affiliation affiliation">CIQUP/Department
of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto 4169-007, Portugal</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0003-1050-2402" title="Orcid link">https://orcid.org/0000-0003-1050-2402</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5d3b3f322f3a382e1d3b3e73282d732d29"><span class="__cf_email__" data-cfemail="7412161b061311073412175a01045a0400">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francesco Mesiti</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienze della Salute, Università
“Magna Græcia” di  Catanzaro, Campus “Salvatore
Venuta”, Catanzaro 88100, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Net4Science
srl, Academic Spinoff, Università “Magna Græcia”
di  Catanzaro, Campus “Salvatore Venuta”, Catanzaro 88100, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">CIQUP/Department
of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto 4169-007, Portugal</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Chavarria</span> - <span class="hlFld-Affiliation affiliation">CIQUP/Department
of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto 4169-007, Portugal</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Annalisa Maruca</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienze della Salute, Università
“Magna Græcia” di  Catanzaro, Campus “Salvatore
Venuta”, Catanzaro 88100, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Net4Science
srl, Academic Spinoff, Università “Magna Græcia”
di  Catanzaro, Campus “Salvatore Venuta”, Catanzaro 88100, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberta Rocca</span> - <span class="hlFld-Affiliation affiliation">Net4Science
srl, Academic Spinoff, Università “Magna Græcia”
di  Catanzaro, Campus “Salvatore Venuta”, Catanzaro 88100, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Experimental and Clinical Medicine, “Magna
Græcia” University of Catanzaro, Campus “S. Venuta”, Viale Europa, Germaneto, Catanzaro 88100, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-0680-7097" title="Orcid link">https://orcid.org/0000-0002-0680-7097</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eva Gil Martins</span> - <span class="hlFld-Affiliation affiliation">UCIBIO-REQUIMTE,
Laboratory of Toxicology, Department of Biological Sciences, Faculty
of Pharmacy, University of Porto, Porto 4050-313, Portugal</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandra Barreiro</span> - <span class="hlFld-Affiliation affiliation">UCIBIO-REQUIMTE,
Laboratory of Toxicology, Department of Biological Sciences, Faculty
of Pharmacy, University of Porto, Porto 4050-313, Portugal</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Renata Silva</span> - <span class="hlFld-Affiliation affiliation">UCIBIO-REQUIMTE,
Laboratory of Toxicology, Department of Biological Sciences, Faculty
of Pharmacy, University of Porto, Porto 4050-313, Portugal</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0001-9962-7548" title="Orcid link">https://orcid.org/0000-0001-9962-7548</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carlos Fernandes</span> - <span class="hlFld-Affiliation affiliation">CIQUP/Department
of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto 4169-007, Portugal</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-0102-0703" title="Orcid link">https://orcid.org/0000-0002-0102-0703</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sheraz Gul</span> - <span class="hlFld-Affiliation affiliation">Fraunhofer
Institute for Translational Medicine and Pharmacology, Hamburg 22525, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Fraunhofer
Cluster of Excellence for Immune-Mediated Diseases CIMD, Hamburg Site, Hamburg 22525, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oliver Keminer</span> - <span class="hlFld-Affiliation affiliation">Fraunhofer
Institute for Translational Medicine and Pharmacology, Hamburg 22525, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Fraunhofer
Cluster of Excellence for Immune-Mediated Diseases CIMD, Hamburg Site, Hamburg 22525, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefano Alcaro</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienze della Salute, Università
“Magna Græcia” di  Catanzaro, Campus “Salvatore
Venuta”, Catanzaro 88100, Italy</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This project was supported by the Foundation for Science and Technology (FCT) and FEDER/COMPETE (Grants UID/QUI/00081/2020 and PTDC/MED-QUI/29164/2017). This article is based upon work from COST Action CA15135.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">ABBREVIATIONS</td></tr><tr><td class="NLM_term">(ATP)</td><td class="NLM_def"><p class="first last">adenosine tri-phosphate</p></td></tr><tr><td class="NLM_term">(BBB)</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">(CNS)</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">(Caco-2)</td><td class="NLM_def"><p class="first last">colon adenocarcinoma cells</p></td></tr><tr><td class="NLM_term">(TBTU)</td><td class="NLM_def"><p class="first last">2-(1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethylaminium tetrafluoroborate</p></td></tr><tr><td class="NLM_term">(coul)</td><td class="NLM_def"><p class="first last">Coulomb</p></td></tr><tr><td class="NLM_term">(DCM)</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">(Crom-2)</td><td class="NLM_def"><p class="first last"><i>N</i>-(3′-chlorophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide</p></td></tr><tr><td class="NLM_term">(Crom-1)</td><td class="NLM_def"><p class="first last"><i>N</i>-(3′,4′-dimethyl phenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide</p></td></tr><tr><td class="NLM_term">(DIPEA)</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">(DMF)</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">(FP)</td><td class="NLM_def"><p class="first last">fluorescence polarization</p></td></tr><tr><td class="NLM_term">(PDB code 2Z5X)</td><td class="NLM_def"><p class="first last"><i>h</i>MAO-A</p></td></tr><tr><td class="NLM_term">(PDB code 6FW0)</td><td class="NLM_def"><p class="first last"><i>h</i>MAO-B</p></td></tr><tr><td class="NLM_term">(HBA)</td><td class="NLM_def"><p class="first last">hydrogen bond acceptors</p></td></tr><tr><td class="NLM_term">(MCF-7)</td><td class="NLM_def"><p class="first last">human breast adenocarcinoma cell-line Michigan Cancer Foundation-7 cells</p></td></tr><tr><td class="NLM_term">(HEK-293)</td><td class="NLM_def"><p class="first last">human embryonic kidney 293 cells</p></td></tr><tr><td class="NLM_term">(HUVEC)</td><td class="NLM_def"><p class="first last">human umbilical vein endothelial cells</p></td></tr><tr><td class="NLM_term">(HBD)</td><td class="NLM_def"><p class="first last">hydrogen bond donors</p></td></tr><tr><td class="NLM_term">(MTT)</td><td class="NLM_def"><p class="first last">methylthiazolyldiphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">(MW)</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">(MAO-A and MAO-B)</td><td class="NLM_def"><p class="first last">monoamine oxidases A and B</p></td></tr><tr><td class="NLM_term">(i-<i>h</i>MAO-B)</td><td class="NLM_def"><p class="first last">MAO-B inhibitors</p></td></tr><tr><td class="NLM_term">(SH-SY5Y)</td><td class="NLM_def"><p class="first last">neuroblastoma cells</p></td></tr><tr><td class="NLM_term">(NR)</td><td class="NLM_def"><p class="first last">neutral red</p></td></tr><tr><td class="NLM_term">(PD)</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term">(RHO 123)</td><td class="NLM_def"><p class="first last">Rhodamine 123</p></td></tr><tr><td class="NLM_term">(RB)</td><td class="NLM_def"><p class="first last">rotatable bonds</p></td></tr><tr><td class="NLM_term">(SAR)</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">(STR)</td><td class="NLM_def"><p class="first last">structure–toxicity relationship</p></td></tr><tr><td class="NLM_term">(tPSA in Å<sup>2</sup>)</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr><tr><td class="NLM_term">(XP G-Score)</td><td class="NLM_def"><p class="first last">XP Glide Score</p></td></tr><tr><td class="NLM_term">(vdW)</td><td class="NLM_def"><p class="first last">van der Waals</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26606" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26606" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 38 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gealageas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devineau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">So, P. P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surendradoss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwalder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goebeler, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dullaghan, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grierson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putnins, E. E.</span></span> <span> </span><span class="NLM_article-title">Development of novel monoamine oxidase-B (MAO-B) inhibitors with reduced blood-brain barrier permeability for the potential management of noncentral nervous system (CNS) diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7043</span>– <span class="NLM_lpage">7064</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01588</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01588" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlCns7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7043-7064&author=R.+Gealageasauthor=A.+Devineauauthor=P.+P.+L.+Soauthor=C.+M.+J.+Kimauthor=J.+Surendradossauthor=C.+Buchwalderauthor=M.+Hellerauthor=V.+Goebelerauthor=E.+M.+Dullaghanauthor=D.+S.+Griersonauthor=E.+E.+Putnins&title=Development+of+novel+monoamine+oxidase-B+%28MAO-B%29+inhibitors+with+reduced+blood-brain+barrier+permeability+for+the+potential+management+of+noncentral+nervous+system+%28CNS%29+diseases&doi=10.1021%2Facs.jmedchem.7b01588"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Novel Monoamine Oxidase-B (MAO-B) Inhibitors with Reduced Blood-Brain Barrier Permeability for the Potential Management of Noncentral Nervous System (CNS) Diseases</span></div><div class="casAuthors">Gealageas, Ronan; Devineau, Alice; So, Pauline P. L.; Kim, Catrina M. J.; Surendradoss, Jayakumar; Buchwalder, Christian; Heller, Markus; Goebeler, Verena; Dullaghan, Edith M.; Grierson, David S.; Putnins, Edward E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7043-7064</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Studies indicate that MAO-B is induced in peripheral inflammatory diseases.  To target peripheral tissues using MAO-B inhibitors that do not permeate the blood-brain barrier (BBB) the MAO-B-selective inhibitor deprenyl was remodeled by replacing the terminal acetylene with a CO2H function, and incorporating a para-OCH2Ar motif (compds. 10a-s).  Further, in compd. 32 ((S)-N-[1-cyano-3-[4-[(3,4-dichlorobenzyl)oxy]phenyl]propan-2-yl]-N-methylglycine hydrochloride) the C-2 side chain corresponded to CH2CN.  In vitro, 10c (N-[(R)-[1-[4-(3-chlorobenzyloxy)phenyl]propan-2-yl](methyl)]glycine hydrochloride), 10j, 10k, and 32 were identified as potent reversible MAO-B inhibitors, and all four compds. were more stable than deprenyl in plasma, liver microsomal, and hepatocyte stability assays.  In vivo, they demonstrated greater plasma bioavailability.  Assessment of in vitro BBB permeability showed that compd. 10k is a P-glycoprotein (P-gp) substrate and 10j displayed mild interaction.  Importantly, compds. 10c, 10j, 10k, and 32 displayed significantly reduced BBB permeability after i.v., s.c., and oral administration.  These polar MAO-B inhibitors are pertinent leads for evaluation of efficacy in noncentral nervous system (CNS) inflammatory disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxwJVafqtiYrVg90H21EOLACvtfcHk0lgnxkpuIYqfsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlCns7bL&md5=46d24762b2205d7e1fef6543ff26997b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01588%26sid%3Dliteratum%253Aachs%26aulast%3DGealageas%26aufirst%3DR.%26aulast%3DDevineau%26aufirst%3DA.%26aulast%3DSo%26aufirst%3DP.%2BP.%2BL.%26aulast%3DKim%26aufirst%3DC.%2BM.%2BJ.%26aulast%3DSurendradoss%26aufirst%3DJ.%26aulast%3DBuchwalder%26aufirst%3DC.%26aulast%3DHeller%26aufirst%3DM.%26aulast%3DGoebeler%26aufirst%3DV.%26aulast%3DDullaghan%26aufirst%3DE.%2BM.%26aulast%3DGrierson%26aufirst%3DD.%2BS.%26aulast%3DPutnins%26aufirst%3DE.%2BE.%26atitle%3DDevelopment%2520of%2520novel%2520monoamine%2520oxidase-B%2520%2528MAO-B%2529%2520inhibitors%2520with%2520reduced%2520blood-brain%2520barrier%2520permeability%2520for%2520the%2520potential%2520management%2520of%2520noncentral%2520nervous%2520system%2520%2528CNS%2529%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D7043%26epage%3D7064%26doi%3D10.1021%2Facs.jmedchem.7b01588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finberg, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabey, J. M.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of MAO-A and MAO-B in psychiatry and neurology</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">340</span>, <span class="refDoi"> DOI: 10.3389/fphar.2016.00340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.3389%2Ffphar.2016.00340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=27803666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlWnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=340&author=J.+P.+Finbergauthor=J.+M.+Rabey&title=Inhibitors+of+MAO-A+and+MAO-B+in+psychiatry+and+neurology&doi=10.3389%2Ffphar.2016.00340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of MAO-A and MAO-B in psychiatry and neurology</span></div><div class="casAuthors">Finberg, John P. M.; Rabey, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">340-354</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Inhibitors of MAO-A and MAO-B are in clin. use for the treatment of psychiatric and neurol. disorders resp.  Elucidation of the mol. structure of the active sites of the enzymes has enabled a precise detn. of the way in which substrates and inhibitor mols. are metabolized, or inhibit metab. of substrates, resp.  Despite the knowledge of the strong antidepressant efficacy of irreversible MAO inhibitors, their clin. use has been limited by their side effect of potentiation of the cardiovascular effects of dietary amines ("cheese effect").  A no. of reversible MAO-A inhibitors which are devoid of cheese effect have been described in the literature, but only one, moclobemide, is currently in clin. use.  The irreversible inhibitors of MAO-B, selegiline and rasagiline, are used clin. in treatment of Parkinson's disease, and a recently introduced reversible MAO-B inhibitor, safinamide, has also been found efficacious.  Modification of the pharmacokinetic characteristics of selegiline by transdermal administration has led to the development of a new drug form for treatment of depression.  The clin. potential of MAO inhibitors together with detailed knowledge of the enzyme's binding site structure should lead to future developments with these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUpMUqQ2oLP7Vg90H21EOLACvtfcHk0li7LotPWg64nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlWnu7k%253D&md5=7d7cf400373f86aa87e1147ce52b6d16</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2016.00340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2016.00340%26sid%3Dliteratum%253Aachs%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%26aulast%3DRabey%26aufirst%3DJ.%2BM.%26atitle%3DInhibitors%2520of%2520MAO-A%2520and%2520MAO-B%2520in%2520psychiatry%2520and%2520neurology%26jtitle%3DFront.%2520Pharmacol.%26date%3D2016%26volume%3D7%26spage%3D340%26doi%3D10.3389%2Ffphar.2016.00340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tripathi, R. K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayyannan, S. R.</span></span> <span> </span><span class="NLM_article-title">Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: an overview and update</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1603</span>– <span class="NLM_lpage">1706</span>, <span class="refDoi"> DOI: 10.1002/med.21561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1002%2Fmed.21561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=30604512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFOjtbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2019&pages=1603-1706&author=R.+K.+P.+Tripathiauthor=S.+R.+Ayyannan&title=Monoamine+oxidase-B+inhibitors+as+potential+neurotherapeutic+agents%3A+an+overview+and+update&doi=10.1002%2Fmed.21561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: An overview and update</span></div><div class="casAuthors">Tripathi, Rati Kailash Prasad; Ayyannan, Senthil Raja</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1603-1706</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Monoamine oxidase (MAO) inhibitors have made significant contributions and remain an indispensable approach of mol. and mechanistic diversity for the discovery of antineurodegenerative drugs.  However, their usage has been hampered by nonselective and/or irreversible action which resulted in drawbacks like liver toxicity, cheese effect, and so forth.  Hence, the search for selective MAO inhibitors (MAOIs) has become a substantial focus in current drug discovery.  This review summarizes our current understanding on MAO-A/MAO-B including their structure, catalytic mechanism, and biol. functions with emphases on the role of MAO-B as a potential therapeutic target for the development of medications treating neurodegenerative disorders.  It also highlights the recent developments in the discovery of potential MAO-B inhibitors (MAO-BIs) belonging to diverse chem. scaffolds, arising from intensive chem.-mechanistic and computational studies documented during past 3 years (2015-2018), with emphases on their potency and selectivity.  Importantly, readers will gain knowledge of various newly established MAO-BI scaffolds and their development potentials.  The comprehensive information provided herein will hopefully accelerate ideas for designing novel selective MAO-BIs with superior activity profiles and crit. discussions will inflict more caution in the decision-making process in the MAOIs discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0XoMpJ5mvjLVg90H21EOLACvtfcHk0li7LotPWg64nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFOjtbnN&md5=f516763a33fbcb6393592794606715a7</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fmed.21561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21561%26sid%3Dliteratum%253Aachs%26aulast%3DTripathi%26aufirst%3DR.%2BK.%2BP.%26aulast%3DAyyannan%26aufirst%3DS.%2BR.%26atitle%3DMonoamine%2520oxidase-B%2520inhibitors%2520as%2520potential%2520neurotherapeutic%2520agents%253A%2520an%2520overview%2520and%2520update%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2019%26volume%3D39%26spage%3D1603%26epage%3D1706%26doi%3D10.1002%2Fmed.21561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarishkin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeon, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Londhe, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pae, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. D.</span></span> <span> </span><span class="NLM_article-title">Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer’s disease</span>. <i>Sci. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">eaav0316</span> <span class="refDoi"> DOI: 10.1126/sciadv.aav0316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1126%2Fsciadv.aav0316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=30906861" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&author=J.+H.+Parkauthor=Y.+H.+Juauthor=J.+W.+Choiauthor=H.+J.+Songauthor=B.+K.+Jangauthor=J.+Wooauthor=H.+Chunauthor=H.+J.+Kimauthor=S.+J.+Shinauthor=O.+Yarishkinauthor=S.+Joauthor=M.+Parkauthor=S.+K.+Yeonauthor=S.+Kimauthor=J.+Kimauthor=M.+H.+Namauthor=A.+M.+Londheauthor=J.+Kimauthor=S.+J.+Choauthor=S.+Choauthor=C.+Leeauthor=S.+Y.+Hwangauthor=S.+W.+Kimauthor=S.+J.+Ohauthor=J.+Choauthor=A.+N.+Paeauthor=C.+J.+Leeauthor=K.+D.+Park&title=Newly+developed+reversible+MAO-B+inhibitor+circumvents+the+shortcomings+of+irreversible+inhibitors+in+Alzheimer%E2%80%99s+disease&doi=10.1126%2Fsciadv.aav0316"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fsciadv.aav0316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fsciadv.aav0316%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DJu%26aufirst%3DY.%2BH.%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DSong%26aufirst%3DH.%2BJ.%26aulast%3DJang%26aufirst%3DB.%2BK.%26aulast%3DWoo%26aufirst%3DJ.%26aulast%3DChun%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DShin%26aufirst%3DS.%2BJ.%26aulast%3DYarishkin%26aufirst%3DO.%26aulast%3DJo%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DM.%26aulast%3DYeon%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DNam%26aufirst%3DM.%2BH.%26aulast%3DLondhe%26aufirst%3DA.%2BM.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DCho%26aufirst%3DS.%2BJ.%26aulast%3DCho%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DHwang%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DOh%26aufirst%3DS.%2BJ.%26aulast%3DCho%26aufirst%3DJ.%26aulast%3DPae%26aufirst%3DA.%2BN.%26aulast%3DLee%26aufirst%3DC.%2BJ.%26aulast%3DPark%26aufirst%3DK.%2BD.%26atitle%3DNewly%2520developed%2520reversible%2520MAO-B%2520inhibitor%2520circumvents%2520the%2520shortcomings%2520of%2520irreversible%2520inhibitors%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DSci.%2520Adv.%26date%3D2019%26volume%3D5%26doi%3D10.1126%2Fsciadv.aav0316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tzvetkov, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stammler, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hristova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonov, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gastreich, M.</span></span> <span> </span><span class="NLM_article-title">Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">470</span>– <span class="NLM_lpage">492</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1016%2Fj.ejmech.2017.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=28107736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVarsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2017&pages=470-492&author=N.+T.+Tzvetkovauthor=H.+G.+Stammlerauthor=B.+Neumannauthor=S.+Hristovaauthor=L.+Antonovauthor=M.+Gastreich&title=Crystal+structures%2C+binding+interactions%2C+and+ADME+evaluation+of+brain+penetrant+N-substituted+indazole-5-carboxamides+as+subnanomolar%2C+selective+monoamine+oxidase+B+and+dual+MAO-A%2FB+inhibitors&doi=10.1016%2Fj.ejmech.2017.01.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors</span></div><div class="casAuthors">Tzvetkov, Nikolay T.; Stammler, Hans-Georg; Neumann, Beate; Hristova, Silvia; Antonov, Liudmil; Gastreich, Marcus</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">470-492</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The pharmacol. and physicochem. anal. of structurally optimized N-alkyl-substituted indazole-5-carboxamides, developed as potential drug and radioligand candidates for the treatment and diagnosis of Parkinson's disease (PD) and other neurol. disorders, is reported.  Recent efforts have been focused on the development of subnanomolar potent, selective MAO-B (N1-alkyl-substituted compds. 12a-14a and 15) and dual active MAO-A/B (N2-methylated compds. 12b-14b) inhibitors with nanomolar potency towards MAO-B and moderately active against MAO-A enzyme, resp.  The most promising drug-like derivs. in both series were N-(3-chloro-4-fluorophenyl)-1-methyl-1H-indazole-5-carboxamide (13a, NTZ-1441, IC50 hMAO-B 0.662 nM, >15000-fold selective vs. MAO-A) and N-(3-chloro-4-fluorophenyl)-2-methyl-2H-indazole-5-carboxamide (13b, NTZ-1442, IC50 hMAO-B 8.08 nM, IC50 hMAO-A 0.56 μM, SI = 70).  Moreover, compds. 13a and 13b were predicted to cross both the gastrointestinal tract (at pH 2.0, 5.5, and 7,4) and the blood-brain barrier (BBB) in vitro with appropriate drug-like properties required for CNS active drugs.  Combined single X-ray/mol. modeling studies provided insights into the enzyme-inhibitor interactions within both MAO isoforms and the rationale for their inhibitory activity with controlled MAO-A/B selectivity - despite their small structural differences.  The binding modes of 12a,b and 13a,b confirmed that the major interactions with hMAO-B were established via the flexible carbonyl group of the carboxamide linkage and the electron-donating nitrogens N1 or N2 of the indazole moiety, allowing further exploration of the alkyl side chain for next step lead optimization efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor1v1iZCTAyrVg90H21EOLACvtfcHk0ljaHx3TbSLirQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVarsbw%253D&md5=77508134a49aff86ed626511a7857f82</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DTzvetkov%26aufirst%3DN.%2BT.%26aulast%3DStammler%26aufirst%3DH.%2BG.%26aulast%3DNeumann%26aufirst%3DB.%26aulast%3DHristova%26aufirst%3DS.%26aulast%3DAntonov%26aufirst%3DL.%26aulast%3DGastreich%26aufirst%3DM.%26atitle%3DCrystal%2520structures%252C%2520binding%2520interactions%252C%2520and%2520ADME%2520evaluation%2520of%2520brain%2520penetrant%2520N-substituted%2520indazole-5-carboxamides%2520as%2520subnanomolar%252C%2520selective%2520monoamine%2520oxidase%2520B%2520and%2520dual%2520MAO-A%252FB%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D127%26spage%3D470%26epage%3D492%26doi%3D10.1016%2Fj.ejmech.2017.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathitharan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furukawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boileau, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guttman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornykiewicz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kish, S. J.</span></span> <span> </span><span class="NLM_article-title">Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">2460</span>– <span class="NLM_lpage">2474</span>, <span class="refDoi"> DOI: 10.1093/brain/awx172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1093%2Fbrain%2Fawx172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=29050386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A280%3ADC%252BC1M7isFartQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2017&pages=2460-2474&author=J.+Tongauthor=G.+Rathitharanauthor=J.+H.+Meyerauthor=Y.+Furukawaauthor=L.+C.+Angauthor=I.+Boileauauthor=M.+Guttmanauthor=O.+Hornykiewiczauthor=S.+J.+Kish&title=Brain+monoamine+oxidase+B+and+A+in+human+parkinsonian+dopamine+deficiency+disorders&doi=10.1093%2Fbrain%2Fawx172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders</span></div><div class="casAuthors">Tong Junchao; Tong Junchao; Rathitharan Gausiha; Kish Stephen J; Meyer Jeffrey H; Furukawa Yoshiaki; Ang Lee-Cyn; Boileau Isabelle; Guttman Mark; Hornykiewicz Oleh</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2460-2474</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">See Jellinger (doi:10.1093/awx190) for a scientific commentary on this article.  The enzyme monoamine oxidases (B and A subtypes, encoded by MAOB and MAOA, respectively) are drug targets in the treatment of Parkinson's disease.  Inhibitors of MAOB are used clinically in Parkinson's disease for symptomatic purposes whereas the potential disease-modifying effect of monoamine oxidase inhibitors is debated.  As astroglial cells express high levels of MAOB, the enzyme has been proposed as a brain imaging marker of astrogliosis, a cellular process possibly involved in Parkinson's disease pathogenesis as elevation of MAOB in astrocytes might be harmful.  Since brain monoamine oxidase status in Parkinson's disease is uncertain, our objective was to measure, by quantitative immunoblotting in autopsied brain homogenates, protein levels of both monoamine oxidases in three different degenerative parkinsonian disorders: Parkinson's disease (n = 11), multiple system atrophy (n = 11), and progressive supranuclear palsy (n = 16) and in matched controls (n = 16).  We hypothesized that if MAOB is 'substantially' localized to astroglial cells, MAOB levels should be generally associated with standard astroglial protein measures (e.g. glial fibrillary acidic protein).  MAOB levels were increased in degenerating putamen (+83%) and substantia nigra (+10%, non-significant) in multiple system atrophy; in caudate (+26%), putamen (+27%), frontal cortex (+31%) and substantia nigra (+23%) of progressive supranuclear palsy; and in frontal cortex (+33%), but not in substantia nigra of Parkinson's disease, a region we previously reported no increase in astrocyte protein markers.  Although the magnitude of MAOB increase was less than those of standard astrocytic markers, significant positive correlations were observed amongst the astrocyte proteins and MAOB.  Despite suggestions that MAOA (versus MAOB) is primarily responsible for metabolism of dopamine in dopamine neurons, there was no loss of the enzyme in the parkinsonian substantia nigra; instead, increased nigral levels of a MAOA fragment and 'turnover' of the enzyme were observed in the conditions.  Our findings provide support that MAOB might serve as a biochemical imaging marker, albeit not entirely specific, for astrocyte activation in human brain.  The observation that MAOB protein concentration is generally increased in degenerating brain areas in multiple system atrophy (especially putamen) and in progressive supranuclear palsy, but not in the nigra in Parkinson's disease, also distinguishes astrocyte behaviour in Parkinson's disease from that in the two 'Parkinson-plus' conditions.  The question remains whether suppression of either MAOB in astrocytes or MAOA in dopamine neurons might influence progression of the parkinsonian disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCP3w9TYeAj4xhnOQkIHOxfW6udTcc2eaZC_Oi5Cc3Urntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7isFartQ%253D%253D&md5=f2857a981a1f403c31f0bd1f4d94389f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawx172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawx172%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DJ.%26aulast%3DRathitharan%26aufirst%3DG.%26aulast%3DMeyer%26aufirst%3DJ.%2BH.%26aulast%3DFurukawa%26aufirst%3DY.%26aulast%3DAng%26aufirst%3DL.%2BC.%26aulast%3DBoileau%26aufirst%3DI.%26aulast%3DGuttman%26aufirst%3DM.%26aulast%3DHornykiewicz%26aufirst%3DO.%26aulast%3DKish%26aufirst%3DS.%2BJ.%26atitle%3DBrain%2520monoamine%2520oxidase%2520B%2520and%2520A%2520in%2520human%2520parkinsonian%2520dopamine%2520deficiency%2520disorders%26jtitle%3DBrain%26date%3D2017%26volume%3D140%26spage%3D2460%26epage%3D2474%26doi%3D10.1093%2Fbrain%2Fawx172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dezsi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vecsei, L.</span></span> <span> </span><span class="NLM_article-title">Monoamine oxidase B onhibitors in Parkinson’s disease</span>. <i>CNS Neurol. Disord.: Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">425</span>– <span class="NLM_lpage">439</span>, <span class="refDoi"> DOI: 10.2174/1871527316666170124165222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.2174%2F1871527316666170124165222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=28124620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1SmtLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=425-439&author=L.+Dezsiauthor=L.+Vecsei&title=Monoamine+oxidase+B+onhibitors+in+Parkinson%E2%80%99s+disease&doi=10.2174%2F1871527316666170124165222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine Oxidase B Inhibitors in Parkinson's Disease</span></div><div class="casAuthors">Dezsi, Livia; Vecsei, Laszlo</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">425-439</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Parkinson's disease (PD) is a neurodegenerative disorder with a prevalence increasing with age.  Oxidative stress and glutamate toxicity are involved in its pathomechanism.  There are still many unmet needs of PD patients, including the alleviation of motor fluctuations and dyskinesias, and the development of therapies with neuroprotective potential.  To give an overview of the pharmacol. properties, the efficacy and safety of the monoamine oxidase B (MAO-B) inhibitors in the treatment of PD, with special focus on the results of randomized clin. trials.  A literature search was conducted in PubMed for 'PD treatment', 'MAO-B inhibitors', 'selegiline', 'rasagiline', 'safinamide' and 'clin. trials' with 'MAO-B inhibitors' in 'Parkinson' disease'.  Results: MAO-B inhibitors have a favorable pharmacokinetic profile, improve the dopamine deficient state and may have neuroprotective properties.  Safinamide exhibits an anti-glutamatergic effect as well.  When applied as monotherapy, MAO-B inhibitors provide a modest, but significant improvement of motor function and delay the need for levodopa.  Rasagiline and safinamide were proven safe and effective when added to a dopamine agonist in early PD.  As add-on to levodopa, MAO-B inhibitors significantly reduced off-time and were comparable in efficacy to COMT inhibitors.  Improvements were achieved as regards certain non-motor symptoms as well.  Due to the efficacy shown in clin. trials and their favorable side-effect profile, MAO-B inhibitors are valuable drugs in the treatment of PD.  They are recommended as monotherapy in the early stages of the disease and as add-on therapy to levodopa in advanced PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMA_sgCUd0GrVg90H21EOLACvtfcHk0lid4wDr5PDwLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1SmtLbE&md5=0d7e67bbd9daf48131efbd6494c620ad</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F1871527316666170124165222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871527316666170124165222%26sid%3Dliteratum%253Aachs%26aulast%3DDezsi%26aufirst%3DL.%26aulast%3DVecsei%26aufirst%3DL.%26atitle%3DMonoamine%2520oxidase%2520B%2520onhibitors%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2017%26volume%3D16%26spage%3D425%26epage%3D439%26doi%3D10.2174%2F1871527316666170124165222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guglielmi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carradori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ammazzalorso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secci, D.</span></span> <span> </span><span class="NLM_article-title">Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement?</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">1035</span>, <span class="refDoi"> DOI: 10.1080/17460441.2019.1637415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1080%2F17460441.2019.1637415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=31268358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A280%3ADC%252BB3Mzjs1Clug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=995-1035&author=P.+Guglielmiauthor=S.+Carradoriauthor=A.+Ammazzalorsoauthor=D.+Secci&title=Novel+approaches+to+the+discovery+of+selective+human+monoamine+oxidase-B+inhibitors%3A+is+there+room+for+improvement%3F&doi=10.1080%2F17460441.2019.1637415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement?</span></div><div class="casAuthors">Guglielmi Paolo; Secci Daniela; Carradori Simone; Ammazzalorso Alessandra</div><div class="citationInfo"><span class="NLM_cas:title">Expert opinion on drug discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">995-1035</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Introduction: Selective monoamine oxidase-B (MAO-B) inhibitors are currently used as coadjuvants for the treatment of early motor symptoms in Parkinson's disease.  They can, based on their chemical structure and mechanism of inhibition, be categorized into reversible and irreversible agents.  Areas covered: This review provides a comprehensive update on the development state of selective MAO-B inhibitors describing the results, structures, structure-activity relationships (SARs) and Medicinal chemistry strategies as well as the related shortcomings over the past five years.  Expert opinion: Researchers have explored and implemented new and old chemical scaffolds achieving high inhibitory potencies and isoform selectivity.  Most of them were characterized and proposed as multitarget agents able to act at different levels (including AChE inhibition, H3R or A2AR antagonism, antioxidant and chelating properties, Aβ1-42 aggregation reduction) in the network of aetiologies of neurodegenerative disorders.  These results can also be used to avoid 'cheese-reaction' effects and the occurrence of serotonergic syndrome in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTFNGmKNdPMSw8IxFYvehhofW6udTcc2eZwx4aN4LSvPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3Mzjs1Clug%253D%253D&md5=7b1ef202f4a7b71c8ec0ba861b5a5d5c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1080%2F17460441.2019.1637415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2019.1637415%26sid%3Dliteratum%253Aachs%26aulast%3DGuglielmi%26aufirst%3DP.%26aulast%3DCarradori%26aufirst%3DS.%26aulast%3DAmmazzalorso%26aufirst%3DA.%26aulast%3DSecci%26aufirst%3DD.%26atitle%3DNovel%2520approaches%2520to%2520the%2520discovery%2520of%2520selective%2520human%2520monoamine%2520oxidase-B%2520inhibitors%253A%2520is%2520there%2520room%2520for%2520improvement%253F%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2019%26volume%3D14%26spage%3D995%26epage%3D1035%26doi%3D10.1080%2F17460441.2019.1637415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orallo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5165</span>– <span class="NLM_lpage">5173</span>, <span class="refDoi"> DOI: 10.1021/jm2004267</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2004267" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlaisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5165-5173&author=A.+Gasparauthor=T.+Silvaauthor=M.+Yanezauthor=D.+Vinaauthor=F.+Oralloauthor=F.+Ortusoauthor=E.+Uriarteauthor=S.+Alcaroauthor=F.+Borges&title=Chromone%2C+a+privileged+scaffold+for+the+development+of+monoamine+oxidase+inhibitors&doi=10.1021%2Fjm2004267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors</span></div><div class="casAuthors">Gaspar, Alexandra; Silva, Tiago; Yanez, Matilde; Vina, Dolores; Orallo, Franscisco; Ortuso, Francesco; Uriarte, Eugenio; Alcaro, Stefano; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5165-5173</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two series of novel chromone derivs. I and II ( R = Ph, 4-OH-C6H4, 3-OH-4-MeO-C6H3, 3,4-(OH)2-C6H3, 3,4-(MeO)2-C6H3, 4-Cl-C6H4, 4-OCF3-C6H4, 4-CF3-C6H4, 4-NO2-C6H4, cyclohexyl, nPr) were synthesized and investigated for their ability to inhibit the activity of monoamine oxidase.  The SAR data indicate that chromone derivs. with substituents in position 3 of γ-pyrone nucleus act preferably as MAO-B inhibitors, with IC50 values in the nanomolar to micromolar range.  Almost all chromone 3-carboxamides display selectivity toward MAO-B.  Identical substitutions on position 2 of γ-pyrone nucleus result in complete loss of activity in both isoforms (chromones I except R = 4-OH-C6H4 and 3,4-(OH)2-C6H3).  Notably, chromone II(R = 4-Cl-C6H4) exhibits an MAO-B IC50 of 63 nM, greater than 1000-fold selectivity over MAO-A, and behaves as a quasi-reversible inhibitor.  Docking expts. onto the MAO binding of the most active compd. highlight different interaction patterns among the isoforms A and B.  The differential anal. of the solvation effects among the chromone isomers gave addnl. insight about the superior outline of the 3-substituted chromone derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKKLGzqjz4yLVg90H21EOLACvtfcHk0lid4wDr5PDwLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlaisb0%253D&md5=27e7bd37930e26f28fb5b624b2360457</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm2004267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2004267%26sid%3Dliteratum%253Aachs%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DSilva%26aufirst%3DT.%26aulast%3DYanez%26aufirst%3DM.%26aulast%3DVina%26aufirst%3DD.%26aulast%3DOrallo%26aufirst%3DF.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DChromone%252C%2520a%2520privileged%2520scaffold%2520for%2520the%2520development%2520of%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5165%26epage%3D5173%26doi%3D10.1021%2Fjm2004267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagide, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavarria, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remiao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">Discovery of new chemical entities for old targets: insights on the lead optimization of chromone-based monoamine oxidase B (MAO-B) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">5879</span>– <span class="NLM_lpage">5893</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00527</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00527" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC28XovVWksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5879-5893&author=J.+Reisauthor=F.+Cagideauthor=D.+Chavarriaauthor=T.+Silvaauthor=C.+Fernandesauthor=A.+Gasparauthor=E.+Uriarteauthor=F.+Remiaoauthor=S.+Alcaroauthor=F.+Ortusoauthor=F.+Borges&title=Discovery+of+new+chemical+entities+for+old+targets%3A+insights+on+the+lead+optimization+of+chromone-based+monoamine+oxidase+B+%28MAO-B%29+inhibitors&doi=10.1021%2Facs.jmedchem.6b00527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors</span></div><div class="casAuthors">Reis, Joana; Cagide, Fernando; Chavarria, Daniel; Silva, Tiago; Fernandes, Carlos; Gaspar, Alexandra; Uriarte, Eugenio; Remiao, Fernando; Alcaro, Stefano; Ortuso, Francesco; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5879-5893</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of new chem. entities endowed with potent, selective, and reversible monoamine oxidase B inhibitory activity is a clin. relevant subject.  Therefore, a small library of chromone derivs. was synthesized and screened toward human monoamine oxidase isoforms (hMAO-A and hMAO-B).  The structure-activity relationships studies strengthen the importance of the amide spacer and the direct linkage of carbonyl group to the γ-pyrone ring, along with the presence of meta and para substituents in the exocyclic ring.  The most potent MAO-B inhibitors were N-(3'-chlorophenyl)-4-oxo-4H-chromene-3-carboxamide (20) (IC50 = 403 pM) and N-(3',4'-dimethylphenyl)-4-oxo-4H-chromene-3-carboxamide (27) (IC50 = 669 pM), acting as competitive and noncompetitive reversible inhibitors, resp.  Computational docking studies provided insights into enzyme-inhibitor interactions and a rationale for the obsd. selectivity and potency.  Compd. 27 stands out due to its favorable toxicol. profile and physicochem. properties, which pointed toward blood-brain barrier permeability, thus being a valid candidate for subsequent animal studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWONk5yTkyN7Vg90H21EOLACvtfcHk0liD5uVgU74GHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XovVWksb8%253D&md5=361d3dde07c197e2bdc41d08746a35f6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00527%26sid%3Dliteratum%253Aachs%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DCagide%26aufirst%3DF.%26aulast%3DChavarria%26aufirst%3DD.%26aulast%3DSilva%26aufirst%3DT.%26aulast%3DFernandes%26aufirst%3DC.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DRemiao%26aufirst%3DF.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520new%2520chemical%2520entities%2520for%2520old%2520targets%253A%2520insights%2520on%2520the%2520lead%2520optimization%2520of%2520chromone-based%2520monoamine%2520oxidase%2520B%2520%2528MAO-B%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5879%26epage%3D5893%26doi%3D10.1021%2Facs.jmedchem.6b00527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagetta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">Coumarin versus chromone monoamine oxidase B inhibitors: quo vadis?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7206</span>– <span class="NLM_lpage">7212</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00918</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00918" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Cntb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7206-7212&author=A.+Fonsecaauthor=J.+Reisauthor=T.+Silvaauthor=M.+J.+Matosauthor=D.+Bagettaauthor=F.+Ortusoauthor=S.+Alcaroauthor=E.+Uriarteauthor=F.+Borges&title=Coumarin+versus+chromone+monoamine+oxidase+B+inhibitors%3A+quo+vadis%3F&doi=10.1021%2Facs.jmedchem.7b00918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Coumarin versus Chromone Monoamine Oxidase B Inhibitors: Quo Vadis?</span></div><div class="casAuthors">Fonseca, Andre; Reis, Joana; Silva, Tiago; Matos, Maria Joao; Bagetta, Donatella; Ortuso, Francesco; Alcaro, Stefano; Uriarte, Eugenio; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7206-7212</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of the lack of significant disease-modifying drugs for neurodegenerative disorders, a pressing need for new chem. entities endowed with IMAO-B still exists.  Within this framework, and for the first time, a study was performed to compare coumarin- and chromone-3-phenylcarboxamide scaffolds.  Compds. I and II were the most potent, selective, and reversible noncompetitive IMAO-B.  The benzopyrone sp2 oxygen atom was found to be position independent and a productive contributor for the ligand-enzyme complex stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogLjC3cJIkZbVg90H21EOLACvtfcHk0liD5uVgU74GHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Cntb7K&md5=4af88b342ccfe910629ef704b6a65fc6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00918%26sid%3Dliteratum%253Aachs%26aulast%3DFonseca%26aufirst%3DA.%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DSilva%26aufirst%3DT.%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DBagetta%26aufirst%3DD.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DCoumarin%2520versus%2520chromone%2520monoamine%2520oxidase%2520B%2520inhibitors%253A%2520quo%2520vadis%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7206%26epage%3D7212%26doi%3D10.1021%2Facs.jmedchem.7b00918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milhazes, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orallo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">Chromone-2- and −3-carboxylic acids inhibit differently monoamine oxidases A and B</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2709</span>– <span class="NLM_lpage">2712</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.03.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1016%2Fj.bmcl.2010.03.081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=20382016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFeqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2709-2712&author=S.+Alcaroauthor=A.+Gasparauthor=F.+Ortusoauthor=N.+Milhazesauthor=F.+Oralloauthor=E.+Uriarteauthor=M.+Yanezauthor=F.+Borges&title=Chromone-2-+and+%E2%88%923-carboxylic+acids+inhibit+differently+monoamine+oxidases+A+and+B&doi=10.1016%2Fj.bmcl.2010.03.081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B</span></div><div class="casAuthors">Alcaro, Stefano; Gaspar, Alexandra; Ortuso, Francesco; Milhazes, Nuno; Orallo, Francisco; Uriarte, Eugenio; Yanez, Matilde; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2709-2712</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Chromone carboxylic acids were evaluated as human monoamine oxidase A and B (hMAO-A and hMAO-B) inhibitors.  The biol. data indicated that only chromone-3-carboxylic acid is a potent hMAO-B inhibitor, with a high degree of selectivity for hMAO-B compared to hMAO-A.  Conversely the chromone-2-carboxylic acid resulted almost inactive against both MAO isoforms.  Docking expts. were performed to elucidate the reasons of the different MAO IC50 data and to explain the absence of activity vs. selectivity, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFt7f6F1PaYbVg90H21EOLACvtfcHk0lirKsDNzkDogg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFeqtbk%253D&md5=a658e00cc4677f548e4607b6179a244b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.03.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.03.081%26sid%3Dliteratum%253Aachs%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DMilhazes%26aufirst%3DN.%26aulast%3DOrallo%26aufirst%3DF.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DYanez%26aufirst%3DM.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DChromone-2-%2520and%2520%25E2%2588%25923-carboxylic%2520acids%2520inhibit%2520differently%2520monoamine%2520oxidases%2520A%2520and%2520B%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2709%26epage%3D2712%26doi%3D10.1016%2Fj.bmcl.2010.03.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manzella, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagide, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mialet-Perez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span> <span> </span><span class="NLM_article-title">Tight-binding inhibition of human monoamine oxidase B by chromone analogs: a kinetic, crystallographic, and biological analysis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4203</span>– <span class="NLM_lpage">4212</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00357</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00357" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsFSnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4203-4212&author=J.+Reisauthor=N.+Manzellaauthor=F.+Cagideauthor=J.+Mialet-Perezauthor=E.+Uriarteauthor=A.+Pariniauthor=F.+Borgesauthor=C.+Binda&title=Tight-binding+inhibition+of+human+monoamine+oxidase+B+by+chromone+analogs%3A+a+kinetic%2C+crystallographic%2C+and+biological+analysis&doi=10.1021%2Facs.jmedchem.8b00357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Tight-Binding Inhibition of Human Monoamine Oxidase B by Chromone Analogs: A Kinetic, Crystallographic, and Biological Analysis</span></div><div class="casAuthors">Reis, Joana; Manzella, Nicola; Cagide, Fernando; Mialet-Perez, Jeanne; Uriarte, Eugenio; Parini, Angelo; Borges, Fernanda; Binda, Claudia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4203-4212</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoamine oxidase B (MAO-B) is a validated drug target for Parkinson's disease.  Chromone derivs. were identified as novel potent and reversible MAO-B inhibitors, and herewith we report on a crystallog. and biochem. anal. to investigate their inhibition mechanism.  The crystal structures of human MAO-B in complex with three chromone analogs bearing different substituents on the exocyclic arom. ring (detd. at 1.6-1.8 Å resoln.) showed that they all bind in the active site cavity of the protein with the chromone moiety located in front of the FAD cofactor.  These inhibitors form two hydrogen bonds with Tyr435 and Cys172 and perfectly fit the hydrophobic flat active site of human MAO-B.  This is reflected in their tight-binding mechanism of inhibition with Ki values of 55, 17, and 31 nM for N-(3',4'-dimethylphenyl)-4-oxo-4H-chromene-3-carboxamide (1), N-(3'-chlorophenyl)-4-oxo-4H-chromene-3-carboxamide (2), and N-(3'-fluorophenyl)-4-oxo-4H-chromene-3-carboxamide (3), resp.  These compds. were also 1000-fold more effective than L-deprenyl in reducing the cellular levels of reactive oxygen species (ROS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI4_ZAaYfpTbVg90H21EOLACvtfcHk0lirKsDNzkDogg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnsFSnsrw%253D&md5=129e0b5bbd744bc3ef74a75bda97a550</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00357%26sid%3Dliteratum%253Aachs%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DManzella%26aufirst%3DN.%26aulast%3DCagide%26aufirst%3DF.%26aulast%3DMialet-Perez%26aufirst%3DJ.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DParini%26aufirst%3DA.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DBinda%26aufirst%3DC.%26atitle%3DTight-binding%2520inhibition%2520of%2520human%2520monoamine%2520oxidase%2520B%2520by%2520chromone%2520analogs%253A%2520a%2520kinetic%252C%2520crystallographic%252C%2520and%2520biological%2520analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4203%26epage%3D4212%26doi%3D10.1021%2Facs.jmedchem.8b00357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duarte, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">Exploring coumarin potentialities: development of new enzymatic inhibitors based on the 6-methyl-3-carboxamidocoumarin scaffold</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">49764</span>– <span class="NLM_lpage">49768</span>, <span class="refDoi"> DOI: 10.1039/C6RA05262B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1039%2FC6RA05262B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC28XnslGrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=49764-49768&author=A.+Fonsecaauthor=M.+J.+Matosauthor=J.+Reisauthor=Y.+Duarteauthor=M.+Guti%C3%A9rrezauthor=L.+Santanaauthor=E.+Uriarteauthor=F.+Borges&title=Exploring+coumarin+potentialities%3A+development+of+new+enzymatic+inhibitors+based+on+the+6-methyl-3-carboxamidocoumarin+scaffold&doi=10.1039%2FC6RA05262B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring coumarin potentialities: development of new enzymatic inhibitors based on the 6-methyl-3-carboxamidocoumarin scaffold</span></div><div class="casAuthors">Fonseca, A.; Matos, M. J.; Reis, J.; Duarte, Y.; Gutierrez, M.; Santana, L.; Uriarte, E.; Borges, F.</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">55</span>),
    <span class="NLM_cas:pages">49764-49768</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Novel 6-methyl-3-carboxamidocoumarins (compds. 4-15) were synthesized by an effective three step synthetic strategy and screened towards MAO, AChE and BuChE enzymes.  In general, the compds. act as selective MAO-B inhibitors.  Compd. 11 is highlighted as a potent (IC50hMAO-B = 4.66 nM), reversible and non-competitive MAO-B inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplBWq-igGTwbVg90H21EOLACvtfcHk0lj4Dvh3VkBSsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnslGrsLc%253D&md5=da27ffcde3302441f92d2610025db7a8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1039%2FC6RA05262B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6RA05262B%26sid%3Dliteratum%253Aachs%26aulast%3DFonseca%26aufirst%3DA.%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DDuarte%26aufirst%3DY.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DM.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DExploring%2520coumarin%2520potentialities%253A%2520development%2520of%2520new%2520enzymatic%2520inhibitors%2520based%2520on%2520the%25206-methyl-3-carboxamidocoumarin%2520scaffold%26jtitle%3DRSC%2520Adv.%26date%3D2016%26volume%3D6%26spage%3D49764%26epage%3D49768%26doi%3D10.1039%2FC6RA05262B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwivedi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 6-aryl substituted 4-quinolones via Suzuki cross coupling</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">6254</span>– <span class="NLM_lpage">6260</span>, <span class="refDoi"> DOI: 10.1039/c3ra45056b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1039%2Fc3ra45056b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1Whug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=6254-6260&author=S.+Guptaauthor=P.+Ghoshauthor=S.+Dwivediauthor=S.+Das&title=Synthesis+of+6-aryl+substituted+4-quinolones+via+Suzuki+cross+coupling&doi=10.1039%2Fc3ra45056b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 6-aryl substituted 4-quinolones via Suzuki cross coupling</span></div><div class="casAuthors">Gupta, Sumanta; Ghosh, Prasanjit; Dwivedi, Seema; Das, Sajal</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6254-6260</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A suitable synthetic approach to obtain bromo and aryl substitution at 6-position of 4-quinolones has been demonstrated.  Arylated quinolones, e.g., I, were synthesized by subjecting 6-bromoquinolones to Suzuki cross coupling reaction with different aryl boronic acids.  Both electron withdrawing and donating groups were well tolerated to provide excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBcDTmzoOdELVg90H21EOLACvtfcHk0lj4Dvh3VkBSsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1Whug%253D%253D&md5=5eb7a0f3ef982d750263932335a162bd</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1039%2Fc3ra45056b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3ra45056b%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DGhosh%26aufirst%3DP.%26aulast%3DDwivedi%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DS.%26atitle%3DSynthesis%2520of%25206-aryl%2520substituted%25204-quinolones%2520via%2520Suzuki%2520cross%2520coupling%26jtitle%3DRSC%2520Adv.%26date%3D2014%26volume%3D4%26spage%3D6254%26epage%3D6260%26doi%3D10.1039%2Fc3ra45056b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hadida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Goor, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arumugam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCartney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazlewood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negulescu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grootenhuis, P. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, ivacaftor), a potent and orally bioavailable CFTR potentiator</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9776</span>– <span class="NLM_lpage">9795</span>, <span class="refDoi"> DOI: 10.1021/jm5012808</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5012808" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGlsb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9776-9795&author=S.+Hadidaauthor=F.+Van+Goorauthor=J.+Zhouauthor=V.+Arumugamauthor=J.+McCartneyauthor=A.+Hazlewoodauthor=C.+Deckerauthor=P.+Negulescuauthor=P.+D.+Grootenhuis&title=Discovery+of+N-%282%2C4-di-tert-butyl-5-hydroxyphenyl%29-4-oxo-1%2C4-dihydroquinoline-3-carboxamide+%28VX-770%2C+ivacaftor%29%2C+a+potent+and+orally+bioavailable+CFTR+potentiator&doi=10.1021%2Fjm5012808"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, Ivacaftor), a Potent and Orally Bioavailable CFTR Potentiator</span></div><div class="casAuthors">Hadida, Sabine; Van Goor, Fredrick; Zhou, Jinglan; Arumugam, Vijayalaksmi; McCartney, Jason; Hazlewood, Anna; Decker, Caroline; Negulescu, Paul; Grootenhuis, Peter D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9776-9795</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Quinolinone-3-carboxamide 1, a novel CFTR potentiator, was discovered using high-throughput screening in NIH-3T3 cells expressing the F508del-CFTR mutation.  Extensive medicinal chem. and iterative structure-activity relationship (SAR) studies to evaluate potency, selectivity, and pharmacokinetic properties resulted in the identification of N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, 48, ivacaftor), an investigational drug candidate approved by the FDA for the treatment of CF patients 6 years of age and older carrying the G551D mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfCmDwR5g0hbVg90H21EOLACvtfcHk0liTqw_blySP5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGlsb%252FO&md5=c4ed161be3b5d7752e7591d2c4847637</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm5012808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5012808%26sid%3Dliteratum%253Aachs%26aulast%3DHadida%26aufirst%3DS.%26aulast%3DVan%2BGoor%26aufirst%3DF.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DArumugam%26aufirst%3DV.%26aulast%3DMcCartney%26aufirst%3DJ.%26aulast%3DHazlewood%26aufirst%3DA.%26aulast%3DDecker%26aufirst%3DC.%26aulast%3DNegulescu%26aufirst%3DP.%26aulast%3DGrootenhuis%26aufirst%3DP.%2BD.%26atitle%3DDiscovery%2520of%2520N-%25282%252C4-di-tert-butyl-5-hydroxyphenyl%2529-4-oxo-1%252C4-dihydroquinoline-3-carboxamide%2520%2528VX-770%252C%2520ivacaftor%2529%252C%2520a%2520potent%2520and%2520orally%2520bioavailable%2520CFTR%2520potentiator%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9776%26epage%3D9795%26doi%3D10.1021%2Fjm5012808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mesiti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruca, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remiao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">4-Oxoquinolines and monoamine oxidase: when tautomerism matters</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>213</i></span>,  <span class="NLM_fpage">113183</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2021.113183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1016%2Fj.ejmech.2021.113183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=33493825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BB3MXitFWmsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=2021&pages=113183&author=F.+Mesitiauthor=A.+Marucaauthor=V.+Silvaauthor=R.+Roccaauthor=C.+Fernandesauthor=F.+Remiaoauthor=E.+Uriarteauthor=S.+Alcaroauthor=A.+Gasparauthor=F.+Borges&title=4-Oxoquinolines+and+monoamine+oxidase%3A+when+tautomerism+matters&doi=10.1016%2Fj.ejmech.2021.113183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">4-Oxoquinolines and monoamine oxidase: When tautomerism matters</span></div><div class="casAuthors">Mesiti, Francesco; Maruca, Annalisa; Silva, Vera; Rocca, Roberta; Fernandes, Carlos; Remiao, Fernando; Uriarte, Eugenio; Alcaro, Stefano; Gaspar, Alexandra; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">113183</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">4-Oxoquinoline derivs. have been often used in drug discovery programs due to their pharmacol. properties.  Inspired on chromone and 4-oxoquinoline chem. structure similarity, a small series of quinoline-based compds. was obtained and screened, for the first time, toward human monoamine oxidases isoforms.  The data showed the N-(3,4-dichlorophenyl)-1-methyl-4-oxo-1,4-dihydroquinoline-3-carboxamide 10 was the most potent and selective MAO-B inhibitor (IC50 = 5.30 ± 0.74 nM and SI: ≥1887).  The data anal. showed that prototropic tautomerism markedly influences the biol. activity.  The unequivocal characterization of the quinoline tautomers was performed to understand the attained data.  To our knowledge, there have been no prior reports on the characterization of quinolone tautomers by 2D NMR techniques, namely by 1H-15N HSQC and 1H-15N HMBC, which are proposed as expedite tools for medicinal chem. campaigns.  Computational studies on enzyme-ligand complexes, obtained after MM-GBSA calcns. and mol. dynamics simulations, supported the exptl. data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT8kqZIvuKW7Vg90H21EOLACvtfcHk0liTqw_blySP5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXitFWmsbs%253D&md5=6942d53de30251a6e6364eae93b767d2</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2021.113183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2021.113183%26sid%3Dliteratum%253Aachs%26aulast%3DMesiti%26aufirst%3DF.%26aulast%3DMaruca%26aufirst%3DA.%26aulast%3DSilva%26aufirst%3DV.%26aulast%3DRocca%26aufirst%3DR.%26aulast%3DFernandes%26aufirst%3DC.%26aulast%3DRemiao%26aufirst%3DF.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3D4-Oxoquinolines%2520and%2520monoamine%2520oxidase%253A%2520when%2520tautomerism%2520matters%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2021%26volume%3D213%26spage%3D113183%26doi%3D10.1016%2Fj.ejmech.2021.113183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesiti, F.</span></span> <span> </span><span class="NLM_article-title">The synthesis, crystal structure and Hirshfeld analysis of 4-(3,4-dimethylanilino)-N-(3,4-dimethylphenyl)quinoline-3-carboxamide</span>. <i>Acta Crystallogr., Sect. E: Crystallogr. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1107/S2056989020000298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1107%2FS2056989020000298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=32071747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitlKgtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2020&pages=201-207&author=L.+R.+Gomesauthor=J.+N.+Lowauthor=F.+Borgesauthor=A.+Gasparauthor=F.+Mesiti&title=The+synthesis%2C+crystal+structure+and+Hirshfeld+analysis+of+4-%283%2C4-dimethylanilino%29-N-%283%2C4-dimethylphenyl%29quinoline-3-carboxamide&doi=10.1107%2FS2056989020000298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis, crystal structure and Hirshfeld analysis of 4-(3,4-dimethylanilino)-N-(3,4-dimethylphenyl)quinoline-3-carboxamide</span></div><div class="casAuthors">Gomes, Ligia R.; Low, John Nicolson; Borges, Fernanda; Gaspar, Alexandra; Mesiti, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section E: Crystallographic Communications</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-207</span>CODEN:
                <span class="NLM_cas:coden">ACSECI</span>;
        ISSN:<span class="NLM_cas:issn">2056-9890</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The structure of the title quinoline carboxamide deriv., C26H25N3O, is described.  The quinoline moiety is not planar as a result of a slight puckering of the pyridine ring.  The secondary amine has a slightly pyramidal geometry, certainly not planar.  Both intra- and intermol. hydrogen bonds are present.  Hirshfeld surface anal. and lattice energies were used to investigate the intermol. interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoohEDeBer7LrVg90H21EOLACvtfcHk0liDTmk1ggLfYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitlKgtr0%253D&md5=a5bf605552dee511605e26e3e5f6aab9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1107%2FS2056989020000298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2056989020000298%26sid%3Dliteratum%253Aachs%26aulast%3DGomes%26aufirst%3DL.%2BR.%26aulast%3DLow%26aufirst%3DJ.%2BN.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DMesiti%26aufirst%3DF.%26atitle%3DThe%2520synthesis%252C%2520crystal%2520structure%2520and%2520Hirshfeld%2520analysis%2520of%25204-%25283%252C4-dimethylanilino%2529-N-%25283%252C4-dimethylphenyl%2529quinoline-3-carboxamide%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520E%253A%2520Crystallogr.%2520Commun.%26date%3D2020%26volume%3D76%26spage%3D201%26epage%3D207%26doi%3D10.1107%2FS2056989020000298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cecchetti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fravolini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fringuelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiaffella, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzini, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabarrini, O.</span></span> <span> </span><span class="NLM_article-title">4H-1-benzothiopyran-4-one-3-carboxylic acids and 3,4-dihydro-2H-isothiazolo[5,4-bbenzothiopyran-3,4-diones as quinolone antibacterial analogs</span>. <i>J. Heterocycl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1143</span>– <span class="NLM_lpage">1148</span>, <span class="refDoi"> DOI: 10.1002/jhet.5570300455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1002%2Fjhet.5570300455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADyaK2cXisVCrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1993&pages=1143-1148&author=V.+Cecchettiauthor=A.+Fravoliniauthor=R.+Fringuelliauthor=F.+Schiaffellaauthor=M.+C.+Lorenziniauthor=O.+Tabarrini&title=4H-1-benzothiopyran-4-one-3-carboxylic+acids+and+3%2C4-dihydro-2H-isothiazolo%5B5%2C4-bbenzothiopyran-3%2C4-diones+as+quinolone+antibacterial+analogs&doi=10.1002%2Fjhet.5570300455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">4H-1-Benzothiopyran-4-one-3-carboxylic acids and 3,4-dihydro-2H-isothiazolo[5,4-b][1]benzothiopyran-3,4-diones as quinolone antibacterial analogs</span></div><div class="casAuthors">Cecchetti, Violetta; Fravolini, Arnaldo; Fringuelli, Renata; Schiaffella, Fausto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Heterocyclic Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1143-8</span>CODEN:
                <span class="NLM_cas:coden">JHTCAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-152X</span>.
    </div><div class="casAbstract">The endocyclic replacement of a nitrogen atom at the 1-position of quinolone antibacterial nucleus with a sulfur atom was investigated.  A series of 1-benzothiopyran-4-one-3-carboxylic acids I and isothiazolo[5,4-b][1]benzothiopyran-3,4-diones II (R = 4-methyl-, 3-methyl-, and 3,5-dimethyl-1-piperazinyl) was prepd.  Antibacterial evaluation of the synthesized compds. showed an activity comparable to that of nalidixic acid for I, while an increased activity against gram-pos. bacteria was obsd. for II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw4Bn6iqHBNbVg90H21EOLACvtfcHk0liDTmk1ggLfYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXisVCrsrs%253D&md5=09697951b80f60cdc5b7d6d7811fd321</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570300455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570300455%26sid%3Dliteratum%253Aachs%26aulast%3DCecchetti%26aufirst%3DV.%26aulast%3DFravolini%26aufirst%3DA.%26aulast%3DFringuelli%26aufirst%3DR.%26aulast%3DSchiaffella%26aufirst%3DF.%26aulast%3DLorenzini%26aufirst%3DM.%2BC.%26aulast%3DTabarrini%26aufirst%3DO.%26atitle%3D4H-1-benzothiopyran-4-one-3-carboxylic%2520acids%2520and%25203%252C4-dihydro-2H-isothiazolo%255B5%252C4-bbenzothiopyran-3%252C4-diones%2520as%2520quinolone%2520antibacterial%2520analogs%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1993%26volume%3D30%26spage%3D1143%26epage%3D1148%26doi%3D10.1002%2Fjhet.5570300455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wentland, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesher, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruett, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldous, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorff, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rake, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coughlin, S. A.</span></span> <span> </span><span class="NLM_article-title">Mammalian topoisomerase II inhibitory activity of 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarboxylic acid and related derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">2801</span>– <span class="NLM_lpage">2809</span>, <span class="refDoi"> DOI: 10.1021/jm00071a010</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00071a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADyaK2cXnslSqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=2801-2809&author=M.+P.+Wentlandauthor=G.+Y.+Lesherauthor=M.+Reumanauthor=M.+D.+Gruettauthor=B.+Singhauthor=S.+C.+Aldousauthor=P.+H.+Dorffauthor=J.+B.+Rakeauthor=S.+A.+Coughlin&title=Mammalian+topoisomerase+II+inhibitory+activity+of+1-cyclopropyl-6%2C8-difluoro-1%2C4-dihydro-7-%282%2C6-dimethyl-4-pyridinyl%29-4-oxo-3-quinolinecarboxylic+acid+and+related+derivatives&doi=10.1021%2Fjm00071a010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian topoisomerase II inhibitory activity of 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarboxylic acid and related derivatives</span></div><div class="casAuthors">Wentland, Mark P.; Lesher, George Y.; Reuman, Michael; Gruett, Monte D.; Singh, Baldev; Aldous, Suzanne C.; Dorff, Peter H.; Rake, James B.; Coughlin, Susan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2801-9</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The title compd. (I), a previously reported potent inhibitor of bacterial DNA gyrase, was found to be interactive with mammalian topoisomerase II (topo II).  In a DNA-cleavage assay using topo II isolated from HeLa cells, I exhibited an EC50 value of 7.6 μM (VP-16; EC50 = 0.81 μM).  A series of analogs modified at the 1-, 2-, 3-, 5-, and 7-positions of I were subsequently made and assessed for topo II inhibition.  Compd. I was considerably more potent than derivs. where the 1-substituent was alkyl, aryl, or H, or when the cyclopropylimino group was replaced with S.  The descarboxyl (i.e., 3-H) analog had potency comparable to that of I; when both these compds. were substituted at the 2-position with Me or Ph, an interesting relationship between activity and the conformation of the carboxyl group emerged.  Upon replacement of the 5-H of I with NH2 or F, sustained potency was seen.  No enhancement of activity was evident upon replacing the 7-substituent of I with other pyridinyl groups, 4-methyl-1-piperazinyl, or pyrrolidinyl groups; however, the 7-(4-hydroxyphenyl) analog (CP-115,953) was 6-fold more potent than I.  The topo II inhibitory properties of I translated to modest in vitro cytotoxicity and in vivo activity vs. P388.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPgstdxMSWf7Vg90H21EOLACvtfcHk0lj0wKXLoafVRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXnslSqug%253D%253D&md5=e03e53662ff80eea35e8b4af8aeb5c04</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm00071a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00071a010%26sid%3Dliteratum%253Aachs%26aulast%3DWentland%26aufirst%3DM.%2BP.%26aulast%3DLesher%26aufirst%3DG.%2BY.%26aulast%3DReuman%26aufirst%3DM.%26aulast%3DGruett%26aufirst%3DM.%2BD.%26aulast%3DSingh%26aufirst%3DB.%26aulast%3DAldous%26aufirst%3DS.%2BC.%26aulast%3DDorff%26aufirst%3DP.%2BH.%26aulast%3DRake%26aufirst%3DJ.%2BB.%26aulast%3DCoughlin%26aufirst%3DS.%2BA.%26atitle%3DMammalian%2520topoisomerase%2520II%2520inhibitory%2520activity%2520of%25201-cyclopropyl-6%252C8-difluoro-1%252C4-dihydro-7-%25282%252C6-dimethyl-4-pyridinyl%2529-4-oxo-3-quinolinecarboxylic%2520acid%2520and%2520related%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D2801%26epage%3D2809%26doi%3D10.1021%2Fjm00071a010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chavarria, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil-Martins, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soares, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remiao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">Design of novel monoamine oxidase-B inhibitors based on piperine scaffold: structure-activity-toxicity, drug-likeness and efflux transport studies</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>185</i></span>,  <span class="NLM_fpage">111770</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.111770</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1016%2Fj.ejmech.2019.111770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=31711793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFCjsr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2020&pages=111770&author=D.+Chavarriaauthor=C.+Fernandesauthor=V.+Silvaauthor=C.+Silvaauthor=E.+Gil-Martinsauthor=P.+Soaresauthor=T.+Silvaauthor=R.+Silvaauthor=F.+Remiaoauthor=P.+J.+Oliveiraauthor=F.+Borges&title=Design+of+novel+monoamine+oxidase-B+inhibitors+based+on+piperine+scaffold%3A+structure-activity-toxicity%2C+drug-likeness+and+efflux+transport+studies&doi=10.1016%2Fj.ejmech.2019.111770"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Design of novel monoamine oxidase-B inhibitors based on piperine scaffold: structure-activity-toxicity, drug-likeness and efflux transport studies</span></div><div class="casAuthors">Chavarria, Daniel; Fernandes, Carlos; Silva, Vera; Silva, Catia; Gil-Martins, Eva; Soares, Pedro; Silva, Tiago; Silva, Renata; Remiao, Fernando; Oliveira, Paulo J.; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111770</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Piperine has been assocd. with neuroprotective effects and monoamine oxidase (MAO) inhibition, thus being an attractive scaffold to develop new antiparkinsonian agents.  Accordingly, we prepd. a small library of piperine derivs. and screened the inhibitory activities towards human MAO isoforms (hMAO-A and hMAO-B).  Structure-activity relationship (SAR) studies pointed out that the combination of α-cyano and benzyl ester groups increased both potency and selectivity towards hMAO-B.  Kinetic expts. with compds. 7 (I), 10 (II) and 15 (III) indicated a competitive hMAO-B inhibition mechanism.  Compds. III and 16 (IV), at 10μM, caused a small but significant decrease in P-gp efflux activity in Caco-2 cells.  III stands out as the most potent piperine-based hMAO-B inhibitor (IC50 = 47.4 nM), displaying favorable drug-like properties and a broad safety window.  III is thus a suitable candidate for lead optimization and the development of multitarget-directed ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSI0xBNDEdRrVg90H21EOLACvtfcHk0lj0wKXLoafVRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFCjsr%252FF&md5=677a2ad762189d6758a553f52c422014</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.111770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.111770%26sid%3Dliteratum%253Aachs%26aulast%3DChavarria%26aufirst%3DD.%26aulast%3DFernandes%26aufirst%3DC.%26aulast%3DSilva%26aufirst%3DV.%26aulast%3DSilva%26aufirst%3DC.%26aulast%3DGil-Martins%26aufirst%3DE.%26aulast%3DSoares%26aufirst%3DP.%26aulast%3DSilva%26aufirst%3DT.%26aulast%3DSilva%26aufirst%3DR.%26aulast%3DRemiao%26aufirst%3DF.%26aulast%3DOliveira%26aufirst%3DP.%2BJ.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DDesign%2520of%2520novel%2520monoamine%2520oxidase-B%2520inhibitors%2520based%2520on%2520piperine%2520scaffold%253A%2520structure-activity-toxicity%252C%2520drug-likeness%2520and%2520efflux%2520transport%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D185%26spage%3D111770%26doi%3D10.1016%2Fj.ejmech.2019.111770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chavarria, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagide, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">Development of piperic acid-based monoamine oxidase inhibitors: synthesis, structural characterization and biological evaluation</span>. <i>J. Mol. Struct.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1182</i></span>,  <span class="NLM_fpage">298</span>– <span class="NLM_lpage">307</span>, <span class="refDoi"> DOI: 10.1016/j.molstruc.2019.01.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1016%2Fj.molstruc.2019.01.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1Ciuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1182&publication_year=2019&pages=298-307&author=D.+Chavarriaauthor=F.+Cagideauthor=M.+Pintoauthor=L.+R.+Gomesauthor=J.+N.+Lowauthor=F.+Borges&title=Development+of+piperic+acid-based+monoamine+oxidase+inhibitors%3A+synthesis%2C+structural+characterization+and+biological+evaluation&doi=10.1016%2Fj.molstruc.2019.01.060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Development of piperic acid-based monoamine oxidase inhibitors: synthesis, structural characterization and biological evaluation</span></div><div class="casAuthors">Chavarria, Daniel; Cagide, Fernando; Pinto, Miguel; Gomes, Ligia R.; Low, John N.; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Structure</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1182</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">298-307</span>CODEN:
                <span class="NLM_cas:coden">JMOSB4</span>;
        ISSN:<span class="NLM_cas:issn">0022-2860</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of piperic acid esters and amides I [R = Ph, Bn; X = NH, O] were synthesized using a two-step strategy.  Mass spectrometry and unidimensional (1H NMR, 13C NMR, DEPT) and bidimensional (COSY, HSQC, HMBC) NMR methodologies were used to study the mol. structure of the final compds. I, resulting in the assignment of all detected signals.  Preliminary biol. data of piperine and the derivs. thereof showed that piperic acid and amides I [R = Ph, Bn; X = NH] did not display significant inhibitory activity at 10 μM against both hMAO-A and hMAO-B.  In contrast, the esters I [R = Ph, Bn; X = O] displayed relevant hMAO inhibitory activities, with IC50 values for hMAO-B lower than piperine and within the nanomolar range.  Moreover, X-ray crystallog. anal. showed relevant differences between amides and esters I [R = Ph, Bn; X = O] constituting a valuable information to understand the ligand-target interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNJ6ffPPPY8bVg90H21EOLACvtfcHk0ljhDE7oXP2IDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1Ciuro%253D&md5=74b696993d82614a8b5c54f5143cf16c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.molstruc.2019.01.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molstruc.2019.01.060%26sid%3Dliteratum%253Aachs%26aulast%3DChavarria%26aufirst%3DD.%26aulast%3DCagide%26aufirst%3DF.%26aulast%3DPinto%26aufirst%3DM.%26aulast%3DGomes%26aufirst%3DL.%2BR.%26aulast%3DLow%26aufirst%3DJ.%2BN.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DDevelopment%2520of%2520piperic%2520acid-based%2520monoamine%2520oxidase%2520inhibitors%253A%2520synthesis%252C%2520structural%2520characterization%2520and%2520biological%2520evaluation%26jtitle%3DJ.%2520Mol.%2520Struct.%26date%3D2019%26volume%3D1182%26spage%3D298%26epage%3D307%26doi%3D10.1016%2Fj.molstruc.2019.01.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonifácio, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieira Coelho, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soares da Silva, P. c.</span></span> <span> </span><span class="NLM_article-title">Kinetic inhibitory profile of BIA 3-202, a novel fast tight-binding, reversible and competitive catechol-O-methyltransferase inhibitor</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>460</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1016/S0014-2999(02)02879-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1016%2FS0014-2999%2802%2902879-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=12559377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFejsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=460&publication_year=2003&pages=163-170&author=M.+J.+Bonif%C3%A1cioauthor=M.+A.+Vieira+Coelhoauthor=P.+c.+Soares+da+Silva&title=Kinetic+inhibitory+profile+of+BIA+3-202%2C+a+novel+fast+tight-binding%2C+reversible+and+competitive+catechol-O-methyltransferase+inhibitor&doi=10.1016%2FS0014-2999%2802%2902879-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic inhibitory profile of BIA 3-202, a novel fast tight-binding, reversible and competitive catechol-O-methyltransferase inhibitor</span></div><div class="casAuthors">Bonifacio, Maria Joao; Vieira-Coelho, Maria Augusta; Soares-da-Silva, Patricio</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">460</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">163-170</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The present study reports the kinetic inhibitory profile of 1-[3,4-dihydroxy-5-nitrophenyl]-2-phenyl-ethanone (BIA 3-202), a novel inhibitor of sol. catechol-O-methyltransferase (COMT) in rat liver.  After an oral single dose (30 mg kg-1), there was a time-dependent recovery of enzyme activity from 98±2% inhibition at 30 min to total recovery at 24 h after treatment.  The inhibitory effect produced by BIA 3-202 on sol. COMT was reversible after gel filtration of the samples.  BIA 3-202 acted as a fast inhibitor of rat liver sol. COMT, interacting immediately with the enzyme after mixing.  No differences were obsd. in the metanephrine formation rates (in nmol mg protein-1 min-1) obtained without and with a 60-min preincubation with 30 nM of BIA 3-202 (1.30±0.02 and 1.35±0.03, resp.).  The tight-binding nature of the inhibition produced by BIA 3-202 was evaluated by performing an Ackermann-Potter plot.  The true Ki for BIA 3-202, derived from the nonlinear regression anal., was 0.19±0.02 nM.  In substrate competition studies, an increase in the concn. of adrenaline resulted in a linear increase in IC50 values for BIA 3-202.  In conclusion, BIA 3-202 behaves as a reversible, potent and fast tight-binding COMT inhibitor that acts competitively at the substrate binding site of rat liver sol. COMT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2qk1wS3eXTLVg90H21EOLACvtfcHk0ljhDE7oXP2IDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFejsA%253D%253D&md5=d7dddd438acffd20b03495f2c30e973f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2902879-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252902879-0%26sid%3Dliteratum%253Aachs%26aulast%3DBonif%25C3%25A1cio%26aufirst%3DM.%2BJ.%26aulast%3DVieira%2BCoelho%26aufirst%3DM.%2BA.%26aulast%3DSoares%2Bda%2BSilva%26aufirst%3DP.%2Bc.%26atitle%3DKinetic%2520inhibitory%2520profile%2520of%2520BIA%25203-202%252C%2520a%2520novel%2520fast%2520tight-binding%252C%2520reversible%2520and%2520competitive%2520catechol-O-methyltransferase%2520inhibitor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D460%26spage%3D163%26epage%3D170%26doi%3D10.1016%2FS0014-2999%2802%2902879-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dharmasena, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wimalasena, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wimalasena, K.</span></span> <span> </span><span class="NLM_article-title">A slow-tight binding inhibitor of dopamine beta-monooxygenase: a transition state analogue for the product release step</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">12414</span>– <span class="NLM_lpage">12420</span>, <span class="refDoi"> DOI: 10.1021/bi0262606</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0262606" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BD38XntVahu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=12414-12420&author=S.+P.+Dharmasenaauthor=D.+S.+Wimalasenaauthor=K.+Wimalasena&title=A+slow-tight+binding+inhibitor+of+dopamine+beta-monooxygenase%3A+a+transition+state+analogue+for+the+product+release+step&doi=10.1021%2Fbi0262606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A Slow-Tight Binding Inhibitor of Dopamine β-Monooxygenase: A Transition State Analogue for the Product Release Step</span></div><div class="casAuthors">Dharmasena, Sanjeewa P.; Wimalasena, D. Shyamali; Wimalasena, Kandatege</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">12414-12420</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The steady-state kinetic data show that 3-hydroxy-4-phenylthiazole-2(3H)-thione (3H4PTT) is a potent tight-binding inhibitor for dopamine β-monooxygenase (DβM) with a dissocn. const. of 0.9 nM.  Ackermann-Potter plots of the enzyme dependence of the inhibition revealed that the stoichiometry of the enzyme inhibition by 3H4PTT is 1:1.  Pre-steady-state progress curves at varying inhibitor with fixed reductant and enzyme concns. clearly show the slow binding behavior of the inhibitor.  The obsd. kinetic behavior is consistent with the apparent direct formation of the tightly bound E·I* complex.  The kon and koff for 3H4PTT which were detd. under pre-steady-state conditions at variable inhibitor concns. were found to be (1.85±0.07) × 106 M-1 s-1 and (1.9±0.6) × 10-3 s-1, resp.  The dissocn. const. calcd. from these rates was similar to that detd. under steady-state conditions, confirming that 3H4PTT is a kinetically well-behaved inhibitor.  The steady-state as well as pre-steady-state kinetic studies at variable DMPD concns. show that the inhibition is competitive with respect to the reductant, demonstrating the exclusive interaction of 3H4PTT with the oxidized form of the enzyme.  The kinetic behavior and the structural properties of 3H4PTT are consistent with the proposal that the E·3H4PTT complex may mimic the transition state for the product (protonated) release step of the enzyme.  Therefore, 3H4PTT could be used as a convenient probe to examine the properties of the E·P complex of the DβM reaction and also as an active site titrant for the oxidized enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKFulR5-aIvbVg90H21EOLACvtfcHk0lj7SdaatWgI0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntVahu7w%253D&md5=67e53a7dc7265aa7b8d7da375e9d8020</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fbi0262606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0262606%26sid%3Dliteratum%253Aachs%26aulast%3DDharmasena%26aufirst%3DS.%2BP.%26aulast%3DWimalasena%26aufirst%3DD.%2BS.%26aulast%3DWimalasena%26aufirst%3DK.%26atitle%3DA%2520slow-tight%2520binding%2520inhibitor%2520of%2520dopamine%2520beta-monooxygenase%253A%2520a%2520transition%2520state%2520analogue%2520for%2520the%2520product%2520release%2520step%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D12414%26epage%3D12420%26doi%3D10.1021%2Fbi0262606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, D. E.</span></span> <span> </span><span class="NLM_article-title">Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. Prediction of blood-brain barrier penetration</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">815</span>– <span class="NLM_lpage">821</span>, <span class="refDoi"> DOI: 10.1021/js980402t</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1021%2Fjs980402t" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10430548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFGitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=815-821&author=D.+E.+Clark&title=Rapid+calculation+of+polar+molecular+surface+area+and+its+application+to+the+prediction+of+transport+phenomena.+Prediction+of+blood-brain+barrier+penetration&doi=10.1021%2Fjs980402t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Calculation of Polar Molecular Surface Area and Its Application to the Prediction of Transport Phenomena. 2. Prediction of Blood-Brain Barrier Penetration</span></div><div class="casAuthors">Clark, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">815-821</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes the derivation of a simple QSAR model for the prediction of log BB from a set of 55 diverse org. compds.  The model contains two variables: polar surface area (PSA) and calcd. logP, both of which can be rapidly computed.  It therefore permits the prediction of log BB for large compd. sets, such as virtual combinatorial libraries.  The performance of this QSAR on two test sets taken from the literature is illustrated and compared with results from other reported computational approaches to log BB prediction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHa3ieLzy0RbVg90H21EOLACvtfcHk0lj7SdaatWgI0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFGitbk%253D&md5=949f8bf41525d8d04694e1288f24b626</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjs980402t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjs980402t%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%2BE.%26atitle%3DRapid%2520calculation%2520of%2520polar%2520molecular%2520surface%2520area%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520transport%2520phenomena.%2520Prediction%2520of%2520blood-brain%2520barrier%2520penetration%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D815%26epage%3D821%26doi%3D10.1021%2Fjs980402t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span> <span> </span><span class="NLM_article-title">Toxicological effects of Caco-2 cells following short-term and long-term exposure to Ag nanoparticles</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">974</span>, <span class="refDoi"> DOI: 10.3390/ijms17060974</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.3390%2Fijms17060974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVGqtbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=974&author=N.+Chenauthor=Z.+M.+Songauthor=H.+Tangauthor=W.+S.+Xiauthor=A.+Caoauthor=Y.+Liuauthor=H.+Wang&title=Toxicological+effects+of+Caco-2+cells+following+short-term+and+long-term+exposure+to+Ag+nanoparticles&doi=10.3390%2Fijms17060974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicological effects of Caco-2 cells following short-term and long-term exposure to Ag nanoparticles</span></div><div class="casAuthors">Chen, Ni; Song, Zheng-Mei; Tang, Huan; Xi, Wen-Song; Cao, Aoneng; Liu, Yuanfang; Wang, Haifang</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">974/1-974/17</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Extensive utilization increases the exposure of humans to Ag nanoparticles (NPs) via the oral pathway.  To comprehensively address the action of Ag NPs to the gastrointestinal systems in real situations, i.e., the long-term low-dose exposure, we evaluated and compared the toxicity of three Ag NPs (20-30 nm with different surface coatings) to the human intestine cell Caco-2 after 1-day and 21-day exposures, using various biol. assays.  In both the short- and long-term exposures, the variety of surface coating predominated the toxicity of Ag NPs in a descending order of citrate-coated Ag NP (Ag-CIT), bare Ag NP (Ag-B), and poly (N-vinyl-2-pyrrolidone)-coated Ag NP (Ag-PVP).  The short-term exposure induced cell growth inhibition and death.  The cell viability loss appeared after cells were exposed to 0.7 μg/mL Ag-CIT, 0.9 μg/mL Ag-B or >1.0 μg/mL Ag-PVP for 24 h.  The short-term and higher-dose exposure also induced reactive oxygen species (ROS) generation, mitochondrial damage, cell membrane leakage, apoptosis, and inflammation (IL-8 level).  The long-term exposure only inhibited the cell proliferation.  After 21-day exposure to 0.4 μg/mL Ag-CIT, the cell viability dropped to less than 50%, while cells exposed to 0.5 μg/mL Ag-PVP remained normal as the control.  Generally, 0.3 μg/mL is the non-toxic dose for the long-term exposure of Caco-2 cells to Ag NPs in this study.  However, cells presented inflammation after exposure to Ag NPs with the non-toxic dose in the long-term exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_Er87Km2i5bVg90H21EOLACvtfcHk0lg1ER63KMypOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVGqtbvJ&md5=e3ac8261459ff584cd9abfeed29f8eab</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.3390%2Fijms17060974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms17060974%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DN.%26aulast%3DSong%26aufirst%3DZ.%2BM.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DXi%26aufirst%3DW.%2BS.%26aulast%3DCao%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DH.%26atitle%3DToxicological%2520effects%2520of%2520Caco-2%2520cells%2520following%2520short-term%2520and%2520long-term%2520exposure%2520to%2520Ag%2520nanoparticles%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2016%26volume%3D17%26spage%3D974%26doi%3D10.3390%2Fijms17060974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kanat, O. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selmanoglu, G.</span></span> <span> </span><span class="NLM_article-title">Neurotoxic effect of Fipronil in neuroblastoma SH-SY5Y cell line</span>. <i>Neurotoxic. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1007/s12640-019-00093-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1007%2Fs12640-019-00093-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=31482323" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2019&pages=30-40&author=O.+N.+Kanatauthor=G.+Selmanoglu&title=Neurotoxic+effect+of+Fipronil+in+neuroblastoma+SH-SY5Y+cell+line&doi=10.1007%2Fs12640-019-00093-z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs12640-019-00093-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12640-019-00093-z%26sid%3Dliteratum%253Aachs%26aulast%3DKanat%26aufirst%3DO.%2BN.%26aulast%3DSelmanoglu%26aufirst%3DG.%26atitle%3DNeurotoxic%2520effect%2520of%2520Fipronil%2520in%2520neuroblastoma%2520SH-SY5Y%2520cell%2520line%26jtitle%3DNeurotoxic.%2520Res.%26date%3D2019%26volume%3D37%26spage%3D30%26epage%3D40%26doi%3D10.1007%2Fs12640-019-00093-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sidell, N.</span></span> <span> </span><span class="NLM_article-title">Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">589</span>– <span class="NLM_lpage">596</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=7040765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADyaL38XktVGjtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1982&pages=589-596&author=N.+Sidell&title=Retinoic+acid-induced+growth+inhibition+and+morphologic+differentiation+of+human+neuroblastoma+cells+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro</span></div><div class="casAuthors">Sidell, Neil</div><div class="citationInfo"><span class="NLM_cas:title">JNCI, Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">589-96</span>CODEN:
                <span class="NLM_cas:coden">JJIND8</span>;
        ISSN:<span class="NLM_cas:issn">0198-0157</span>.
    </div><div class="casAbstract">retinoic acid (RA)  [302-79-4] induced concn.-dependent morphol. differentiation and growth inhibition in the LA-N-1 human neuroblastoma cell line.  Time course studies demonstrated a significant increase in the formation of long neurites in LA-N-1 cultures within 48 h of RA addn.; max. expression of differentiation occurred at ∼4 days.  This differentiation profile corresponding to a detectable decrease in [3H]thymidine incorporation at 48 h and complete inhibition of cell growth after 3-4 days.  The RA-induced morphol. differentiation and growth inhibition persisted despite removal of the drug.  A soft agar assay system showed that RA also inhibited the ability of LA-N-1 cells to form anchorage-independent colonies and induced morphol. differentiation in colonies that did develop.  These findings suggest that RA promoted the differentiation of LA-N-1 neuroblastoma cells, resulting in an altered expression of the malignant phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJDFQL0AGlPLVg90H21EOLACvtfcHk0lg1ER63KMypOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XktVGjtrg%253D&md5=eb1854ced7b449b3a942d33abedb84a4</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSidell%26aufirst%3DN.%26atitle%3DRetinoic%2520acid-induced%2520growth%2520inhibition%2520and%2520morphologic%2520differentiation%2520of%2520human%2520neuroblastoma%2520cells%2520in%2520vitro%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1982%26volume%3D68%26spage%3D589%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kovalevich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langford, D.</span></span> <span> </span><span class="NLM_article-title">Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1078</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1007/978-1-62703-640-5_2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1007%2F978-1-62703-640-5_2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=23975817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsFOhsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1078&publication_year=2013&pages=9-21&author=J.+Kovalevichauthor=D.+Langford&title=Considerations+for+the+use+of+SH-SY5Y+neuroblastoma+cells+in+neurobiology&doi=10.1007%2F978-1-62703-640-5_2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Considerations for the Use of SH - SY5Y Neuroblastoma Cells in Neurobiology</span></div><div class="casAuthors">Kovalevich, Jane; Langford, Dianne</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1078</span>
        (<span class="NLM_cas:issue">Neuronal Cell Culture</span>),
    <span class="NLM_cas:pages">9-21</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The use of primary mammalian neurons derived from embryonic central nervous system tissue is limited by the fact that once terminally differentiated into mature neurons, the cells can no longer be propagated.  Transformed neuronal-like cell lines can be used in vitro to overcome this limitation.  However, several caveats exist when utilizing cells derived from malignant tumors.  In this context, the popular SH - SY5Y neuroblastoma cell line and its use in in vitro systems is described.  Originally derived from a metastatic bone tumor biopsy, SH - SY5Y (ATCC CRL-2266) cells are a subline of the parental line SK - N - SH (ATCC HTB-11).  SK-N-SH were subcloned three times; first to SH - SY , then to SH - SY5 , and finally to SH - SY5Y .  SH - SY5Y were deposited to the ATCC in 1970 by June L.  Biedler.Three important characteristics of SH - SY5Y cells should be considered when using these cells in in vitro studies.  First, cultures include both adherent and floating cells, both types of which are viable.  Few studies address the biol. significance of the adherent vs. floating phenotypes, but most reported studies utilize adherent populations and discard the floating cells during media changes.  Second, early studies by Biedler's group indicated that the parental differentiated SK - N - SH cells contained two morphol. distinct phenotypes: neuroblast-like cells and epithelial-like cells (Ross et al., J Nat Cancer Inst 71:741-747, 1983).  These two phenotypes may correspond to the "N" and "S" types described in later studies in SH - SY5Y by Encinas et al. (J Neurochem 75:991-1003, 2000).  Cells with neuroblast-like morphol. are pos. for tyrosine hydroxylase (TH) and dopamine-β-hydroxylase characteristic of catecholaminergic neurons, whereas the epithelial-like counterpart cells lacked these enzymic activities (Ross et al., J Nat Cancer Inst 71:741-747, 1983).  Third, SH - SY5Y cells can be differentiated to a more mature neuron-like phenotype that is characterized by neuronal markers.  There are several methods to differentiate SH - SY5Y cells and are mentioned below.  Retinoic acid is the most commonly used means for differentiation and will be addressed in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCVTav2R1Mr7Vg90H21EOLACvtfcHk0li2pLFNfFcFnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsFOhsb8%253D&md5=c4b1a3d107c070810b83efd461a2d0ec</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2F978-1-62703-640-5_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-62703-640-5_2%26sid%3Dliteratum%253Aachs%26aulast%3DKovalevich%26aufirst%3DJ.%26aulast%3DLangford%26aufirst%3DD.%26atitle%3DConsiderations%2520for%2520the%2520use%2520of%2520SH-SY5Y%2520neuroblastoma%2520cells%2520in%2520neurobiology%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2013%26volume%3D1078%26spage%3D9%26epage%3D21%26doi%3D10.1007%2F978-1-62703-640-5_2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarmento, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remião, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otero-Espinar, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">PEGylated PLGA nanoparticles as a smart carrier to increase the cellular uptake of a coumarin-based monoamine oxidase B inhibitor</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">39557</span>– <span class="NLM_lpage">39569</span>, <span class="refDoi"> DOI: 10.1021/acsami.8b17224</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.8b17224" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFygt7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=39557-39569&author=C.+Fernandesauthor=C.+Martinsauthor=A.+Fonsecaauthor=R.+Nunesauthor=M.+J.+Matosauthor=R.+Silvaauthor=J.+Garridoauthor=B.+Sarmentoauthor=F.+Remi%C3%A3oauthor=F.+J.+Otero-Espinarauthor=E.+Uriarteauthor=F.+Borges&title=PEGylated+PLGA+nanoparticles+as+a+smart+carrier+to+increase+the+cellular+uptake+of+a+coumarin-based+monoamine+oxidase+B+inhibitor&doi=10.1021%2Facsami.8b17224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">PEGylated PLGA Nanoparticles As a Smart Carrier to Increase the Cellular Uptake of a Coumarin-Based Monoamine Oxidase B Inhibitor</span></div><div class="casAuthors">Fernandes, Carlos; Martins, Claudia; Fonseca, Andre; Nunes, Rute; Matos, Maria Joao; Silva, Renata; Garrido, Jorge; Sarmento, Bruno; Remiao, Fernando; Otero-Espinar, Francisco J.; Uriarte, Eugenio; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">39557-39569</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Despite research efforts to discover new drugs for Parkinson treatment, the majority of candidates fail in preclin. and clin. trials due to inadequate pharmacokinetic properties, namely blood-brain barrier permeability.  Within the high demand to introduce new drugs to market, nanotechnol. can be used as a soln.  Accordingly, PEGylated PLGA nanoparticles (NPs) were used as a smart delivery carrier to solve the suboptimal aq. soly., which precludes its use in in vivo assays, of a potent, reversible, and selective monoamine oxidase B inhibitor (IMAO-B) (coumarin C75, IC50 = 28.89 ± 1.18 nM).  Long-term stable <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="7929353e38393a4e4c">[email protected]</a> NPs were obtained by nanopptn. method, with sizes around 105 nm and a zeta potential of -10.1 mV.  The encapsulation efficacy was around 50%, achieving the final C75 concn. of 807 ± 30 μM in the nanoformulation, which corresponds to a therapeutic concn. 27828-fold higher than its IC50 value.  Coumarin C75 showed cytotoxic effects at 50 μM after 48 and 72 h of exposure in SH-SY5Y, Caco-2, and hCMEC/D3 cell lines.  Remarkably, no cytotoxic effects were obsd. after nanoencapsulation.  Furthermore, the data obtained from the P-gp-Glo assay and the cellular uptake studies showed that C75 is a P-glycoprotein (P-gp) substrate having a lower uptake profile in intestinal and brain endothelial cells.  Moreover, it was shown that this membrane transporter influences C75 permeability profile in Caco-2 and hCMEC/D3 cells.  Interestingly, PLGA NPs inhibited P-gp and were able to cross intestinal and brain membranes allowing the successful transport of C75 through this type of biol. barriers.  Overall, this work showed that nanotechnol. can be used to solve drug discovery related drawbacks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGoyUTZrGr5LVg90H21EOLACvtfcHk0li2pLFNfFcFnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFygt7nE&md5=b19a73ee84bffe3b3d70013ace56d25e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facsami.8b17224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.8b17224%26sid%3Dliteratum%253Aachs%26aulast%3DFernandes%26aufirst%3DC.%26aulast%3DMartins%26aufirst%3DC.%26aulast%3DFonseca%26aufirst%3DA.%26aulast%3DNunes%26aufirst%3DR.%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DSilva%26aufirst%3DR.%26aulast%3DGarrido%26aufirst%3DJ.%26aulast%3DSarmento%26aufirst%3DB.%26aulast%3DRemi%25C3%25A3o%26aufirst%3DF.%26aulast%3DOtero-Espinar%26aufirst%3DF.%2BJ.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DPEGylated%2520PLGA%2520nanoparticles%2520as%2520a%2520smart%2520carrier%2520to%2520increase%2520the%2520cellular%2520uptake%2520of%2520a%2520coumarin-based%2520monoamine%2520oxidase%2520B%2520inhibitor%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2018%26volume%3D10%26spage%3D39557%26epage%3D39569%26doi%3D10.1021%2Facsami.8b17224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Repetto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Peso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zurita, J. L.</span></span> <span> </span><span class="NLM_article-title">Neutral red uptake assay for the estimation of cell viability/cytotoxicity</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1125</span>– <span class="NLM_lpage">1131</span>, <span class="refDoi"> DOI: 10.1038/nprot.2008.75</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1038%2Fnprot.2008.75" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=18600217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotFakurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1125-1131&author=G.+Repettoauthor=A.+del+Pesoauthor=J.+L.+Zurita&title=Neutral+red+uptake+assay+for+the+estimation+of+cell+viability%2Fcytotoxicity&doi=10.1038%2Fnprot.2008.75"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Neutral red uptake assay for the estimation of cell viability/cytotoxicity</span></div><div class="casAuthors">Repetto, Guillermo; del Peso, Ana; Zurita, Jorge L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1125-1131</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The neutral red uptake assay provides a quant. estn. of the no. of viable cells in a culture.  It is one of the most used cytotoxicity tests with many biomedical and environmental applications.  It is based on the ability of viable cells to incorporate and bind the supravital dye neutral red in the lysosomes.  Most primary cells and cell lines from diverse origin may be successfully used.  Cells are seeded in 96-well tissue culture plates and are treated for the appropriate period.  The plates are then incubated for 2 h with a medium contg. neutral red.  The cells are subsequently washed, the dye is extd. in each well and the absorbance is read using a spectrophotometer.  The procedure is cheaper and more sensitive than other cytotoxicity tests (tetrazolium salts, enzyme leakage or protein content).  Once the cells were treated, the assay can be completed in <3 h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCcpd7QjH04rVg90H21EOLACvtfcHk0liTrS6ufbuxJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotFakurk%253D&md5=30461f51c2ad668a3cadb4843c93b43e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2008.75&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2008.75%26sid%3Dliteratum%253Aachs%26aulast%3DRepetto%26aufirst%3DG.%26aulast%3Ddel%2BPeso%26aufirst%3DA.%26aulast%3DZurita%26aufirst%3DJ.%2BL.%26atitle%3DNeutral%2520red%2520uptake%2520assay%2520for%2520the%2520estimation%2520of%2520cell%2520viability%252Fcytotoxicity%26jtitle%3DNat.%2520Protoc.%26date%3D2008%26volume%3D3%26spage%3D1125%26epage%3D1131%26doi%3D10.1038%2Fnprot.2008.75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moraes, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuzikov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellinger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calogeropoulou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prousis, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pisa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacono, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freitas-Junior, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dos Santos Pascoalino, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertolacini, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrens, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keminer, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinshagen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordeiro-da-Silva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santarem, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venturelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrigley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karunakaran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kebede, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panecka-Hofman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenske, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alunda, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corral, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uliassi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linciano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quotadamo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santucci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borsari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gul, S.</span></span> <span> </span><span class="NLM_article-title">Accelerating drug discovery efforts for trypanosomatidic infections using an integrated transnational academic drug discovery platform</span>. <i>SLAS Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">346</span>– <span class="NLM_lpage">361</span>, <span class="refDoi"> DOI: 10.1177/2472555218823171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1177%2F2472555218823171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=30784368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktVOjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&pages=346-361&author=C.+B.+Moraesauthor=G.+Wittauthor=M.+Kuzikovauthor=B.+Ellingerauthor=T.+Calogeropoulouauthor=K.+C.+Prousisauthor=S.+Manganiauthor=F.+Di+Pisaauthor=G.+Landiauthor=L.+D.+Iaconoauthor=C.+Pozziauthor=L.+H.+Freitas-Juniorauthor=B.+Dos+Santos+Pascoalinoauthor=C.+P.+Bertolaciniauthor=B.+Behrensauthor=O.+Keminerauthor=J.+Leuauthor=M.+Wolfauthor=J.+Reinshagenauthor=A.+Cordeiro-da-Silvaauthor=N.+Santaremauthor=A.+Venturelliauthor=S.+Wrigleyauthor=D.+Karunakaranauthor=B.+Kebedeauthor=I.+Pohnerauthor=W.+Mullerauthor=J.+Panecka-Hofmanauthor=R.+C.+Wadeauthor=M.+Fenskeauthor=J.+Closauthor=J.+M.+Alundaauthor=M.+J.+Corralauthor=E.+Uliassiauthor=M.+L.+Bolognesiauthor=P.+Lincianoauthor=A.+Quotadamoauthor=S.+Ferrariauthor=M.+Santucciauthor=C.+Borsariauthor=M.+P.+Costiauthor=S.+Gul&title=Accelerating+drug+discovery+efforts+for+trypanosomatidic+infections+using+an+integrated+transnational+academic+drug+discovery+platform&doi=10.1177%2F2472555218823171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform</span></div><div class="casAuthors">Moraes, Carolina B.; Witt, Gesa; Kuzikov, Maria; Ellinger, Bernhard; Calogeropoulou, Theodora; Prousis, Kyriakos C.; Mangani, Stefano; Di Pisa, Flavio; Landi, Giacomo; Iacono, Lucia Dello; Pozzi, Cecilia; Freitas-Junior, Lucio H.; dos Santos Pascoalino, Bruno; Bertolacini, Claudia P.; Behrens, Birte; Keminer, Oliver; Leu, Jennifer; Wolf, Markus; Reinshagen, Jeanette; Cordeiro-da-Silva, Anabela; Santarem, Nuno; Venturelli, Alberto; Wrigley, Stephen; Karunakaran, Deepa; Kebede, Bethlehem; Pohner, Ina; Muller, Wolfgang; Panecka-Hofman, Joanna; Wade, Rebecca C.; Fenske, Martina; Clos, Joachim; Alunda, Jose Maria; Corral, Maria Jesus; Uliassi, Elisa; Bolognesi, Maria Laura; Linciano, Pasquale; Quotadamo, Antonio; Ferrari, Stefania; Santucci, Matteo; Borsari, Chiara; Costi, Maria Paola; Gul, Sheraz</div><div class="citationInfo"><span class="NLM_cas:title">SLAS Discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">346-361</span>CODEN:
                <span class="NLM_cas:coden">SDLIBT</span>;
        ISSN:<span class="NLM_cas:issn">2472-5560</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">According to the World Health Organization, more than 1 billion people are at risk of or are affected by neglected tropical diseases.  Examples of such diseases include trypanosomiasis, which causes sleeping sickness; leishmaniasis; and Chagas disease, all of which are prevalent in Africa, South America, and India.  Our aim within the New Medicines for Trypanosomatidic Infections project was to use (1) synthetic and natural product libraries, (2) screening, and (3) a preclin. absorption, distribution, metab., and excretion-toxicity (ADME-Tox) profiling platform to identify compds. that can enter the trypanosomatidic drug discovery value chain.  The synthetic compd. libraries originated from multiple scaffolds with known antiparasitic activity and natural products from the Hypha Discovery MycoDiverse natural products library.  Our focus was first to employ target-based screening to identify inhibitors of the protozoan Trypanosoma brucei pteridine reductase 1 (TbPTR1) and second to use a Trypanosoma brucei phenotypic assay that made use of the T. brucei brucei parasite to identify compds. that inhibited cell growth and caused death.  Some of the compds. underwent structure-activity relationship expansion and, when appropriate, were evaluated in a preclin. ADME-Tox assay panel.  This preclin. platform has led to the identification of lead-like compds. as well as validated hits in the trypanosomatidic drug discovery value chain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0xfcsY_u7srVg90H21EOLACvtfcHk0liTrS6ufbuxJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktVOjtLs%253D&md5=20a4cc188eb6ccd8ba97141846873324</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1177%2F2472555218823171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2472555218823171%26sid%3Dliteratum%253Aachs%26aulast%3DMoraes%26aufirst%3DC.%2BB.%26aulast%3DWitt%26aufirst%3DG.%26aulast%3DKuzikov%26aufirst%3DM.%26aulast%3DEllinger%26aufirst%3DB.%26aulast%3DCalogeropoulou%26aufirst%3DT.%26aulast%3DProusis%26aufirst%3DK.%2BC.%26aulast%3DMangani%26aufirst%3DS.%26aulast%3DDi%2BPisa%26aufirst%3DF.%26aulast%3DLandi%26aufirst%3DG.%26aulast%3DIacono%26aufirst%3DL.%2BD.%26aulast%3DPozzi%26aufirst%3DC.%26aulast%3DFreitas-Junior%26aufirst%3DL.%2BH.%26aulast%3DDos%2BSantos%2BPascoalino%26aufirst%3DB.%26aulast%3DBertolacini%26aufirst%3DC.%2BP.%26aulast%3DBehrens%26aufirst%3DB.%26aulast%3DKeminer%26aufirst%3DO.%26aulast%3DLeu%26aufirst%3DJ.%26aulast%3DWolf%26aufirst%3DM.%26aulast%3DReinshagen%26aufirst%3DJ.%26aulast%3DCordeiro-da-Silva%26aufirst%3DA.%26aulast%3DSantarem%26aufirst%3DN.%26aulast%3DVenturelli%26aufirst%3DA.%26aulast%3DWrigley%26aufirst%3DS.%26aulast%3DKarunakaran%26aufirst%3DD.%26aulast%3DKebede%26aufirst%3DB.%26aulast%3DPohner%26aufirst%3DI.%26aulast%3DMuller%26aufirst%3DW.%26aulast%3DPanecka-Hofman%26aufirst%3DJ.%26aulast%3DWade%26aufirst%3DR.%2BC.%26aulast%3DFenske%26aufirst%3DM.%26aulast%3DClos%26aufirst%3DJ.%26aulast%3DAlunda%26aufirst%3DJ.%2BM.%26aulast%3DCorral%26aufirst%3DM.%2BJ.%26aulast%3DUliassi%26aufirst%3DE.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DLinciano%26aufirst%3DP.%26aulast%3DQuotadamo%26aufirst%3DA.%26aulast%3DFerrari%26aufirst%3DS.%26aulast%3DSantucci%26aufirst%3DM.%26aulast%3DBorsari%26aufirst%3DC.%26aulast%3DCosti%26aufirst%3DM.%2BP.%26aulast%3DGul%26aufirst%3DS.%26atitle%3DAccelerating%2520drug%2520discovery%2520efforts%2520for%2520trypanosomatidic%2520infections%2520using%2520an%2520integrated%2520transnational%2520academic%2520drug%2520discovery%2520platform%26jtitle%3DSLAS%2520Discovery%26date%3D2019%26volume%3D24%26spage%3D346%26epage%3D361%26doi%3D10.1177%2F2472555218823171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">P-glycoprotein mediated efflux limits the transport of the novel anti-Parkinson’s disease candidate drug FLZ across the physiological and PD pathological in vitro BBB models</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e102442</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0102442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1371%2Fjournal.pone.0102442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=25036090" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=Q.+Liuauthor=J.+Houauthor=X.+Chenauthor=G.+Liuauthor=D.+Zhangauthor=H.+Sunauthor=J.+Zhang&title=P-glycoprotein+mediated+efflux+limits+the+transport+of+the+novel+anti-Parkinson%E2%80%99s+disease+candidate+drug+FLZ+across+the+physiological+and+PD+pathological+in+vitro+BBB+models&doi=10.1371%2Fjournal.pone.0102442"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0102442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0102442%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DP-glycoprotein%2520mediated%2520efflux%2520limits%2520the%2520transport%2520of%2520the%2520novel%2520anti-Parkinson%25E2%2580%2599s%2520disease%2520candidate%2520drug%2520FLZ%2520across%2520the%2520physiological%2520and%2520PD%2520pathological%2520in%2520vitro%2520BBB%2520models%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0102442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bicker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortuna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcao, A.</span></span> <span> </span><span class="NLM_article-title">Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review</span>. <i>Eur. J. Pharm. Biopharm.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">432</span>, <span class="refDoi"> DOI: 10.1016/j.ejpb.2014.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1016%2Fj.ejpb.2014.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=24686194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtlWgu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2014&pages=409-432&author=J.+Bickerauthor=G.+Alvesauthor=A.+Fortunaauthor=A.+Falcao&title=Blood-brain+barrier+models+and+their+relevance+for+a+successful+development+of+CNS+drug+delivery+systems%3A+a+review&doi=10.1016%2Fj.ejpb.2014.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: A review</span></div><div class="casAuthors">Bicker, Joana; Alves, Gilberto; Fortuna, Ana; Falcao, Amilcar</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-432</span>CODEN:
                <span class="NLM_cas:coden">EJPBEL</span>;
        ISSN:<span class="NLM_cas:issn">0939-6411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  During the research and development of new drugs directed at the central nervous system, there is a considerable attrition rate caused by their hampered access to the brain by the blood-brain barrier.  Throughout the years, several in vitro models have been developed in an attempt to mimic crit. functionalities of the blood-brain barrier and reliably predict the permeability of drug candidates.  However, the current challenge lies in developing a model that retains fundamental blood-brain barrier characteristics and simultaneously remains compatible with the high throughput demands of pharmaceutical industries.  This review firstly describes the roles of all elements of the neurovascular unit and their influence on drug brain penetration.  In vitro models, including non-cell based and cell-based models, and in vivo models are herein presented, with a particular emphasis on their methodol. aspects.  Lastly, their contribution to the improvement of brain drug delivery strategies and drug transport across the blood-brain barrier is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph-OEiYO0znrVg90H21EOLACvtfcHk0lgms3xG27kH6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtlWgu7Y%253D&md5=73c2d2182182626c039ccb469b65eec4</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpb.2014.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpb.2014.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DBicker%26aufirst%3DJ.%26aulast%3DAlves%26aufirst%3DG.%26aulast%3DFortuna%26aufirst%3DA.%26aulast%3DFalcao%26aufirst%3DA.%26atitle%3DBlood-brain%2520barrier%2520models%2520and%2520their%2520relevance%2520for%2520a%2520successful%2520development%2520of%2520CNS%2520drug%2520delivery%2520systems%253A%2520a%2520review%26jtitle%3DEur.%2520J.%2520Pharm.%2520Biopharm.%26date%3D2014%26volume%3D87%26spage%3D409%26epage%3D432%26doi%3D10.1016%2Fj.ejpb.2014.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartz, A. M.</span></span> <span> </span><span class="NLM_article-title">Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">196</span>– <span class="NLM_lpage">209</span>, <span class="refDoi"> DOI: 10.1124/pr.107.07109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1124%2Fpr.107.07109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=18560012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitlWlsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=196-209&author=D.+S.+Millerauthor=B.+Bauerauthor=A.+M.+Hartz&title=Modulation+of+P-glycoprotein+at+the+blood-brain+barrier%3A+opportunities+to+improve+central+nervous+system+pharmacotherapy&doi=10.1124%2Fpr.107.07109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy</span></div><div class="casAuthors">Miller, David S.; Bauer, Bjorn; Hartz, Anika M. S.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">196-209</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Pharmacotherapy of central nervous system (CNS) disorders (e.g., neurodegenerative diseases, epilepsy, brain cancer, and neuro-AIDS) is limited by the blood-brain barrier.  P-glycoprotein, an ATP-driven, drug efflux transporter, is a crit. element of that barrier.  High level of expression, luminal membrane location, multispecificity, and high transport potency make P-glycoprotein a selective gatekeeper of the blood-brain barrier and thus a primary obstacle to drug delivery into the brain.  As such, P-glycoprotein limits entry into the CNS for a large no. of prescribed drugs, contributes to the poor success rate of CNS drug candidates, and probably contributes to patient-to-patient variability in response to CNS pharmacotherapy.  Modulating P-glycoprotein could therefore improve drug delivery into the brain.  Here we review the current understanding of signaling mechanisms responsible for the modulation of P-glycoprotein activity/expression at the blood-brain barrier with an emphasis on recent studies from our labs.  Using intact brain capillaries from rats and mice, we have identified multiple extracellular and intracellular signals that regulate this transporter; several signaling pathways have been mapped.  Three pathways are triggered by elements of the brain's innate immune response, one by glutamate, one by xenobiotic-nuclear receptor (pregnane X receptor) interactions, and one by elevated β-amyloid levels.  Signaling is complex, with several pathways sharing common signaling elements [tumor necrosis factor (TNF) receptor 1, endothelin (ET) B receptor, protein kinase C, and nitric-oxide synthase], suggesting a regulatory network.  Several pathways include autocrine/paracrine elements, involving release of the proinflammatory cytokine, TNF-α, and the polypeptide hormone, ET-1.  Finally, several steps in signaling are potential therapeutic targets that could be used to modulate P-glycoprotein activity in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoHVx_SSsfFLVg90H21EOLACvtfcHk0lgms3xG27kH6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitlWlsrs%253D&md5=b82ef70a8d7d087c7216ec52b30282fc</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1124%2Fpr.107.07109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.107.07109%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DD.%2BS.%26aulast%3DBauer%26aufirst%3DB.%26aulast%3DHartz%26aufirst%3DA.%2BM.%26atitle%3DModulation%2520of%2520P-glycoprotein%2520at%2520the%2520blood-brain%2520barrier%253A%2520opportunities%2520to%2520improve%2520central%2520nervous%2520system%2520pharmacotherapy%26jtitle%3DPharmacol.%2520Rev.%26date%3D2008%26volume%3D60%26spage%3D196%26epage%3D209%26doi%3D10.1124%2Fpr.107.07109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gameiro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha-Pereira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastos, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remiao, F.</span></span> <span> </span><span class="NLM_article-title">Cellular models and in vitro assays for the screening of modulators of P-gp, MRP1 and BCRP</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">600</span>, <span class="refDoi"> DOI: 10.3390/molecules22040600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.3390%2Fmolecules22040600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVyls7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=600&author=M.+Gameiroauthor=R.+Silvaauthor=C.+Rocha-Pereiraauthor=H.+Carmoauthor=F.+Carvalhoauthor=M.+L.+Bastosauthor=F.+Remiao&title=Cellular+models+and+in+vitro+assays+for+the+screening+of+modulators+of+P-gp%2C+MRP1+and+BCRP&doi=10.3390%2Fmolecules22040600"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular models and in vitro assays for the screening of modulators of P-gp, MRP1 and BCRP</span></div><div class="casAuthors">Gameiro, Mariline; Silva, Renata; Rocha-Pereira, Carolina; Carmo, Helena; Carvalho, Felix; Bastos, Maria de Lourdes; Remiao, Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">600/1-600/48</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">ATP (ATP)-binding cassette (ABC) transporters are highly expressed in tumor cells, as well as in organs involved in absorption and secretion processes, mediating the ATP-dependent efflux of compds., both endogenous substances and xenobiotics, including drugs.  Their expression and activity levels are modulated by the presence of inhibitors, inducers and/or activators.  In vitro, ex vivo and in vivo studies with both known and newly synthesized P-glycoprotein (P-gp) inducers and/or activators have shown the usefulness of these transport mechanisms in reducing the systemic exposure and specific tissue access of potentially harmful compds.  This article focuses on the main ABC transporters involved in multidrug resistance [P-gp, multidrug resistance-assocd. protein 1 (MRP1) and breast cancer resistance protein (BCRP)] expressed in tissues of toxicol. relevance, such as the blood-brain barrier, cardiovascular system, liver, kidney and intestine.  Moreover, it provides a review of the available cellular models, in vitro and ex vivo assays for the screening and selection of safe and specific inducers and activators of these membrane transporters.  The available cellular models and in vitro assays have been proposed as high throughput and low-cost alternatives to excessive animal testing, allowing the evaluation of a large no. of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn1D36bj5L3rVg90H21EOLACvtfcHk0lhF0OsVKt5gJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVyls7jN&md5=b974657a22d9086985179fc3e2bc811b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22040600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22040600%26sid%3Dliteratum%253Aachs%26aulast%3DGameiro%26aufirst%3DM.%26aulast%3DSilva%26aufirst%3DR.%26aulast%3DRocha-Pereira%26aufirst%3DC.%26aulast%3DCarmo%26aufirst%3DH.%26aulast%3DCarvalho%26aufirst%3DF.%26aulast%3DBastos%26aufirst%3DM.%2BL.%26aulast%3DRemiao%26aufirst%3DF.%26atitle%3DCellular%2520models%2520and%2520in%2520vitro%2520assays%2520for%2520the%2520screening%2520of%2520modulators%2520of%2520P-gp%252C%2520MRP1%2520and%2520BCRP%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D600%26doi%3D10.3390%2Fmolecules22040600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCaffrey, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staatz, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Covarrubias, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finch, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demarco, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laracuente, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronaldson, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, T. P.</span></span> <span> </span><span class="NLM_article-title">P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">962</span>– <span class="NLM_lpage">975</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2012.07831.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1111%2Fj.1471-4159.2012.07831.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=22716933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Wrtr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2012&pages=962-975&author=G.+McCaffreyauthor=W.+D.+Staatzauthor=L.+Sanchez-Covarrubiasauthor=J.+D.+Finchauthor=K.+Demarcoauthor=M.+L.+Laracuenteauthor=P.+T.+Ronaldsonauthor=T.+P.+Davis&title=P-glycoprotein+trafficking+at+the+blood-brain+barrier+altered+by+peripheral+inflammatory+hyperalgesia&doi=10.1111%2Fj.1471-4159.2012.07831.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia</span></div><div class="casAuthors">McCaffrey, Gwen; Staatz, William D.; Sanchez-Covarrubias, Lucy; Finch, Jessica D.; DeMarco, Kristen; Laracuente, Mei-Li; Ronaldson, Patrick T.; Davis, Thomas P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">5&6</span>),
    <span class="NLM_cas:pages">962-975</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">P-glycoprotein (ABCB1/MDR1, EC 3.6.3.44), the major efflux transporter at the blood-brain barrier (BBB), is a formidable obstacle to CNS pharmacotherapy.  Understanding the mechanism(s) for increased P-glycoprotein activity at the BBB during peripheral inflammatory pain is crit. in the development of novel strategies to overcome the significant decreases in CNS analgesic drug delivery.  In this study, we employed the λ-carrageenan pain model (using female Sprague-Dawley rats), combined with confocal microscopy and subcellular fractionation of cerebral microvessels, to det. if increased P-glycoprotein function, following the onset of peripheral inflammatory pain, is assocd. with a change in P-glycoprotein trafficking which leads to pain-induced effects on analgesic drug delivery.  Injection of λ-carrageenan into the rat hind paw induced a localized, inflammatory pain (hyperalgesia) and simultaneously, at the BBB, a rapid change in colocalization of P-glycoprotein with caveolin-1, a key scaffolding/trafficking protein.  Subcellular fractionation of isolated cerebral microvessels revealed that the bulk of P-glycoprotein constitutively traffics to membrane domains contg. high mol. wt., disulfide-bonded P-glycoprotein-contg. structures that cofractionate with membrane domains enriched with monomeric and high mol. wt., disulfide-bonded, caveolin-1-contg. structures.  Peripheral inflammatory pain promoted a dynamic redistribution between membrane domains of P-glycoprotein and caveolin-1.  Disassembly of high mol. wt. P-glycoprotein-contg. structures within microvascular endothelial luminal membrane domains was accompanied by an increase in ATPase activity, suggesting a potential for functionally active P-glycoprotein.  These results are the first observation that peripheral inflammatory pain leads to specific structural changes in P-glycoprotein responsible for controlling analgesic drug delivery to the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnxy5wlcfYjrVg90H21EOLACvtfcHk0lhF0OsVKt5gJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Wrtr%252FP&md5=2fcfe248612d860f74354c3b9709d833</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2012.07831.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2012.07831.x%26sid%3Dliteratum%253Aachs%26aulast%3DMcCaffrey%26aufirst%3DG.%26aulast%3DStaatz%26aufirst%3DW.%2BD.%26aulast%3DSanchez-Covarrubias%26aufirst%3DL.%26aulast%3DFinch%26aufirst%3DJ.%2BD.%26aulast%3DDemarco%26aufirst%3DK.%26aulast%3DLaracuente%26aufirst%3DM.%2BL.%26aulast%3DRonaldson%26aufirst%3DP.%2BT.%26aulast%3DDavis%26aufirst%3DT.%2BP.%26atitle%3DP-glycoprotein%2520trafficking%2520at%2520the%2520blood-brain%2520barrier%2520altered%2520by%2520peripheral%2520inflammatory%2520hyperalgesia%26jtitle%3DJ.%2520Neurochem.%26date%3D2012%26volume%3D122%26spage%3D962%26epage%3D975%26doi%3D10.1111%2Fj.1471-4159.2012.07831.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reichert, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Freitas, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampaio-Silva, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rokita-Rosa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bydlowski, S. P.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis mechanisms involved in neurodegenerative diseases</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">8765</span>, <span class="refDoi"> DOI: 10.3390/ijms21228765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.3390%2Fijms21228765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFyhtbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=8765&author=C.+O.+Reichertauthor=F.+A.+de+Freitasauthor=J.+Sampaio-Silvaauthor=L.+Rokita-Rosaauthor=P.+L.+Barrosauthor=D.+Levyauthor=S.+P.+Bydlowski&title=Ferroptosis+mechanisms+involved+in+neurodegenerative+diseases&doi=10.3390%2Fijms21228765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis mechanisms involved in neurodegenerative diseases</span></div><div class="casAuthors">Reichert, Cadiele Oliana; de Freitas, Fabio Alessandro; Sampaio-Silva, Juliana; Rokita-Rosa, Leonardo; de Lima Barros, Priscila; Levy, Debora; Bydlowski, Sergio Paulo</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8765</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Ferroptosis is a type of cell death that was described less than a decade ago.  It is caused by the excess of free intracellular iron that leads to lipid (hydro) peroxidn.  Iron is essential as a redox metal in several physiol. functions.  The brain is one of the organs known to be affected by iron homeostatic balance disruption.  Since the 1960s, increased concn. of iron in the central nervous system has been assocd. with oxidative stress, oxidn. of proteins and lipids, and cell death.  Here, we review the main mechanisms involved in the process of ferroptosis such as lipid peroxidn., glutathione peroxidase 4 enzyme activity, and iron metab.  Moreover, the assocn. of ferroptosis with the pathophysiol. of some neurodegenerative diseases, namely Alzheimer's, Parkinson's, and Huntington's diseases, has also been addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt86wEDzzmMLVg90H21EOLACvtfcHk0ljZT-xf4rEfUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFyhtbnK&md5=34c5488fb87a100c6453bb8d023a886d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.3390%2Fijms21228765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms21228765%26sid%3Dliteratum%253Aachs%26aulast%3DReichert%26aufirst%3DC.%2BO.%26aulast%3Dde%2BFreitas%26aufirst%3DF.%2BA.%26aulast%3DSampaio-Silva%26aufirst%3DJ.%26aulast%3DRokita-Rosa%26aufirst%3DL.%26aulast%3DBarros%26aufirst%3DP.%2BL.%26aulast%3DLevy%26aufirst%3DD.%26aulast%3DBydlowski%26aufirst%3DS.%2BP.%26atitle%3DFerroptosis%2520mechanisms%2520involved%2520in%2520neurodegenerative%2520diseases%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2020%26volume%3D21%26spage%3D8765%26doi%3D10.3390%2Fijms21228765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/medium/jm1c00510_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00510&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/medium/jm1c00510_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Rational design followed for the mapping of the chromone-3-phenylcarboxamide pharmacophore.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00510&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/medium/jm1c00510_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Strategy Pursued for Synthesis of (A) Chromane-3-phenylcarboxamides (<b>2</b>–<b>5</b>), (B) Chromene-3-phenylcarboxamides (<b>7</b>–<b>10</b>), (C) Coumarin-3-phenylcarboxamides (<b>14</b>–<b>17</b>), (D) 2-Oxoquinoline-3-phenylcarboxamides (<b>20</b>–<b>22</b>) and <i>N</i>-Methyl-2-oxoquinoline-3-phenylcarboxamides (<b>23</b>–<b>25</b>), and (E) Thiochromone-3-phenylcarboxamides (<b>30</b> and <b>31</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00510&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (A,B) (a) POCl<sub>3</sub>, DMF, appropriate arylamine, rt, 24 h; (C) (a) diethyl malonate, EtOH, pyrimidine, reflux, overnight; (b) NaOH (ethanolic solution), reflux, 1 h; (c) POCl<sub>3</sub>, DMF, appropriate arylamine, rt, 24 h; (D) (a) CH<sub>3</sub>I, K<sub>2</sub>CO<sub>3</sub>, 60 °C, argon, 1 h; (b) DIPEA, TBTU, appropriate arylamine, rt, 24 h; (E) (a) <i>N</i>,<i>N</i>-dimethylformamide dimethyl acetal, 115 °C, 1 h; (b) H<sub>2</sub>S, −30 °C, 4 h, argon; (c) HCl, AcOH, reflux, 4 h; (d) POCl<sub>3</sub>, appropriate arylamine, rt, 24 h.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/medium/jm1c00510_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Synopsis of the SAR data obtained in the present work.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00510&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/medium/jm1c00510_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Time-dependent enzyme inhibition studies for rasagiline, safinamide, and compound <b>31</b>. Enzymatic activity is expressed in the amount of 4-hydroxyquinoline (4-HQ, nmol). Data are the mean ± SD of three different experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00510&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/medium/jm1c00510_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Double reciprocal plot of the initial velocity of <i>h</i>MAO-B at increasing substrate concentrations (10–100 μM) in the absence or the presence of compound <b>31</b>. (B) Effect of total enzyme concentration on <i>h</i>MAO-B inhibition by compound <b>31</b> (Ackermann–Potter plot).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00510&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/medium/jm1c00510_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Best docking pose of the most active compounds for each series (A) <b>5<i>R</i></b>, (B) <b>5<i>S</i></b>, (C) <b>10</b>, (D) <b>15</b>, and (E) <b>31</b> against <i>h</i>MAO-B. Ligands are shown in green carbon ball-and-sticks, while the protein is represented as a gray surface and FAD in CPK. H-bonds, halogen, and π–π interactions are displayed as dashed purple, violet, and cyan lines, respectively. Amino acid residues involved in the molecular interactions are shown as gray carbon sticks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00510&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/medium/jm1c00510_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cellular viability of differentiated SH-SY5Y (A,B) and Caco-2 cells (C,D) following treatment with <b>Crom-1</b>, <b>Crom-2</b>, and compounds <b>5</b>, <b>7</b>, <b>8</b>, <b>10</b>, <b>14</b>, <b>15</b>, <b>30</b>, and <b>31</b> at 1 (black) and 10 μM (orange) for 24 h. Cytotoxicity was evaluated by measuring metabolic (A,C) and lysosomal activities (B,D) using MTT reduction and NR uptake assays, respectively. Results are expressed as mean ± SEM from at least three independent experiments, performed in triplicate. Statistical comparisons were performed by one-way ANOVA (A,B) and by Kruskal–Wallis test (C,D). In all cases, <i>p</i> values lower than 0.05 were considered significant (*<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001, and ****<i>p</i> < 0.0001 vs untreated cells).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00510&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/medium/jm1c00510_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Evaluation of P-gp activity by fluorescence spectroscopy in Caco-2 cells exposed to <b>Crom-1</b>, <b>Crom-2</b>, and compounds <b>10</b> and <b>31</b> (10 μM) during the incubation period with the fluorescent substrate (RHO 123, 5 μM). Results are presented as mean ± SEM from at least three independent experiments, performed in triplicate. Statistical comparisons were performed by one-way ANOVA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00510&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/medium/jm1c00510_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Evaluation of the protective effect of i-<i>h</i>MAO-B in differentiated SH-SY5Y cells against iron(III) (1000 and 1500 μM). The dashed line is the control data obtained from nontreated cells, while solid and squared bars are related with the data from cells exposed to iron(III) at 1000 and 1500 μM, respectively. The data are expressed as the means of three independent experiments together with the standard deviation (mean ± SD). Statistical comparisons were made using two-way ANOVA. In all cases, <i>p</i> values lower than 0.05 were considered significant (<sup>####</sup><i>p</i> < 0.0001 vs the control data; **<i>p</i> < 0.01 vs iron(III) values).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00510/20210716/images/large/jm1c00510_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00510&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i51">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17765" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17765" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 38 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gealageas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devineau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">So, P. P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surendradoss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwalder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goebeler, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dullaghan, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grierson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putnins, E. E.</span></span> <span> </span><span class="NLM_article-title">Development of novel monoamine oxidase-B (MAO-B) inhibitors with reduced blood-brain barrier permeability for the potential management of noncentral nervous system (CNS) diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7043</span>– <span class="NLM_lpage">7064</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01588</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01588" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlCns7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7043-7064&author=R.+Gealageasauthor=A.+Devineauauthor=P.+P.+L.+Soauthor=C.+M.+J.+Kimauthor=J.+Surendradossauthor=C.+Buchwalderauthor=M.+Hellerauthor=V.+Goebelerauthor=E.+M.+Dullaghanauthor=D.+S.+Griersonauthor=E.+E.+Putnins&title=Development+of+novel+monoamine+oxidase-B+%28MAO-B%29+inhibitors+with+reduced+blood-brain+barrier+permeability+for+the+potential+management+of+noncentral+nervous+system+%28CNS%29+diseases&doi=10.1021%2Facs.jmedchem.7b01588"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Novel Monoamine Oxidase-B (MAO-B) Inhibitors with Reduced Blood-Brain Barrier Permeability for the Potential Management of Noncentral Nervous System (CNS) Diseases</span></div><div class="casAuthors">Gealageas, Ronan; Devineau, Alice; So, Pauline P. L.; Kim, Catrina M. J.; Surendradoss, Jayakumar; Buchwalder, Christian; Heller, Markus; Goebeler, Verena; Dullaghan, Edith M.; Grierson, David S.; Putnins, Edward E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7043-7064</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Studies indicate that MAO-B is induced in peripheral inflammatory diseases.  To target peripheral tissues using MAO-B inhibitors that do not permeate the blood-brain barrier (BBB) the MAO-B-selective inhibitor deprenyl was remodeled by replacing the terminal acetylene with a CO2H function, and incorporating a para-OCH2Ar motif (compds. 10a-s).  Further, in compd. 32 ((S)-N-[1-cyano-3-[4-[(3,4-dichlorobenzyl)oxy]phenyl]propan-2-yl]-N-methylglycine hydrochloride) the C-2 side chain corresponded to CH2CN.  In vitro, 10c (N-[(R)-[1-[4-(3-chlorobenzyloxy)phenyl]propan-2-yl](methyl)]glycine hydrochloride), 10j, 10k, and 32 were identified as potent reversible MAO-B inhibitors, and all four compds. were more stable than deprenyl in plasma, liver microsomal, and hepatocyte stability assays.  In vivo, they demonstrated greater plasma bioavailability.  Assessment of in vitro BBB permeability showed that compd. 10k is a P-glycoprotein (P-gp) substrate and 10j displayed mild interaction.  Importantly, compds. 10c, 10j, 10k, and 32 displayed significantly reduced BBB permeability after i.v., s.c., and oral administration.  These polar MAO-B inhibitors are pertinent leads for evaluation of efficacy in noncentral nervous system (CNS) inflammatory disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxwJVafqtiYrVg90H21EOLACvtfcHk0lilAsF3jaW4TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlCns7bL&md5=46d24762b2205d7e1fef6543ff26997b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01588%26sid%3Dliteratum%253Aachs%26aulast%3DGealageas%26aufirst%3DR.%26aulast%3DDevineau%26aufirst%3DA.%26aulast%3DSo%26aufirst%3DP.%2BP.%2BL.%26aulast%3DKim%26aufirst%3DC.%2BM.%2BJ.%26aulast%3DSurendradoss%26aufirst%3DJ.%26aulast%3DBuchwalder%26aufirst%3DC.%26aulast%3DHeller%26aufirst%3DM.%26aulast%3DGoebeler%26aufirst%3DV.%26aulast%3DDullaghan%26aufirst%3DE.%2BM.%26aulast%3DGrierson%26aufirst%3DD.%2BS.%26aulast%3DPutnins%26aufirst%3DE.%2BE.%26atitle%3DDevelopment%2520of%2520novel%2520monoamine%2520oxidase-B%2520%2528MAO-B%2529%2520inhibitors%2520with%2520reduced%2520blood-brain%2520barrier%2520permeability%2520for%2520the%2520potential%2520management%2520of%2520noncentral%2520nervous%2520system%2520%2528CNS%2529%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D7043%26epage%3D7064%26doi%3D10.1021%2Facs.jmedchem.7b01588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finberg, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabey, J. M.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of MAO-A and MAO-B in psychiatry and neurology</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">340</span>, <span class="refDoi"> DOI: 10.3389/fphar.2016.00340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.3389%2Ffphar.2016.00340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=27803666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlWnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=340&author=J.+P.+Finbergauthor=J.+M.+Rabey&title=Inhibitors+of+MAO-A+and+MAO-B+in+psychiatry+and+neurology&doi=10.3389%2Ffphar.2016.00340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of MAO-A and MAO-B in psychiatry and neurology</span></div><div class="casAuthors">Finberg, John P. M.; Rabey, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">340-354</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Inhibitors of MAO-A and MAO-B are in clin. use for the treatment of psychiatric and neurol. disorders resp.  Elucidation of the mol. structure of the active sites of the enzymes has enabled a precise detn. of the way in which substrates and inhibitor mols. are metabolized, or inhibit metab. of substrates, resp.  Despite the knowledge of the strong antidepressant efficacy of irreversible MAO inhibitors, their clin. use has been limited by their side effect of potentiation of the cardiovascular effects of dietary amines ("cheese effect").  A no. of reversible MAO-A inhibitors which are devoid of cheese effect have been described in the literature, but only one, moclobemide, is currently in clin. use.  The irreversible inhibitors of MAO-B, selegiline and rasagiline, are used clin. in treatment of Parkinson's disease, and a recently introduced reversible MAO-B inhibitor, safinamide, has also been found efficacious.  Modification of the pharmacokinetic characteristics of selegiline by transdermal administration has led to the development of a new drug form for treatment of depression.  The clin. potential of MAO inhibitors together with detailed knowledge of the enzyme's binding site structure should lead to future developments with these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUpMUqQ2oLP7Vg90H21EOLACvtfcHk0lilAsF3jaW4TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlWnu7k%253D&md5=7d7cf400373f86aa87e1147ce52b6d16</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2016.00340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2016.00340%26sid%3Dliteratum%253Aachs%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%26aulast%3DRabey%26aufirst%3DJ.%2BM.%26atitle%3DInhibitors%2520of%2520MAO-A%2520and%2520MAO-B%2520in%2520psychiatry%2520and%2520neurology%26jtitle%3DFront.%2520Pharmacol.%26date%3D2016%26volume%3D7%26spage%3D340%26doi%3D10.3389%2Ffphar.2016.00340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tripathi, R. K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayyannan, S. R.</span></span> <span> </span><span class="NLM_article-title">Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: an overview and update</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1603</span>– <span class="NLM_lpage">1706</span>, <span class="refDoi"> DOI: 10.1002/med.21561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1002%2Fmed.21561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=30604512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFOjtbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2019&pages=1603-1706&author=R.+K.+P.+Tripathiauthor=S.+R.+Ayyannan&title=Monoamine+oxidase-B+inhibitors+as+potential+neurotherapeutic+agents%3A+an+overview+and+update&doi=10.1002%2Fmed.21561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: An overview and update</span></div><div class="casAuthors">Tripathi, Rati Kailash Prasad; Ayyannan, Senthil Raja</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1603-1706</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Monoamine oxidase (MAO) inhibitors have made significant contributions and remain an indispensable approach of mol. and mechanistic diversity for the discovery of antineurodegenerative drugs.  However, their usage has been hampered by nonselective and/or irreversible action which resulted in drawbacks like liver toxicity, cheese effect, and so forth.  Hence, the search for selective MAO inhibitors (MAOIs) has become a substantial focus in current drug discovery.  This review summarizes our current understanding on MAO-A/MAO-B including their structure, catalytic mechanism, and biol. functions with emphases on the role of MAO-B as a potential therapeutic target for the development of medications treating neurodegenerative disorders.  It also highlights the recent developments in the discovery of potential MAO-B inhibitors (MAO-BIs) belonging to diverse chem. scaffolds, arising from intensive chem.-mechanistic and computational studies documented during past 3 years (2015-2018), with emphases on their potency and selectivity.  Importantly, readers will gain knowledge of various newly established MAO-BI scaffolds and their development potentials.  The comprehensive information provided herein will hopefully accelerate ideas for designing novel selective MAO-BIs with superior activity profiles and crit. discussions will inflict more caution in the decision-making process in the MAOIs discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0XoMpJ5mvjLVg90H21EOLACvtfcHk0lhdbjCVahogmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFOjtbnN&md5=f516763a33fbcb6393592794606715a7</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fmed.21561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21561%26sid%3Dliteratum%253Aachs%26aulast%3DTripathi%26aufirst%3DR.%2BK.%2BP.%26aulast%3DAyyannan%26aufirst%3DS.%2BR.%26atitle%3DMonoamine%2520oxidase-B%2520inhibitors%2520as%2520potential%2520neurotherapeutic%2520agents%253A%2520an%2520overview%2520and%2520update%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2019%26volume%3D39%26spage%3D1603%26epage%3D1706%26doi%3D10.1002%2Fmed.21561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarishkin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeon, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Londhe, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pae, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. D.</span></span> <span> </span><span class="NLM_article-title">Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer’s disease</span>. <i>Sci. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">eaav0316</span> <span class="refDoi"> DOI: 10.1126/sciadv.aav0316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1126%2Fsciadv.aav0316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=30906861" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&author=J.+H.+Parkauthor=Y.+H.+Juauthor=J.+W.+Choiauthor=H.+J.+Songauthor=B.+K.+Jangauthor=J.+Wooauthor=H.+Chunauthor=H.+J.+Kimauthor=S.+J.+Shinauthor=O.+Yarishkinauthor=S.+Joauthor=M.+Parkauthor=S.+K.+Yeonauthor=S.+Kimauthor=J.+Kimauthor=M.+H.+Namauthor=A.+M.+Londheauthor=J.+Kimauthor=S.+J.+Choauthor=S.+Choauthor=C.+Leeauthor=S.+Y.+Hwangauthor=S.+W.+Kimauthor=S.+J.+Ohauthor=J.+Choauthor=A.+N.+Paeauthor=C.+J.+Leeauthor=K.+D.+Park&title=Newly+developed+reversible+MAO-B+inhibitor+circumvents+the+shortcomings+of+irreversible+inhibitors+in+Alzheimer%E2%80%99s+disease&doi=10.1126%2Fsciadv.aav0316"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fsciadv.aav0316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fsciadv.aav0316%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DJu%26aufirst%3DY.%2BH.%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DSong%26aufirst%3DH.%2BJ.%26aulast%3DJang%26aufirst%3DB.%2BK.%26aulast%3DWoo%26aufirst%3DJ.%26aulast%3DChun%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DShin%26aufirst%3DS.%2BJ.%26aulast%3DYarishkin%26aufirst%3DO.%26aulast%3DJo%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DM.%26aulast%3DYeon%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DNam%26aufirst%3DM.%2BH.%26aulast%3DLondhe%26aufirst%3DA.%2BM.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DCho%26aufirst%3DS.%2BJ.%26aulast%3DCho%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DHwang%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DOh%26aufirst%3DS.%2BJ.%26aulast%3DCho%26aufirst%3DJ.%26aulast%3DPae%26aufirst%3DA.%2BN.%26aulast%3DLee%26aufirst%3DC.%2BJ.%26aulast%3DPark%26aufirst%3DK.%2BD.%26atitle%3DNewly%2520developed%2520reversible%2520MAO-B%2520inhibitor%2520circumvents%2520the%2520shortcomings%2520of%2520irreversible%2520inhibitors%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DSci.%2520Adv.%26date%3D2019%26volume%3D5%26doi%3D10.1126%2Fsciadv.aav0316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tzvetkov, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stammler, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hristova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonov, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gastreich, M.</span></span> <span> </span><span class="NLM_article-title">Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">470</span>– <span class="NLM_lpage">492</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1016%2Fj.ejmech.2017.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=28107736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVarsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2017&pages=470-492&author=N.+T.+Tzvetkovauthor=H.+G.+Stammlerauthor=B.+Neumannauthor=S.+Hristovaauthor=L.+Antonovauthor=M.+Gastreich&title=Crystal+structures%2C+binding+interactions%2C+and+ADME+evaluation+of+brain+penetrant+N-substituted+indazole-5-carboxamides+as+subnanomolar%2C+selective+monoamine+oxidase+B+and+dual+MAO-A%2FB+inhibitors&doi=10.1016%2Fj.ejmech.2017.01.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors</span></div><div class="casAuthors">Tzvetkov, Nikolay T.; Stammler, Hans-Georg; Neumann, Beate; Hristova, Silvia; Antonov, Liudmil; Gastreich, Marcus</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">470-492</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The pharmacol. and physicochem. anal. of structurally optimized N-alkyl-substituted indazole-5-carboxamides, developed as potential drug and radioligand candidates for the treatment and diagnosis of Parkinson's disease (PD) and other neurol. disorders, is reported.  Recent efforts have been focused on the development of subnanomolar potent, selective MAO-B (N1-alkyl-substituted compds. 12a-14a and 15) and dual active MAO-A/B (N2-methylated compds. 12b-14b) inhibitors with nanomolar potency towards MAO-B and moderately active against MAO-A enzyme, resp.  The most promising drug-like derivs. in both series were N-(3-chloro-4-fluorophenyl)-1-methyl-1H-indazole-5-carboxamide (13a, NTZ-1441, IC50 hMAO-B 0.662 nM, >15000-fold selective vs. MAO-A) and N-(3-chloro-4-fluorophenyl)-2-methyl-2H-indazole-5-carboxamide (13b, NTZ-1442, IC50 hMAO-B 8.08 nM, IC50 hMAO-A 0.56 μM, SI = 70).  Moreover, compds. 13a and 13b were predicted to cross both the gastrointestinal tract (at pH 2.0, 5.5, and 7,4) and the blood-brain barrier (BBB) in vitro with appropriate drug-like properties required for CNS active drugs.  Combined single X-ray/mol. modeling studies provided insights into the enzyme-inhibitor interactions within both MAO isoforms and the rationale for their inhibitory activity with controlled MAO-A/B selectivity - despite their small structural differences.  The binding modes of 12a,b and 13a,b confirmed that the major interactions with hMAO-B were established via the flexible carbonyl group of the carboxamide linkage and the electron-donating nitrogens N1 or N2 of the indazole moiety, allowing further exploration of the alkyl side chain for next step lead optimization efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor1v1iZCTAyrVg90H21EOLACvtfcHk0lhdbjCVahogmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVarsbw%253D&md5=77508134a49aff86ed626511a7857f82</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DTzvetkov%26aufirst%3DN.%2BT.%26aulast%3DStammler%26aufirst%3DH.%2BG.%26aulast%3DNeumann%26aufirst%3DB.%26aulast%3DHristova%26aufirst%3DS.%26aulast%3DAntonov%26aufirst%3DL.%26aulast%3DGastreich%26aufirst%3DM.%26atitle%3DCrystal%2520structures%252C%2520binding%2520interactions%252C%2520and%2520ADME%2520evaluation%2520of%2520brain%2520penetrant%2520N-substituted%2520indazole-5-carboxamides%2520as%2520subnanomolar%252C%2520selective%2520monoamine%2520oxidase%2520B%2520and%2520dual%2520MAO-A%252FB%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D127%26spage%3D470%26epage%3D492%26doi%3D10.1016%2Fj.ejmech.2017.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathitharan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furukawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boileau, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guttman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornykiewicz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kish, S. J.</span></span> <span> </span><span class="NLM_article-title">Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">2460</span>– <span class="NLM_lpage">2474</span>, <span class="refDoi"> DOI: 10.1093/brain/awx172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1093%2Fbrain%2Fawx172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=29050386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A280%3ADC%252BC1M7isFartQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2017&pages=2460-2474&author=J.+Tongauthor=G.+Rathitharanauthor=J.+H.+Meyerauthor=Y.+Furukawaauthor=L.+C.+Angauthor=I.+Boileauauthor=M.+Guttmanauthor=O.+Hornykiewiczauthor=S.+J.+Kish&title=Brain+monoamine+oxidase+B+and+A+in+human+parkinsonian+dopamine+deficiency+disorders&doi=10.1093%2Fbrain%2Fawx172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders</span></div><div class="casAuthors">Tong Junchao; Tong Junchao; Rathitharan Gausiha; Kish Stephen J; Meyer Jeffrey H; Furukawa Yoshiaki; Ang Lee-Cyn; Boileau Isabelle; Guttman Mark; Hornykiewicz Oleh</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2460-2474</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">See Jellinger (doi:10.1093/awx190) for a scientific commentary on this article.  The enzyme monoamine oxidases (B and A subtypes, encoded by MAOB and MAOA, respectively) are drug targets in the treatment of Parkinson's disease.  Inhibitors of MAOB are used clinically in Parkinson's disease for symptomatic purposes whereas the potential disease-modifying effect of monoamine oxidase inhibitors is debated.  As astroglial cells express high levels of MAOB, the enzyme has been proposed as a brain imaging marker of astrogliosis, a cellular process possibly involved in Parkinson's disease pathogenesis as elevation of MAOB in astrocytes might be harmful.  Since brain monoamine oxidase status in Parkinson's disease is uncertain, our objective was to measure, by quantitative immunoblotting in autopsied brain homogenates, protein levels of both monoamine oxidases in three different degenerative parkinsonian disorders: Parkinson's disease (n = 11), multiple system atrophy (n = 11), and progressive supranuclear palsy (n = 16) and in matched controls (n = 16).  We hypothesized that if MAOB is 'substantially' localized to astroglial cells, MAOB levels should be generally associated with standard astroglial protein measures (e.g. glial fibrillary acidic protein).  MAOB levels were increased in degenerating putamen (+83%) and substantia nigra (+10%, non-significant) in multiple system atrophy; in caudate (+26%), putamen (+27%), frontal cortex (+31%) and substantia nigra (+23%) of progressive supranuclear palsy; and in frontal cortex (+33%), but not in substantia nigra of Parkinson's disease, a region we previously reported no increase in astrocyte protein markers.  Although the magnitude of MAOB increase was less than those of standard astrocytic markers, significant positive correlations were observed amongst the astrocyte proteins and MAOB.  Despite suggestions that MAOA (versus MAOB) is primarily responsible for metabolism of dopamine in dopamine neurons, there was no loss of the enzyme in the parkinsonian substantia nigra; instead, increased nigral levels of a MAOA fragment and 'turnover' of the enzyme were observed in the conditions.  Our findings provide support that MAOB might serve as a biochemical imaging marker, albeit not entirely specific, for astrocyte activation in human brain.  The observation that MAOB protein concentration is generally increased in degenerating brain areas in multiple system atrophy (especially putamen) and in progressive supranuclear palsy, but not in the nigra in Parkinson's disease, also distinguishes astrocyte behaviour in Parkinson's disease from that in the two 'Parkinson-plus' conditions.  The question remains whether suppression of either MAOB in astrocytes or MAOA in dopamine neurons might influence progression of the parkinsonian disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCP3w9TYeAj4xhnOQkIHOxfW6udTcc2eYN2RNrWHsCQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7isFartQ%253D%253D&md5=f2857a981a1f403c31f0bd1f4d94389f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawx172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawx172%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DJ.%26aulast%3DRathitharan%26aufirst%3DG.%26aulast%3DMeyer%26aufirst%3DJ.%2BH.%26aulast%3DFurukawa%26aufirst%3DY.%26aulast%3DAng%26aufirst%3DL.%2BC.%26aulast%3DBoileau%26aufirst%3DI.%26aulast%3DGuttman%26aufirst%3DM.%26aulast%3DHornykiewicz%26aufirst%3DO.%26aulast%3DKish%26aufirst%3DS.%2BJ.%26atitle%3DBrain%2520monoamine%2520oxidase%2520B%2520and%2520A%2520in%2520human%2520parkinsonian%2520dopamine%2520deficiency%2520disorders%26jtitle%3DBrain%26date%3D2017%26volume%3D140%26spage%3D2460%26epage%3D2474%26doi%3D10.1093%2Fbrain%2Fawx172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dezsi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vecsei, L.</span></span> <span> </span><span class="NLM_article-title">Monoamine oxidase B onhibitors in Parkinson’s disease</span>. <i>CNS Neurol. Disord.: Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">425</span>– <span class="NLM_lpage">439</span>, <span class="refDoi"> DOI: 10.2174/1871527316666170124165222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.2174%2F1871527316666170124165222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=28124620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1SmtLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=425-439&author=L.+Dezsiauthor=L.+Vecsei&title=Monoamine+oxidase+B+onhibitors+in+Parkinson%E2%80%99s+disease&doi=10.2174%2F1871527316666170124165222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine Oxidase B Inhibitors in Parkinson's Disease</span></div><div class="casAuthors">Dezsi, Livia; Vecsei, Laszlo</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">425-439</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Parkinson's disease (PD) is a neurodegenerative disorder with a prevalence increasing with age.  Oxidative stress and glutamate toxicity are involved in its pathomechanism.  There are still many unmet needs of PD patients, including the alleviation of motor fluctuations and dyskinesias, and the development of therapies with neuroprotective potential.  To give an overview of the pharmacol. properties, the efficacy and safety of the monoamine oxidase B (MAO-B) inhibitors in the treatment of PD, with special focus on the results of randomized clin. trials.  A literature search was conducted in PubMed for 'PD treatment', 'MAO-B inhibitors', 'selegiline', 'rasagiline', 'safinamide' and 'clin. trials' with 'MAO-B inhibitors' in 'Parkinson' disease'.  Results: MAO-B inhibitors have a favorable pharmacokinetic profile, improve the dopamine deficient state and may have neuroprotective properties.  Safinamide exhibits an anti-glutamatergic effect as well.  When applied as monotherapy, MAO-B inhibitors provide a modest, but significant improvement of motor function and delay the need for levodopa.  Rasagiline and safinamide were proven safe and effective when added to a dopamine agonist in early PD.  As add-on to levodopa, MAO-B inhibitors significantly reduced off-time and were comparable in efficacy to COMT inhibitors.  Improvements were achieved as regards certain non-motor symptoms as well.  Due to the efficacy shown in clin. trials and their favorable side-effect profile, MAO-B inhibitors are valuable drugs in the treatment of PD.  They are recommended as monotherapy in the early stages of the disease and as add-on therapy to levodopa in advanced PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMA_sgCUd0GrVg90H21EOLACvtfcHk0liC2-yWl2zKHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1SmtLbE&md5=0d7e67bbd9daf48131efbd6494c620ad</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F1871527316666170124165222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871527316666170124165222%26sid%3Dliteratum%253Aachs%26aulast%3DDezsi%26aufirst%3DL.%26aulast%3DVecsei%26aufirst%3DL.%26atitle%3DMonoamine%2520oxidase%2520B%2520onhibitors%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2017%26volume%3D16%26spage%3D425%26epage%3D439%26doi%3D10.2174%2F1871527316666170124165222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guglielmi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carradori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ammazzalorso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secci, D.</span></span> <span> </span><span class="NLM_article-title">Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement?</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">1035</span>, <span class="refDoi"> DOI: 10.1080/17460441.2019.1637415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1080%2F17460441.2019.1637415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=31268358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A280%3ADC%252BB3Mzjs1Clug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=995-1035&author=P.+Guglielmiauthor=S.+Carradoriauthor=A.+Ammazzalorsoauthor=D.+Secci&title=Novel+approaches+to+the+discovery+of+selective+human+monoamine+oxidase-B+inhibitors%3A+is+there+room+for+improvement%3F&doi=10.1080%2F17460441.2019.1637415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement?</span></div><div class="casAuthors">Guglielmi Paolo; Secci Daniela; Carradori Simone; Ammazzalorso Alessandra</div><div class="citationInfo"><span class="NLM_cas:title">Expert opinion on drug discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">995-1035</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Introduction: Selective monoamine oxidase-B (MAO-B) inhibitors are currently used as coadjuvants for the treatment of early motor symptoms in Parkinson's disease.  They can, based on their chemical structure and mechanism of inhibition, be categorized into reversible and irreversible agents.  Areas covered: This review provides a comprehensive update on the development state of selective MAO-B inhibitors describing the results, structures, structure-activity relationships (SARs) and Medicinal chemistry strategies as well as the related shortcomings over the past five years.  Expert opinion: Researchers have explored and implemented new and old chemical scaffolds achieving high inhibitory potencies and isoform selectivity.  Most of them were characterized and proposed as multitarget agents able to act at different levels (including AChE inhibition, H3R or A2AR antagonism, antioxidant and chelating properties, Aβ1-42 aggregation reduction) in the network of aetiologies of neurodegenerative disorders.  These results can also be used to avoid 'cheese-reaction' effects and the occurrence of serotonergic syndrome in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTFNGmKNdPMSw8IxFYvehhofW6udTcc2eZ8m2XrkCiFnrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3Mzjs1Clug%253D%253D&md5=7b1ef202f4a7b71c8ec0ba861b5a5d5c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1080%2F17460441.2019.1637415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2019.1637415%26sid%3Dliteratum%253Aachs%26aulast%3DGuglielmi%26aufirst%3DP.%26aulast%3DCarradori%26aufirst%3DS.%26aulast%3DAmmazzalorso%26aufirst%3DA.%26aulast%3DSecci%26aufirst%3DD.%26atitle%3DNovel%2520approaches%2520to%2520the%2520discovery%2520of%2520selective%2520human%2520monoamine%2520oxidase-B%2520inhibitors%253A%2520is%2520there%2520room%2520for%2520improvement%253F%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2019%26volume%3D14%26spage%3D995%26epage%3D1035%26doi%3D10.1080%2F17460441.2019.1637415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orallo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5165</span>– <span class="NLM_lpage">5173</span>, <span class="refDoi"> DOI: 10.1021/jm2004267</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2004267" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlaisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5165-5173&author=A.+Gasparauthor=T.+Silvaauthor=M.+Yanezauthor=D.+Vinaauthor=F.+Oralloauthor=F.+Ortusoauthor=E.+Uriarteauthor=S.+Alcaroauthor=F.+Borges&title=Chromone%2C+a+privileged+scaffold+for+the+development+of+monoamine+oxidase+inhibitors&doi=10.1021%2Fjm2004267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors</span></div><div class="casAuthors">Gaspar, Alexandra; Silva, Tiago; Yanez, Matilde; Vina, Dolores; Orallo, Franscisco; Ortuso, Francesco; Uriarte, Eugenio; Alcaro, Stefano; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5165-5173</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two series of novel chromone derivs. I and II ( R = Ph, 4-OH-C6H4, 3-OH-4-MeO-C6H3, 3,4-(OH)2-C6H3, 3,4-(MeO)2-C6H3, 4-Cl-C6H4, 4-OCF3-C6H4, 4-CF3-C6H4, 4-NO2-C6H4, cyclohexyl, nPr) were synthesized and investigated for their ability to inhibit the activity of monoamine oxidase.  The SAR data indicate that chromone derivs. with substituents in position 3 of γ-pyrone nucleus act preferably as MAO-B inhibitors, with IC50 values in the nanomolar to micromolar range.  Almost all chromone 3-carboxamides display selectivity toward MAO-B.  Identical substitutions on position 2 of γ-pyrone nucleus result in complete loss of activity in both isoforms (chromones I except R = 4-OH-C6H4 and 3,4-(OH)2-C6H3).  Notably, chromone II(R = 4-Cl-C6H4) exhibits an MAO-B IC50 of 63 nM, greater than 1000-fold selectivity over MAO-A, and behaves as a quasi-reversible inhibitor.  Docking expts. onto the MAO binding of the most active compd. highlight different interaction patterns among the isoforms A and B.  The differential anal. of the solvation effects among the chromone isomers gave addnl. insight about the superior outline of the 3-substituted chromone derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKKLGzqjz4yLVg90H21EOLACvtfcHk0li0TafoZcD5Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlaisb0%253D&md5=27e7bd37930e26f28fb5b624b2360457</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm2004267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2004267%26sid%3Dliteratum%253Aachs%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DSilva%26aufirst%3DT.%26aulast%3DYanez%26aufirst%3DM.%26aulast%3DVina%26aufirst%3DD.%26aulast%3DOrallo%26aufirst%3DF.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DChromone%252C%2520a%2520privileged%2520scaffold%2520for%2520the%2520development%2520of%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5165%26epage%3D5173%26doi%3D10.1021%2Fjm2004267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagide, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavarria, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remiao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">Discovery of new chemical entities for old targets: insights on the lead optimization of chromone-based monoamine oxidase B (MAO-B) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">5879</span>– <span class="NLM_lpage">5893</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00527</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00527" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC28XovVWksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5879-5893&author=J.+Reisauthor=F.+Cagideauthor=D.+Chavarriaauthor=T.+Silvaauthor=C.+Fernandesauthor=A.+Gasparauthor=E.+Uriarteauthor=F.+Remiaoauthor=S.+Alcaroauthor=F.+Ortusoauthor=F.+Borges&title=Discovery+of+new+chemical+entities+for+old+targets%3A+insights+on+the+lead+optimization+of+chromone-based+monoamine+oxidase+B+%28MAO-B%29+inhibitors&doi=10.1021%2Facs.jmedchem.6b00527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors</span></div><div class="casAuthors">Reis, Joana; Cagide, Fernando; Chavarria, Daniel; Silva, Tiago; Fernandes, Carlos; Gaspar, Alexandra; Uriarte, Eugenio; Remiao, Fernando; Alcaro, Stefano; Ortuso, Francesco; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5879-5893</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of new chem. entities endowed with potent, selective, and reversible monoamine oxidase B inhibitory activity is a clin. relevant subject.  Therefore, a small library of chromone derivs. was synthesized and screened toward human monoamine oxidase isoforms (hMAO-A and hMAO-B).  The structure-activity relationships studies strengthen the importance of the amide spacer and the direct linkage of carbonyl group to the γ-pyrone ring, along with the presence of meta and para substituents in the exocyclic ring.  The most potent MAO-B inhibitors were N-(3'-chlorophenyl)-4-oxo-4H-chromene-3-carboxamide (20) (IC50 = 403 pM) and N-(3',4'-dimethylphenyl)-4-oxo-4H-chromene-3-carboxamide (27) (IC50 = 669 pM), acting as competitive and noncompetitive reversible inhibitors, resp.  Computational docking studies provided insights into enzyme-inhibitor interactions and a rationale for the obsd. selectivity and potency.  Compd. 27 stands out due to its favorable toxicol. profile and physicochem. properties, which pointed toward blood-brain barrier permeability, thus being a valid candidate for subsequent animal studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWONk5yTkyN7Vg90H21EOLACvtfcHk0li0TafoZcD5Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XovVWksb8%253D&md5=361d3dde07c197e2bdc41d08746a35f6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00527%26sid%3Dliteratum%253Aachs%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DCagide%26aufirst%3DF.%26aulast%3DChavarria%26aufirst%3DD.%26aulast%3DSilva%26aufirst%3DT.%26aulast%3DFernandes%26aufirst%3DC.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DRemiao%26aufirst%3DF.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520new%2520chemical%2520entities%2520for%2520old%2520targets%253A%2520insights%2520on%2520the%2520lead%2520optimization%2520of%2520chromone-based%2520monoamine%2520oxidase%2520B%2520%2528MAO-B%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5879%26epage%3D5893%26doi%3D10.1021%2Facs.jmedchem.6b00527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagetta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">Coumarin versus chromone monoamine oxidase B inhibitors: quo vadis?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7206</span>– <span class="NLM_lpage">7212</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00918</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00918" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Cntb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7206-7212&author=A.+Fonsecaauthor=J.+Reisauthor=T.+Silvaauthor=M.+J.+Matosauthor=D.+Bagettaauthor=F.+Ortusoauthor=S.+Alcaroauthor=E.+Uriarteauthor=F.+Borges&title=Coumarin+versus+chromone+monoamine+oxidase+B+inhibitors%3A+quo+vadis%3F&doi=10.1021%2Facs.jmedchem.7b00918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Coumarin versus Chromone Monoamine Oxidase B Inhibitors: Quo Vadis?</span></div><div class="casAuthors">Fonseca, Andre; Reis, Joana; Silva, Tiago; Matos, Maria Joao; Bagetta, Donatella; Ortuso, Francesco; Alcaro, Stefano; Uriarte, Eugenio; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7206-7212</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of the lack of significant disease-modifying drugs for neurodegenerative disorders, a pressing need for new chem. entities endowed with IMAO-B still exists.  Within this framework, and for the first time, a study was performed to compare coumarin- and chromone-3-phenylcarboxamide scaffolds.  Compds. I and II were the most potent, selective, and reversible noncompetitive IMAO-B.  The benzopyrone sp2 oxygen atom was found to be position independent and a productive contributor for the ligand-enzyme complex stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogLjC3cJIkZbVg90H21EOLACvtfcHk0lg_i60NC2RZhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Cntb7K&md5=4af88b342ccfe910629ef704b6a65fc6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00918%26sid%3Dliteratum%253Aachs%26aulast%3DFonseca%26aufirst%3DA.%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DSilva%26aufirst%3DT.%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DBagetta%26aufirst%3DD.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DCoumarin%2520versus%2520chromone%2520monoamine%2520oxidase%2520B%2520inhibitors%253A%2520quo%2520vadis%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7206%26epage%3D7212%26doi%3D10.1021%2Facs.jmedchem.7b00918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milhazes, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orallo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">Chromone-2- and −3-carboxylic acids inhibit differently monoamine oxidases A and B</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2709</span>– <span class="NLM_lpage">2712</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.03.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1016%2Fj.bmcl.2010.03.081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=20382016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFeqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2709-2712&author=S.+Alcaroauthor=A.+Gasparauthor=F.+Ortusoauthor=N.+Milhazesauthor=F.+Oralloauthor=E.+Uriarteauthor=M.+Yanezauthor=F.+Borges&title=Chromone-2-+and+%E2%88%923-carboxylic+acids+inhibit+differently+monoamine+oxidases+A+and+B&doi=10.1016%2Fj.bmcl.2010.03.081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B</span></div><div class="casAuthors">Alcaro, Stefano; Gaspar, Alexandra; Ortuso, Francesco; Milhazes, Nuno; Orallo, Francisco; Uriarte, Eugenio; Yanez, Matilde; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2709-2712</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Chromone carboxylic acids were evaluated as human monoamine oxidase A and B (hMAO-A and hMAO-B) inhibitors.  The biol. data indicated that only chromone-3-carboxylic acid is a potent hMAO-B inhibitor, with a high degree of selectivity for hMAO-B compared to hMAO-A.  Conversely the chromone-2-carboxylic acid resulted almost inactive against both MAO isoforms.  Docking expts. were performed to elucidate the reasons of the different MAO IC50 data and to explain the absence of activity vs. selectivity, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFt7f6F1PaYbVg90H21EOLACvtfcHk0lg_i60NC2RZhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFeqtbk%253D&md5=a658e00cc4677f548e4607b6179a244b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.03.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.03.081%26sid%3Dliteratum%253Aachs%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DMilhazes%26aufirst%3DN.%26aulast%3DOrallo%26aufirst%3DF.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DYanez%26aufirst%3DM.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DChromone-2-%2520and%2520%25E2%2588%25923-carboxylic%2520acids%2520inhibit%2520differently%2520monoamine%2520oxidases%2520A%2520and%2520B%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2709%26epage%3D2712%26doi%3D10.1016%2Fj.bmcl.2010.03.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manzella, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagide, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mialet-Perez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span> <span> </span><span class="NLM_article-title">Tight-binding inhibition of human monoamine oxidase B by chromone analogs: a kinetic, crystallographic, and biological analysis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4203</span>– <span class="NLM_lpage">4212</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00357</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00357" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsFSnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4203-4212&author=J.+Reisauthor=N.+Manzellaauthor=F.+Cagideauthor=J.+Mialet-Perezauthor=E.+Uriarteauthor=A.+Pariniauthor=F.+Borgesauthor=C.+Binda&title=Tight-binding+inhibition+of+human+monoamine+oxidase+B+by+chromone+analogs%3A+a+kinetic%2C+crystallographic%2C+and+biological+analysis&doi=10.1021%2Facs.jmedchem.8b00357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Tight-Binding Inhibition of Human Monoamine Oxidase B by Chromone Analogs: A Kinetic, Crystallographic, and Biological Analysis</span></div><div class="casAuthors">Reis, Joana; Manzella, Nicola; Cagide, Fernando; Mialet-Perez, Jeanne; Uriarte, Eugenio; Parini, Angelo; Borges, Fernanda; Binda, Claudia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4203-4212</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoamine oxidase B (MAO-B) is a validated drug target for Parkinson's disease.  Chromone derivs. were identified as novel potent and reversible MAO-B inhibitors, and herewith we report on a crystallog. and biochem. anal. to investigate their inhibition mechanism.  The crystal structures of human MAO-B in complex with three chromone analogs bearing different substituents on the exocyclic arom. ring (detd. at 1.6-1.8 Å resoln.) showed that they all bind in the active site cavity of the protein with the chromone moiety located in front of the FAD cofactor.  These inhibitors form two hydrogen bonds with Tyr435 and Cys172 and perfectly fit the hydrophobic flat active site of human MAO-B.  This is reflected in their tight-binding mechanism of inhibition with Ki values of 55, 17, and 31 nM for N-(3',4'-dimethylphenyl)-4-oxo-4H-chromene-3-carboxamide (1), N-(3'-chlorophenyl)-4-oxo-4H-chromene-3-carboxamide (2), and N-(3'-fluorophenyl)-4-oxo-4H-chromene-3-carboxamide (3), resp.  These compds. were also 1000-fold more effective than L-deprenyl in reducing the cellular levels of reactive oxygen species (ROS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI4_ZAaYfpTbVg90H21EOLACvtfcHk0liNS0q8Yc75nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnsFSnsrw%253D&md5=129e0b5bbd744bc3ef74a75bda97a550</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00357%26sid%3Dliteratum%253Aachs%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DManzella%26aufirst%3DN.%26aulast%3DCagide%26aufirst%3DF.%26aulast%3DMialet-Perez%26aufirst%3DJ.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DParini%26aufirst%3DA.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DBinda%26aufirst%3DC.%26atitle%3DTight-binding%2520inhibition%2520of%2520human%2520monoamine%2520oxidase%2520B%2520by%2520chromone%2520analogs%253A%2520a%2520kinetic%252C%2520crystallographic%252C%2520and%2520biological%2520analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4203%26epage%3D4212%26doi%3D10.1021%2Facs.jmedchem.8b00357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duarte, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">Exploring coumarin potentialities: development of new enzymatic inhibitors based on the 6-methyl-3-carboxamidocoumarin scaffold</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">49764</span>– <span class="NLM_lpage">49768</span>, <span class="refDoi"> DOI: 10.1039/C6RA05262B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1039%2FC6RA05262B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC28XnslGrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=49764-49768&author=A.+Fonsecaauthor=M.+J.+Matosauthor=J.+Reisauthor=Y.+Duarteauthor=M.+Guti%C3%A9rrezauthor=L.+Santanaauthor=E.+Uriarteauthor=F.+Borges&title=Exploring+coumarin+potentialities%3A+development+of+new+enzymatic+inhibitors+based+on+the+6-methyl-3-carboxamidocoumarin+scaffold&doi=10.1039%2FC6RA05262B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring coumarin potentialities: development of new enzymatic inhibitors based on the 6-methyl-3-carboxamidocoumarin scaffold</span></div><div class="casAuthors">Fonseca, A.; Matos, M. J.; Reis, J.; Duarte, Y.; Gutierrez, M.; Santana, L.; Uriarte, E.; Borges, F.</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">55</span>),
    <span class="NLM_cas:pages">49764-49768</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Novel 6-methyl-3-carboxamidocoumarins (compds. 4-15) were synthesized by an effective three step synthetic strategy and screened towards MAO, AChE and BuChE enzymes.  In general, the compds. act as selective MAO-B inhibitors.  Compd. 11 is highlighted as a potent (IC50hMAO-B = 4.66 nM), reversible and non-competitive MAO-B inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplBWq-igGTwbVg90H21EOLACvtfcHk0liNS0q8Yc75nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnslGrsLc%253D&md5=da27ffcde3302441f92d2610025db7a8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1039%2FC6RA05262B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6RA05262B%26sid%3Dliteratum%253Aachs%26aulast%3DFonseca%26aufirst%3DA.%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DDuarte%26aufirst%3DY.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DM.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DExploring%2520coumarin%2520potentialities%253A%2520development%2520of%2520new%2520enzymatic%2520inhibitors%2520based%2520on%2520the%25206-methyl-3-carboxamidocoumarin%2520scaffold%26jtitle%3DRSC%2520Adv.%26date%3D2016%26volume%3D6%26spage%3D49764%26epage%3D49768%26doi%3D10.1039%2FC6RA05262B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwivedi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 6-aryl substituted 4-quinolones via Suzuki cross coupling</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">6254</span>– <span class="NLM_lpage">6260</span>, <span class="refDoi"> DOI: 10.1039/c3ra45056b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1039%2Fc3ra45056b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1Whug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=6254-6260&author=S.+Guptaauthor=P.+Ghoshauthor=S.+Dwivediauthor=S.+Das&title=Synthesis+of+6-aryl+substituted+4-quinolones+via+Suzuki+cross+coupling&doi=10.1039%2Fc3ra45056b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 6-aryl substituted 4-quinolones via Suzuki cross coupling</span></div><div class="casAuthors">Gupta, Sumanta; Ghosh, Prasanjit; Dwivedi, Seema; Das, Sajal</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6254-6260</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A suitable synthetic approach to obtain bromo and aryl substitution at 6-position of 4-quinolones has been demonstrated.  Arylated quinolones, e.g., I, were synthesized by subjecting 6-bromoquinolones to Suzuki cross coupling reaction with different aryl boronic acids.  Both electron withdrawing and donating groups were well tolerated to provide excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBcDTmzoOdELVg90H21EOLACvtfcHk0lh1SzCSgY4LaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1Whug%253D%253D&md5=5eb7a0f3ef982d750263932335a162bd</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1039%2Fc3ra45056b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3ra45056b%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DGhosh%26aufirst%3DP.%26aulast%3DDwivedi%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DS.%26atitle%3DSynthesis%2520of%25206-aryl%2520substituted%25204-quinolones%2520via%2520Suzuki%2520cross%2520coupling%26jtitle%3DRSC%2520Adv.%26date%3D2014%26volume%3D4%26spage%3D6254%26epage%3D6260%26doi%3D10.1039%2Fc3ra45056b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hadida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Goor, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arumugam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCartney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazlewood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negulescu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grootenhuis, P. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, ivacaftor), a potent and orally bioavailable CFTR potentiator</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9776</span>– <span class="NLM_lpage">9795</span>, <span class="refDoi"> DOI: 10.1021/jm5012808</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5012808" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGlsb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9776-9795&author=S.+Hadidaauthor=F.+Van+Goorauthor=J.+Zhouauthor=V.+Arumugamauthor=J.+McCartneyauthor=A.+Hazlewoodauthor=C.+Deckerauthor=P.+Negulescuauthor=P.+D.+Grootenhuis&title=Discovery+of+N-%282%2C4-di-tert-butyl-5-hydroxyphenyl%29-4-oxo-1%2C4-dihydroquinoline-3-carboxamide+%28VX-770%2C+ivacaftor%29%2C+a+potent+and+orally+bioavailable+CFTR+potentiator&doi=10.1021%2Fjm5012808"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, Ivacaftor), a Potent and Orally Bioavailable CFTR Potentiator</span></div><div class="casAuthors">Hadida, Sabine; Van Goor, Fredrick; Zhou, Jinglan; Arumugam, Vijayalaksmi; McCartney, Jason; Hazlewood, Anna; Decker, Caroline; Negulescu, Paul; Grootenhuis, Peter D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9776-9795</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Quinolinone-3-carboxamide 1, a novel CFTR potentiator, was discovered using high-throughput screening in NIH-3T3 cells expressing the F508del-CFTR mutation.  Extensive medicinal chem. and iterative structure-activity relationship (SAR) studies to evaluate potency, selectivity, and pharmacokinetic properties resulted in the identification of N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, 48, ivacaftor), an investigational drug candidate approved by the FDA for the treatment of CF patients 6 years of age and older carrying the G551D mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfCmDwR5g0hbVg90H21EOLACvtfcHk0lh1SzCSgY4LaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGlsb%252FO&md5=c4ed161be3b5d7752e7591d2c4847637</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm5012808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5012808%26sid%3Dliteratum%253Aachs%26aulast%3DHadida%26aufirst%3DS.%26aulast%3DVan%2BGoor%26aufirst%3DF.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DArumugam%26aufirst%3DV.%26aulast%3DMcCartney%26aufirst%3DJ.%26aulast%3DHazlewood%26aufirst%3DA.%26aulast%3DDecker%26aufirst%3DC.%26aulast%3DNegulescu%26aufirst%3DP.%26aulast%3DGrootenhuis%26aufirst%3DP.%2BD.%26atitle%3DDiscovery%2520of%2520N-%25282%252C4-di-tert-butyl-5-hydroxyphenyl%2529-4-oxo-1%252C4-dihydroquinoline-3-carboxamide%2520%2528VX-770%252C%2520ivacaftor%2529%252C%2520a%2520potent%2520and%2520orally%2520bioavailable%2520CFTR%2520potentiator%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9776%26epage%3D9795%26doi%3D10.1021%2Fjm5012808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mesiti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruca, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remiao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">4-Oxoquinolines and monoamine oxidase: when tautomerism matters</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>213</i></span>,  <span class="NLM_fpage">113183</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2021.113183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1016%2Fj.ejmech.2021.113183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=33493825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BB3MXitFWmsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=2021&pages=113183&author=F.+Mesitiauthor=A.+Marucaauthor=V.+Silvaauthor=R.+Roccaauthor=C.+Fernandesauthor=F.+Remiaoauthor=E.+Uriarteauthor=S.+Alcaroauthor=A.+Gasparauthor=F.+Borges&title=4-Oxoquinolines+and+monoamine+oxidase%3A+when+tautomerism+matters&doi=10.1016%2Fj.ejmech.2021.113183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">4-Oxoquinolines and monoamine oxidase: When tautomerism matters</span></div><div class="casAuthors">Mesiti, Francesco; Maruca, Annalisa; Silva, Vera; Rocca, Roberta; Fernandes, Carlos; Remiao, Fernando; Uriarte, Eugenio; Alcaro, Stefano; Gaspar, Alexandra; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">113183</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">4-Oxoquinoline derivs. have been often used in drug discovery programs due to their pharmacol. properties.  Inspired on chromone and 4-oxoquinoline chem. structure similarity, a small series of quinoline-based compds. was obtained and screened, for the first time, toward human monoamine oxidases isoforms.  The data showed the N-(3,4-dichlorophenyl)-1-methyl-4-oxo-1,4-dihydroquinoline-3-carboxamide 10 was the most potent and selective MAO-B inhibitor (IC50 = 5.30 ± 0.74 nM and SI: ≥1887).  The data anal. showed that prototropic tautomerism markedly influences the biol. activity.  The unequivocal characterization of the quinoline tautomers was performed to understand the attained data.  To our knowledge, there have been no prior reports on the characterization of quinolone tautomers by 2D NMR techniques, namely by 1H-15N HSQC and 1H-15N HMBC, which are proposed as expedite tools for medicinal chem. campaigns.  Computational studies on enzyme-ligand complexes, obtained after MM-GBSA calcns. and mol. dynamics simulations, supported the exptl. data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT8kqZIvuKW7Vg90H21EOLACvtfcHk0lh1SzCSgY4LaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXitFWmsbs%253D&md5=6942d53de30251a6e6364eae93b767d2</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2021.113183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2021.113183%26sid%3Dliteratum%253Aachs%26aulast%3DMesiti%26aufirst%3DF.%26aulast%3DMaruca%26aufirst%3DA.%26aulast%3DSilva%26aufirst%3DV.%26aulast%3DRocca%26aufirst%3DR.%26aulast%3DFernandes%26aufirst%3DC.%26aulast%3DRemiao%26aufirst%3DF.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3D4-Oxoquinolines%2520and%2520monoamine%2520oxidase%253A%2520when%2520tautomerism%2520matters%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2021%26volume%3D213%26spage%3D113183%26doi%3D10.1016%2Fj.ejmech.2021.113183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesiti, F.</span></span> <span> </span><span class="NLM_article-title">The synthesis, crystal structure and Hirshfeld analysis of 4-(3,4-dimethylanilino)-N-(3,4-dimethylphenyl)quinoline-3-carboxamide</span>. <i>Acta Crystallogr., Sect. E: Crystallogr. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1107/S2056989020000298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1107%2FS2056989020000298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=32071747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitlKgtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2020&pages=201-207&author=L.+R.+Gomesauthor=J.+N.+Lowauthor=F.+Borgesauthor=A.+Gasparauthor=F.+Mesiti&title=The+synthesis%2C+crystal+structure+and+Hirshfeld+analysis+of+4-%283%2C4-dimethylanilino%29-N-%283%2C4-dimethylphenyl%29quinoline-3-carboxamide&doi=10.1107%2FS2056989020000298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis, crystal structure and Hirshfeld analysis of 4-(3,4-dimethylanilino)-N-(3,4-dimethylphenyl)quinoline-3-carboxamide</span></div><div class="casAuthors">Gomes, Ligia R.; Low, John Nicolson; Borges, Fernanda; Gaspar, Alexandra; Mesiti, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section E: Crystallographic Communications</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-207</span>CODEN:
                <span class="NLM_cas:coden">ACSECI</span>;
        ISSN:<span class="NLM_cas:issn">2056-9890</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The structure of the title quinoline carboxamide deriv., C26H25N3O, is described.  The quinoline moiety is not planar as a result of a slight puckering of the pyridine ring.  The secondary amine has a slightly pyramidal geometry, certainly not planar.  Both intra- and intermol. hydrogen bonds are present.  Hirshfeld surface anal. and lattice energies were used to investigate the intermol. interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoohEDeBer7LrVg90H21EOLACvtfcHk0lgaStuGlqQq1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitlKgtr0%253D&md5=a5bf605552dee511605e26e3e5f6aab9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1107%2FS2056989020000298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2056989020000298%26sid%3Dliteratum%253Aachs%26aulast%3DGomes%26aufirst%3DL.%2BR.%26aulast%3DLow%26aufirst%3DJ.%2BN.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DMesiti%26aufirst%3DF.%26atitle%3DThe%2520synthesis%252C%2520crystal%2520structure%2520and%2520Hirshfeld%2520analysis%2520of%25204-%25283%252C4-dimethylanilino%2529-N-%25283%252C4-dimethylphenyl%2529quinoline-3-carboxamide%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520E%253A%2520Crystallogr.%2520Commun.%26date%3D2020%26volume%3D76%26spage%3D201%26epage%3D207%26doi%3D10.1107%2FS2056989020000298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cecchetti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fravolini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fringuelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiaffella, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzini, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabarrini, O.</span></span> <span> </span><span class="NLM_article-title">4H-1-benzothiopyran-4-one-3-carboxylic acids and 3,4-dihydro-2H-isothiazolo[5,4-bbenzothiopyran-3,4-diones as quinolone antibacterial analogs</span>. <i>J. Heterocycl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1143</span>– <span class="NLM_lpage">1148</span>, <span class="refDoi"> DOI: 10.1002/jhet.5570300455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1002%2Fjhet.5570300455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADyaK2cXisVCrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1993&pages=1143-1148&author=V.+Cecchettiauthor=A.+Fravoliniauthor=R.+Fringuelliauthor=F.+Schiaffellaauthor=M.+C.+Lorenziniauthor=O.+Tabarrini&title=4H-1-benzothiopyran-4-one-3-carboxylic+acids+and+3%2C4-dihydro-2H-isothiazolo%5B5%2C4-bbenzothiopyran-3%2C4-diones+as+quinolone+antibacterial+analogs&doi=10.1002%2Fjhet.5570300455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">4H-1-Benzothiopyran-4-one-3-carboxylic acids and 3,4-dihydro-2H-isothiazolo[5,4-b][1]benzothiopyran-3,4-diones as quinolone antibacterial analogs</span></div><div class="casAuthors">Cecchetti, Violetta; Fravolini, Arnaldo; Fringuelli, Renata; Schiaffella, Fausto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Heterocyclic Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1143-8</span>CODEN:
                <span class="NLM_cas:coden">JHTCAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-152X</span>.
    </div><div class="casAbstract">The endocyclic replacement of a nitrogen atom at the 1-position of quinolone antibacterial nucleus with a sulfur atom was investigated.  A series of 1-benzothiopyran-4-one-3-carboxylic acids I and isothiazolo[5,4-b][1]benzothiopyran-3,4-diones II (R = 4-methyl-, 3-methyl-, and 3,5-dimethyl-1-piperazinyl) was prepd.  Antibacterial evaluation of the synthesized compds. showed an activity comparable to that of nalidixic acid for I, while an increased activity against gram-pos. bacteria was obsd. for II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw4Bn6iqHBNbVg90H21EOLACvtfcHk0lgaStuGlqQq1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXisVCrsrs%253D&md5=09697951b80f60cdc5b7d6d7811fd321</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570300455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570300455%26sid%3Dliteratum%253Aachs%26aulast%3DCecchetti%26aufirst%3DV.%26aulast%3DFravolini%26aufirst%3DA.%26aulast%3DFringuelli%26aufirst%3DR.%26aulast%3DSchiaffella%26aufirst%3DF.%26aulast%3DLorenzini%26aufirst%3DM.%2BC.%26aulast%3DTabarrini%26aufirst%3DO.%26atitle%3D4H-1-benzothiopyran-4-one-3-carboxylic%2520acids%2520and%25203%252C4-dihydro-2H-isothiazolo%255B5%252C4-bbenzothiopyran-3%252C4-diones%2520as%2520quinolone%2520antibacterial%2520analogs%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1993%26volume%3D30%26spage%3D1143%26epage%3D1148%26doi%3D10.1002%2Fjhet.5570300455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wentland, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesher, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruett, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldous, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorff, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rake, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coughlin, S. A.</span></span> <span> </span><span class="NLM_article-title">Mammalian topoisomerase II inhibitory activity of 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarboxylic acid and related derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">2801</span>– <span class="NLM_lpage">2809</span>, <span class="refDoi"> DOI: 10.1021/jm00071a010</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00071a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADyaK2cXnslSqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=2801-2809&author=M.+P.+Wentlandauthor=G.+Y.+Lesherauthor=M.+Reumanauthor=M.+D.+Gruettauthor=B.+Singhauthor=S.+C.+Aldousauthor=P.+H.+Dorffauthor=J.+B.+Rakeauthor=S.+A.+Coughlin&title=Mammalian+topoisomerase+II+inhibitory+activity+of+1-cyclopropyl-6%2C8-difluoro-1%2C4-dihydro-7-%282%2C6-dimethyl-4-pyridinyl%29-4-oxo-3-quinolinecarboxylic+acid+and+related+derivatives&doi=10.1021%2Fjm00071a010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian topoisomerase II inhibitory activity of 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarboxylic acid and related derivatives</span></div><div class="casAuthors">Wentland, Mark P.; Lesher, George Y.; Reuman, Michael; Gruett, Monte D.; Singh, Baldev; Aldous, Suzanne C.; Dorff, Peter H.; Rake, James B.; Coughlin, Susan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2801-9</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The title compd. (I), a previously reported potent inhibitor of bacterial DNA gyrase, was found to be interactive with mammalian topoisomerase II (topo II).  In a DNA-cleavage assay using topo II isolated from HeLa cells, I exhibited an EC50 value of 7.6 μM (VP-16; EC50 = 0.81 μM).  A series of analogs modified at the 1-, 2-, 3-, 5-, and 7-positions of I were subsequently made and assessed for topo II inhibition.  Compd. I was considerably more potent than derivs. where the 1-substituent was alkyl, aryl, or H, or when the cyclopropylimino group was replaced with S.  The descarboxyl (i.e., 3-H) analog had potency comparable to that of I; when both these compds. were substituted at the 2-position with Me or Ph, an interesting relationship between activity and the conformation of the carboxyl group emerged.  Upon replacement of the 5-H of I with NH2 or F, sustained potency was seen.  No enhancement of activity was evident upon replacing the 7-substituent of I with other pyridinyl groups, 4-methyl-1-piperazinyl, or pyrrolidinyl groups; however, the 7-(4-hydroxyphenyl) analog (CP-115,953) was 6-fold more potent than I.  The topo II inhibitory properties of I translated to modest in vitro cytotoxicity and in vivo activity vs. P388.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPgstdxMSWf7Vg90H21EOLACvtfcHk0lgnK_B4IkXiQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXnslSqug%253D%253D&md5=e03e53662ff80eea35e8b4af8aeb5c04</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm00071a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00071a010%26sid%3Dliteratum%253Aachs%26aulast%3DWentland%26aufirst%3DM.%2BP.%26aulast%3DLesher%26aufirst%3DG.%2BY.%26aulast%3DReuman%26aufirst%3DM.%26aulast%3DGruett%26aufirst%3DM.%2BD.%26aulast%3DSingh%26aufirst%3DB.%26aulast%3DAldous%26aufirst%3DS.%2BC.%26aulast%3DDorff%26aufirst%3DP.%2BH.%26aulast%3DRake%26aufirst%3DJ.%2BB.%26aulast%3DCoughlin%26aufirst%3DS.%2BA.%26atitle%3DMammalian%2520topoisomerase%2520II%2520inhibitory%2520activity%2520of%25201-cyclopropyl-6%252C8-difluoro-1%252C4-dihydro-7-%25282%252C6-dimethyl-4-pyridinyl%2529-4-oxo-3-quinolinecarboxylic%2520acid%2520and%2520related%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D2801%26epage%3D2809%26doi%3D10.1021%2Fjm00071a010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chavarria, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil-Martins, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soares, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remiao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">Design of novel monoamine oxidase-B inhibitors based on piperine scaffold: structure-activity-toxicity, drug-likeness and efflux transport studies</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>185</i></span>,  <span class="NLM_fpage">111770</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.111770</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1016%2Fj.ejmech.2019.111770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=31711793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFCjsr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2020&pages=111770&author=D.+Chavarriaauthor=C.+Fernandesauthor=V.+Silvaauthor=C.+Silvaauthor=E.+Gil-Martinsauthor=P.+Soaresauthor=T.+Silvaauthor=R.+Silvaauthor=F.+Remiaoauthor=P.+J.+Oliveiraauthor=F.+Borges&title=Design+of+novel+monoamine+oxidase-B+inhibitors+based+on+piperine+scaffold%3A+structure-activity-toxicity%2C+drug-likeness+and+efflux+transport+studies&doi=10.1016%2Fj.ejmech.2019.111770"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Design of novel monoamine oxidase-B inhibitors based on piperine scaffold: structure-activity-toxicity, drug-likeness and efflux transport studies</span></div><div class="casAuthors">Chavarria, Daniel; Fernandes, Carlos; Silva, Vera; Silva, Catia; Gil-Martins, Eva; Soares, Pedro; Silva, Tiago; Silva, Renata; Remiao, Fernando; Oliveira, Paulo J.; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111770</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Piperine has been assocd. with neuroprotective effects and monoamine oxidase (MAO) inhibition, thus being an attractive scaffold to develop new antiparkinsonian agents.  Accordingly, we prepd. a small library of piperine derivs. and screened the inhibitory activities towards human MAO isoforms (hMAO-A and hMAO-B).  Structure-activity relationship (SAR) studies pointed out that the combination of α-cyano and benzyl ester groups increased both potency and selectivity towards hMAO-B.  Kinetic expts. with compds. 7 (I), 10 (II) and 15 (III) indicated a competitive hMAO-B inhibition mechanism.  Compds. III and 16 (IV), at 10μM, caused a small but significant decrease in P-gp efflux activity in Caco-2 cells.  III stands out as the most potent piperine-based hMAO-B inhibitor (IC50 = 47.4 nM), displaying favorable drug-like properties and a broad safety window.  III is thus a suitable candidate for lead optimization and the development of multitarget-directed ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSI0xBNDEdRrVg90H21EOLACvtfcHk0lgnK_B4IkXiQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFCjsr%252FF&md5=677a2ad762189d6758a553f52c422014</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.111770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.111770%26sid%3Dliteratum%253Aachs%26aulast%3DChavarria%26aufirst%3DD.%26aulast%3DFernandes%26aufirst%3DC.%26aulast%3DSilva%26aufirst%3DV.%26aulast%3DSilva%26aufirst%3DC.%26aulast%3DGil-Martins%26aufirst%3DE.%26aulast%3DSoares%26aufirst%3DP.%26aulast%3DSilva%26aufirst%3DT.%26aulast%3DSilva%26aufirst%3DR.%26aulast%3DRemiao%26aufirst%3DF.%26aulast%3DOliveira%26aufirst%3DP.%2BJ.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DDesign%2520of%2520novel%2520monoamine%2520oxidase-B%2520inhibitors%2520based%2520on%2520piperine%2520scaffold%253A%2520structure-activity-toxicity%252C%2520drug-likeness%2520and%2520efflux%2520transport%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D185%26spage%3D111770%26doi%3D10.1016%2Fj.ejmech.2019.111770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chavarria, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagide, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">Development of piperic acid-based monoamine oxidase inhibitors: synthesis, structural characterization and biological evaluation</span>. <i>J. Mol. Struct.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1182</i></span>,  <span class="NLM_fpage">298</span>– <span class="NLM_lpage">307</span>, <span class="refDoi"> DOI: 10.1016/j.molstruc.2019.01.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1016%2Fj.molstruc.2019.01.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1Ciuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1182&publication_year=2019&pages=298-307&author=D.+Chavarriaauthor=F.+Cagideauthor=M.+Pintoauthor=L.+R.+Gomesauthor=J.+N.+Lowauthor=F.+Borges&title=Development+of+piperic+acid-based+monoamine+oxidase+inhibitors%3A+synthesis%2C+structural+characterization+and+biological+evaluation&doi=10.1016%2Fj.molstruc.2019.01.060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Development of piperic acid-based monoamine oxidase inhibitors: synthesis, structural characterization and biological evaluation</span></div><div class="casAuthors">Chavarria, Daniel; Cagide, Fernando; Pinto, Miguel; Gomes, Ligia R.; Low, John N.; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Structure</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1182</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">298-307</span>CODEN:
                <span class="NLM_cas:coden">JMOSB4</span>;
        ISSN:<span class="NLM_cas:issn">0022-2860</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of piperic acid esters and amides I [R = Ph, Bn; X = NH, O] were synthesized using a two-step strategy.  Mass spectrometry and unidimensional (1H NMR, 13C NMR, DEPT) and bidimensional (COSY, HSQC, HMBC) NMR methodologies were used to study the mol. structure of the final compds. I, resulting in the assignment of all detected signals.  Preliminary biol. data of piperine and the derivs. thereof showed that piperic acid and amides I [R = Ph, Bn; X = NH] did not display significant inhibitory activity at 10 μM against both hMAO-A and hMAO-B.  In contrast, the esters I [R = Ph, Bn; X = O] displayed relevant hMAO inhibitory activities, with IC50 values for hMAO-B lower than piperine and within the nanomolar range.  Moreover, X-ray crystallog. anal. showed relevant differences between amides and esters I [R = Ph, Bn; X = O] constituting a valuable information to understand the ligand-target interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNJ6ffPPPY8bVg90H21EOLACvtfcHk0lgnK_B4IkXiQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1Ciuro%253D&md5=74b696993d82614a8b5c54f5143cf16c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.molstruc.2019.01.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molstruc.2019.01.060%26sid%3Dliteratum%253Aachs%26aulast%3DChavarria%26aufirst%3DD.%26aulast%3DCagide%26aufirst%3DF.%26aulast%3DPinto%26aufirst%3DM.%26aulast%3DGomes%26aufirst%3DL.%2BR.%26aulast%3DLow%26aufirst%3DJ.%2BN.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DDevelopment%2520of%2520piperic%2520acid-based%2520monoamine%2520oxidase%2520inhibitors%253A%2520synthesis%252C%2520structural%2520characterization%2520and%2520biological%2520evaluation%26jtitle%3DJ.%2520Mol.%2520Struct.%26date%3D2019%26volume%3D1182%26spage%3D298%26epage%3D307%26doi%3D10.1016%2Fj.molstruc.2019.01.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonifácio, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieira Coelho, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soares da Silva, P. c.</span></span> <span> </span><span class="NLM_article-title">Kinetic inhibitory profile of BIA 3-202, a novel fast tight-binding, reversible and competitive catechol-O-methyltransferase inhibitor</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>460</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1016/S0014-2999(02)02879-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1016%2FS0014-2999%2802%2902879-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=12559377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFejsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=460&publication_year=2003&pages=163-170&author=M.+J.+Bonif%C3%A1cioauthor=M.+A.+Vieira+Coelhoauthor=P.+c.+Soares+da+Silva&title=Kinetic+inhibitory+profile+of+BIA+3-202%2C+a+novel+fast+tight-binding%2C+reversible+and+competitive+catechol-O-methyltransferase+inhibitor&doi=10.1016%2FS0014-2999%2802%2902879-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic inhibitory profile of BIA 3-202, a novel fast tight-binding, reversible and competitive catechol-O-methyltransferase inhibitor</span></div><div class="casAuthors">Bonifacio, Maria Joao; Vieira-Coelho, Maria Augusta; Soares-da-Silva, Patricio</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">460</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">163-170</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The present study reports the kinetic inhibitory profile of 1-[3,4-dihydroxy-5-nitrophenyl]-2-phenyl-ethanone (BIA 3-202), a novel inhibitor of sol. catechol-O-methyltransferase (COMT) in rat liver.  After an oral single dose (30 mg kg-1), there was a time-dependent recovery of enzyme activity from 98±2% inhibition at 30 min to total recovery at 24 h after treatment.  The inhibitory effect produced by BIA 3-202 on sol. COMT was reversible after gel filtration of the samples.  BIA 3-202 acted as a fast inhibitor of rat liver sol. COMT, interacting immediately with the enzyme after mixing.  No differences were obsd. in the metanephrine formation rates (in nmol mg protein-1 min-1) obtained without and with a 60-min preincubation with 30 nM of BIA 3-202 (1.30±0.02 and 1.35±0.03, resp.).  The tight-binding nature of the inhibition produced by BIA 3-202 was evaluated by performing an Ackermann-Potter plot.  The true Ki for BIA 3-202, derived from the nonlinear regression anal., was 0.19±0.02 nM.  In substrate competition studies, an increase in the concn. of adrenaline resulted in a linear increase in IC50 values for BIA 3-202.  In conclusion, BIA 3-202 behaves as a reversible, potent and fast tight-binding COMT inhibitor that acts competitively at the substrate binding site of rat liver sol. COMT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2qk1wS3eXTLVg90H21EOLACvtfcHk0li6OGagmNZpyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFejsA%253D%253D&md5=d7dddd438acffd20b03495f2c30e973f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2902879-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252902879-0%26sid%3Dliteratum%253Aachs%26aulast%3DBonif%25C3%25A1cio%26aufirst%3DM.%2BJ.%26aulast%3DVieira%2BCoelho%26aufirst%3DM.%2BA.%26aulast%3DSoares%2Bda%2BSilva%26aufirst%3DP.%2Bc.%26atitle%3DKinetic%2520inhibitory%2520profile%2520of%2520BIA%25203-202%252C%2520a%2520novel%2520fast%2520tight-binding%252C%2520reversible%2520and%2520competitive%2520catechol-O-methyltransferase%2520inhibitor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D460%26spage%3D163%26epage%3D170%26doi%3D10.1016%2FS0014-2999%2802%2902879-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dharmasena, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wimalasena, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wimalasena, K.</span></span> <span> </span><span class="NLM_article-title">A slow-tight binding inhibitor of dopamine beta-monooxygenase: a transition state analogue for the product release step</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">12414</span>– <span class="NLM_lpage">12420</span>, <span class="refDoi"> DOI: 10.1021/bi0262606</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0262606" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BD38XntVahu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=12414-12420&author=S.+P.+Dharmasenaauthor=D.+S.+Wimalasenaauthor=K.+Wimalasena&title=A+slow-tight+binding+inhibitor+of+dopamine+beta-monooxygenase%3A+a+transition+state+analogue+for+the+product+release+step&doi=10.1021%2Fbi0262606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A Slow-Tight Binding Inhibitor of Dopamine β-Monooxygenase: A Transition State Analogue for the Product Release Step</span></div><div class="casAuthors">Dharmasena, Sanjeewa P.; Wimalasena, D. Shyamali; Wimalasena, Kandatege</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">12414-12420</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The steady-state kinetic data show that 3-hydroxy-4-phenylthiazole-2(3H)-thione (3H4PTT) is a potent tight-binding inhibitor for dopamine β-monooxygenase (DβM) with a dissocn. const. of 0.9 nM.  Ackermann-Potter plots of the enzyme dependence of the inhibition revealed that the stoichiometry of the enzyme inhibition by 3H4PTT is 1:1.  Pre-steady-state progress curves at varying inhibitor with fixed reductant and enzyme concns. clearly show the slow binding behavior of the inhibitor.  The obsd. kinetic behavior is consistent with the apparent direct formation of the tightly bound E·I* complex.  The kon and koff for 3H4PTT which were detd. under pre-steady-state conditions at variable inhibitor concns. were found to be (1.85±0.07) × 106 M-1 s-1 and (1.9±0.6) × 10-3 s-1, resp.  The dissocn. const. calcd. from these rates was similar to that detd. under steady-state conditions, confirming that 3H4PTT is a kinetically well-behaved inhibitor.  The steady-state as well as pre-steady-state kinetic studies at variable DMPD concns. show that the inhibition is competitive with respect to the reductant, demonstrating the exclusive interaction of 3H4PTT with the oxidized form of the enzyme.  The kinetic behavior and the structural properties of 3H4PTT are consistent with the proposal that the E·3H4PTT complex may mimic the transition state for the product (protonated) release step of the enzyme.  Therefore, 3H4PTT could be used as a convenient probe to examine the properties of the E·P complex of the DβM reaction and also as an active site titrant for the oxidized enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKFulR5-aIvbVg90H21EOLACvtfcHk0li6OGagmNZpyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntVahu7w%253D&md5=67e53a7dc7265aa7b8d7da375e9d8020</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fbi0262606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0262606%26sid%3Dliteratum%253Aachs%26aulast%3DDharmasena%26aufirst%3DS.%2BP.%26aulast%3DWimalasena%26aufirst%3DD.%2BS.%26aulast%3DWimalasena%26aufirst%3DK.%26atitle%3DA%2520slow-tight%2520binding%2520inhibitor%2520of%2520dopamine%2520beta-monooxygenase%253A%2520a%2520transition%2520state%2520analogue%2520for%2520the%2520product%2520release%2520step%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D12414%26epage%3D12420%26doi%3D10.1021%2Fbi0262606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, D. E.</span></span> <span> </span><span class="NLM_article-title">Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. Prediction of blood-brain barrier penetration</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">815</span>– <span class="NLM_lpage">821</span>, <span class="refDoi"> DOI: 10.1021/js980402t</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1021%2Fjs980402t" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10430548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFGitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=815-821&author=D.+E.+Clark&title=Rapid+calculation+of+polar+molecular+surface+area+and+its+application+to+the+prediction+of+transport+phenomena.+Prediction+of+blood-brain+barrier+penetration&doi=10.1021%2Fjs980402t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Calculation of Polar Molecular Surface Area and Its Application to the Prediction of Transport Phenomena. 2. Prediction of Blood-Brain Barrier Penetration</span></div><div class="casAuthors">Clark, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">815-821</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes the derivation of a simple QSAR model for the prediction of log BB from a set of 55 diverse org. compds.  The model contains two variables: polar surface area (PSA) and calcd. logP, both of which can be rapidly computed.  It therefore permits the prediction of log BB for large compd. sets, such as virtual combinatorial libraries.  The performance of this QSAR on two test sets taken from the literature is illustrated and compared with results from other reported computational approaches to log BB prediction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHa3ieLzy0RbVg90H21EOLACvtfcHk0lhyGvCg6FxGZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFGitbk%253D&md5=949f8bf41525d8d04694e1288f24b626</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjs980402t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjs980402t%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%2BE.%26atitle%3DRapid%2520calculation%2520of%2520polar%2520molecular%2520surface%2520area%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520transport%2520phenomena.%2520Prediction%2520of%2520blood-brain%2520barrier%2520penetration%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D815%26epage%3D821%26doi%3D10.1021%2Fjs980402t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span> <span> </span><span class="NLM_article-title">Toxicological effects of Caco-2 cells following short-term and long-term exposure to Ag nanoparticles</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">974</span>, <span class="refDoi"> DOI: 10.3390/ijms17060974</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.3390%2Fijms17060974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVGqtbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=974&author=N.+Chenauthor=Z.+M.+Songauthor=H.+Tangauthor=W.+S.+Xiauthor=A.+Caoauthor=Y.+Liuauthor=H.+Wang&title=Toxicological+effects+of+Caco-2+cells+following+short-term+and+long-term+exposure+to+Ag+nanoparticles&doi=10.3390%2Fijms17060974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicological effects of Caco-2 cells following short-term and long-term exposure to Ag nanoparticles</span></div><div class="casAuthors">Chen, Ni; Song, Zheng-Mei; Tang, Huan; Xi, Wen-Song; Cao, Aoneng; Liu, Yuanfang; Wang, Haifang</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">974/1-974/17</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Extensive utilization increases the exposure of humans to Ag nanoparticles (NPs) via the oral pathway.  To comprehensively address the action of Ag NPs to the gastrointestinal systems in real situations, i.e., the long-term low-dose exposure, we evaluated and compared the toxicity of three Ag NPs (20-30 nm with different surface coatings) to the human intestine cell Caco-2 after 1-day and 21-day exposures, using various biol. assays.  In both the short- and long-term exposures, the variety of surface coating predominated the toxicity of Ag NPs in a descending order of citrate-coated Ag NP (Ag-CIT), bare Ag NP (Ag-B), and poly (N-vinyl-2-pyrrolidone)-coated Ag NP (Ag-PVP).  The short-term exposure induced cell growth inhibition and death.  The cell viability loss appeared after cells were exposed to 0.7 μg/mL Ag-CIT, 0.9 μg/mL Ag-B or >1.0 μg/mL Ag-PVP for 24 h.  The short-term and higher-dose exposure also induced reactive oxygen species (ROS) generation, mitochondrial damage, cell membrane leakage, apoptosis, and inflammation (IL-8 level).  The long-term exposure only inhibited the cell proliferation.  After 21-day exposure to 0.4 μg/mL Ag-CIT, the cell viability dropped to less than 50%, while cells exposed to 0.5 μg/mL Ag-PVP remained normal as the control.  Generally, 0.3 μg/mL is the non-toxic dose for the long-term exposure of Caco-2 cells to Ag NPs in this study.  However, cells presented inflammation after exposure to Ag NPs with the non-toxic dose in the long-term exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_Er87Km2i5bVg90H21EOLACvtfcHk0lhyGvCg6FxGZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVGqtbvJ&md5=e3ac8261459ff584cd9abfeed29f8eab</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.3390%2Fijms17060974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms17060974%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DN.%26aulast%3DSong%26aufirst%3DZ.%2BM.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DXi%26aufirst%3DW.%2BS.%26aulast%3DCao%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DH.%26atitle%3DToxicological%2520effects%2520of%2520Caco-2%2520cells%2520following%2520short-term%2520and%2520long-term%2520exposure%2520to%2520Ag%2520nanoparticles%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2016%26volume%3D17%26spage%3D974%26doi%3D10.3390%2Fijms17060974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kanat, O. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selmanoglu, G.</span></span> <span> </span><span class="NLM_article-title">Neurotoxic effect of Fipronil in neuroblastoma SH-SY5Y cell line</span>. <i>Neurotoxic. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1007/s12640-019-00093-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1007%2Fs12640-019-00093-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=31482323" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2019&pages=30-40&author=O.+N.+Kanatauthor=G.+Selmanoglu&title=Neurotoxic+effect+of+Fipronil+in+neuroblastoma+SH-SY5Y+cell+line&doi=10.1007%2Fs12640-019-00093-z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs12640-019-00093-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12640-019-00093-z%26sid%3Dliteratum%253Aachs%26aulast%3DKanat%26aufirst%3DO.%2BN.%26aulast%3DSelmanoglu%26aufirst%3DG.%26atitle%3DNeurotoxic%2520effect%2520of%2520Fipronil%2520in%2520neuroblastoma%2520SH-SY5Y%2520cell%2520line%26jtitle%3DNeurotoxic.%2520Res.%26date%3D2019%26volume%3D37%26spage%3D30%26epage%3D40%26doi%3D10.1007%2Fs12640-019-00093-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sidell, N.</span></span> <span> </span><span class="NLM_article-title">Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">589</span>– <span class="NLM_lpage">596</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=7040765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADyaL38XktVGjtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1982&pages=589-596&author=N.+Sidell&title=Retinoic+acid-induced+growth+inhibition+and+morphologic+differentiation+of+human+neuroblastoma+cells+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro</span></div><div class="casAuthors">Sidell, Neil</div><div class="citationInfo"><span class="NLM_cas:title">JNCI, Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">589-96</span>CODEN:
                <span class="NLM_cas:coden">JJIND8</span>;
        ISSN:<span class="NLM_cas:issn">0198-0157</span>.
    </div><div class="casAbstract">retinoic acid (RA)  [302-79-4] induced concn.-dependent morphol. differentiation and growth inhibition in the LA-N-1 human neuroblastoma cell line.  Time course studies demonstrated a significant increase in the formation of long neurites in LA-N-1 cultures within 48 h of RA addn.; max. expression of differentiation occurred at ∼4 days.  This differentiation profile corresponding to a detectable decrease in [3H]thymidine incorporation at 48 h and complete inhibition of cell growth after 3-4 days.  The RA-induced morphol. differentiation and growth inhibition persisted despite removal of the drug.  A soft agar assay system showed that RA also inhibited the ability of LA-N-1 cells to form anchorage-independent colonies and induced morphol. differentiation in colonies that did develop.  These findings suggest that RA promoted the differentiation of LA-N-1 neuroblastoma cells, resulting in an altered expression of the malignant phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJDFQL0AGlPLVg90H21EOLACvtfcHk0lhyGvCg6FxGZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XktVGjtrg%253D&md5=eb1854ced7b449b3a942d33abedb84a4</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSidell%26aufirst%3DN.%26atitle%3DRetinoic%2520acid-induced%2520growth%2520inhibition%2520and%2520morphologic%2520differentiation%2520of%2520human%2520neuroblastoma%2520cells%2520in%2520vitro%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1982%26volume%3D68%26spage%3D589%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kovalevich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langford, D.</span></span> <span> </span><span class="NLM_article-title">Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1078</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1007/978-1-62703-640-5_2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1007%2F978-1-62703-640-5_2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=23975817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsFOhsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1078&publication_year=2013&pages=9-21&author=J.+Kovalevichauthor=D.+Langford&title=Considerations+for+the+use+of+SH-SY5Y+neuroblastoma+cells+in+neurobiology&doi=10.1007%2F978-1-62703-640-5_2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Considerations for the Use of SH - SY5Y Neuroblastoma Cells in Neurobiology</span></div><div class="casAuthors">Kovalevich, Jane; Langford, Dianne</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1078</span>
        (<span class="NLM_cas:issue">Neuronal Cell Culture</span>),
    <span class="NLM_cas:pages">9-21</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The use of primary mammalian neurons derived from embryonic central nervous system tissue is limited by the fact that once terminally differentiated into mature neurons, the cells can no longer be propagated.  Transformed neuronal-like cell lines can be used in vitro to overcome this limitation.  However, several caveats exist when utilizing cells derived from malignant tumors.  In this context, the popular SH - SY5Y neuroblastoma cell line and its use in in vitro systems is described.  Originally derived from a metastatic bone tumor biopsy, SH - SY5Y (ATCC CRL-2266) cells are a subline of the parental line SK - N - SH (ATCC HTB-11).  SK-N-SH were subcloned three times; first to SH - SY , then to SH - SY5 , and finally to SH - SY5Y .  SH - SY5Y were deposited to the ATCC in 1970 by June L.  Biedler.Three important characteristics of SH - SY5Y cells should be considered when using these cells in in vitro studies.  First, cultures include both adherent and floating cells, both types of which are viable.  Few studies address the biol. significance of the adherent vs. floating phenotypes, but most reported studies utilize adherent populations and discard the floating cells during media changes.  Second, early studies by Biedler's group indicated that the parental differentiated SK - N - SH cells contained two morphol. distinct phenotypes: neuroblast-like cells and epithelial-like cells (Ross et al., J Nat Cancer Inst 71:741-747, 1983).  These two phenotypes may correspond to the "N" and "S" types described in later studies in SH - SY5Y by Encinas et al. (J Neurochem 75:991-1003, 2000).  Cells with neuroblast-like morphol. are pos. for tyrosine hydroxylase (TH) and dopamine-β-hydroxylase characteristic of catecholaminergic neurons, whereas the epithelial-like counterpart cells lacked these enzymic activities (Ross et al., J Nat Cancer Inst 71:741-747, 1983).  Third, SH - SY5Y cells can be differentiated to a more mature neuron-like phenotype that is characterized by neuronal markers.  There are several methods to differentiate SH - SY5Y cells and are mentioned below.  Retinoic acid is the most commonly used means for differentiation and will be addressed in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCVTav2R1Mr7Vg90H21EOLACvtfcHk0lhm7WQygp4eAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsFOhsb8%253D&md5=c4b1a3d107c070810b83efd461a2d0ec</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2F978-1-62703-640-5_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-62703-640-5_2%26sid%3Dliteratum%253Aachs%26aulast%3DKovalevich%26aufirst%3DJ.%26aulast%3DLangford%26aufirst%3DD.%26atitle%3DConsiderations%2520for%2520the%2520use%2520of%2520SH-SY5Y%2520neuroblastoma%2520cells%2520in%2520neurobiology%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2013%26volume%3D1078%26spage%3D9%26epage%3D21%26doi%3D10.1007%2F978-1-62703-640-5_2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarmento, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remião, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otero-Espinar, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">PEGylated PLGA nanoparticles as a smart carrier to increase the cellular uptake of a coumarin-based monoamine oxidase B inhibitor</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">39557</span>– <span class="NLM_lpage">39569</span>, <span class="refDoi"> DOI: 10.1021/acsami.8b17224</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.8b17224" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFygt7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=39557-39569&author=C.+Fernandesauthor=C.+Martinsauthor=A.+Fonsecaauthor=R.+Nunesauthor=M.+J.+Matosauthor=R.+Silvaauthor=J.+Garridoauthor=B.+Sarmentoauthor=F.+Remi%C3%A3oauthor=F.+J.+Otero-Espinarauthor=E.+Uriarteauthor=F.+Borges&title=PEGylated+PLGA+nanoparticles+as+a+smart+carrier+to+increase+the+cellular+uptake+of+a+coumarin-based+monoamine+oxidase+B+inhibitor&doi=10.1021%2Facsami.8b17224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">PEGylated PLGA Nanoparticles As a Smart Carrier to Increase the Cellular Uptake of a Coumarin-Based Monoamine Oxidase B Inhibitor</span></div><div class="casAuthors">Fernandes, Carlos; Martins, Claudia; Fonseca, Andre; Nunes, Rute; Matos, Maria Joao; Silva, Renata; Garrido, Jorge; Sarmento, Bruno; Remiao, Fernando; Otero-Espinar, Francisco J.; Uriarte, Eugenio; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">39557-39569</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Despite research efforts to discover new drugs for Parkinson treatment, the majority of candidates fail in preclin. and clin. trials due to inadequate pharmacokinetic properties, namely blood-brain barrier permeability.  Within the high demand to introduce new drugs to market, nanotechnol. can be used as a soln.  Accordingly, PEGylated PLGA nanoparticles (NPs) were used as a smart delivery carrier to solve the suboptimal aq. soly., which precludes its use in in vivo assays, of a potent, reversible, and selective monoamine oxidase B inhibitor (IMAO-B) (coumarin C75, IC50 = 28.89 ± 1.18 nM).  Long-term stable <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="88d8c4cfc9c8cbbfbd">[email protected]</a> NPs were obtained by nanopptn. method, with sizes around 105 nm and a zeta potential of -10.1 mV.  The encapsulation efficacy was around 50%, achieving the final C75 concn. of 807 ± 30 μM in the nanoformulation, which corresponds to a therapeutic concn. 27828-fold higher than its IC50 value.  Coumarin C75 showed cytotoxic effects at 50 μM after 48 and 72 h of exposure in SH-SY5Y, Caco-2, and hCMEC/D3 cell lines.  Remarkably, no cytotoxic effects were obsd. after nanoencapsulation.  Furthermore, the data obtained from the P-gp-Glo assay and the cellular uptake studies showed that C75 is a P-glycoprotein (P-gp) substrate having a lower uptake profile in intestinal and brain endothelial cells.  Moreover, it was shown that this membrane transporter influences C75 permeability profile in Caco-2 and hCMEC/D3 cells.  Interestingly, PLGA NPs inhibited P-gp and were able to cross intestinal and brain membranes allowing the successful transport of C75 through this type of biol. barriers.  Overall, this work showed that nanotechnol. can be used to solve drug discovery related drawbacks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGoyUTZrGr5LVg90H21EOLACvtfcHk0lhm7WQygp4eAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFygt7nE&md5=b19a73ee84bffe3b3d70013ace56d25e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facsami.8b17224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.8b17224%26sid%3Dliteratum%253Aachs%26aulast%3DFernandes%26aufirst%3DC.%26aulast%3DMartins%26aufirst%3DC.%26aulast%3DFonseca%26aufirst%3DA.%26aulast%3DNunes%26aufirst%3DR.%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DSilva%26aufirst%3DR.%26aulast%3DGarrido%26aufirst%3DJ.%26aulast%3DSarmento%26aufirst%3DB.%26aulast%3DRemi%25C3%25A3o%26aufirst%3DF.%26aulast%3DOtero-Espinar%26aufirst%3DF.%2BJ.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DPEGylated%2520PLGA%2520nanoparticles%2520as%2520a%2520smart%2520carrier%2520to%2520increase%2520the%2520cellular%2520uptake%2520of%2520a%2520coumarin-based%2520monoamine%2520oxidase%2520B%2520inhibitor%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2018%26volume%3D10%26spage%3D39557%26epage%3D39569%26doi%3D10.1021%2Facsami.8b17224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Repetto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Peso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zurita, J. L.</span></span> <span> </span><span class="NLM_article-title">Neutral red uptake assay for the estimation of cell viability/cytotoxicity</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1125</span>– <span class="NLM_lpage">1131</span>, <span class="refDoi"> DOI: 10.1038/nprot.2008.75</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1038%2Fnprot.2008.75" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=18600217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotFakurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1125-1131&author=G.+Repettoauthor=A.+del+Pesoauthor=J.+L.+Zurita&title=Neutral+red+uptake+assay+for+the+estimation+of+cell+viability%2Fcytotoxicity&doi=10.1038%2Fnprot.2008.75"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Neutral red uptake assay for the estimation of cell viability/cytotoxicity</span></div><div class="casAuthors">Repetto, Guillermo; del Peso, Ana; Zurita, Jorge L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1125-1131</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The neutral red uptake assay provides a quant. estn. of the no. of viable cells in a culture.  It is one of the most used cytotoxicity tests with many biomedical and environmental applications.  It is based on the ability of viable cells to incorporate and bind the supravital dye neutral red in the lysosomes.  Most primary cells and cell lines from diverse origin may be successfully used.  Cells are seeded in 96-well tissue culture plates and are treated for the appropriate period.  The plates are then incubated for 2 h with a medium contg. neutral red.  The cells are subsequently washed, the dye is extd. in each well and the absorbance is read using a spectrophotometer.  The procedure is cheaper and more sensitive than other cytotoxicity tests (tetrazolium salts, enzyme leakage or protein content).  Once the cells were treated, the assay can be completed in <3 h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCcpd7QjH04rVg90H21EOLACvtfcHk0li-SM9KXVt9hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotFakurk%253D&md5=30461f51c2ad668a3cadb4843c93b43e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2008.75&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2008.75%26sid%3Dliteratum%253Aachs%26aulast%3DRepetto%26aufirst%3DG.%26aulast%3Ddel%2BPeso%26aufirst%3DA.%26aulast%3DZurita%26aufirst%3DJ.%2BL.%26atitle%3DNeutral%2520red%2520uptake%2520assay%2520for%2520the%2520estimation%2520of%2520cell%2520viability%252Fcytotoxicity%26jtitle%3DNat.%2520Protoc.%26date%3D2008%26volume%3D3%26spage%3D1125%26epage%3D1131%26doi%3D10.1038%2Fnprot.2008.75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moraes, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuzikov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellinger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calogeropoulou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prousis, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pisa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacono, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freitas-Junior, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dos Santos Pascoalino, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertolacini, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrens, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keminer, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinshagen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordeiro-da-Silva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santarem, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venturelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrigley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karunakaran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kebede, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panecka-Hofman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenske, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alunda, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corral, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uliassi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linciano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quotadamo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santucci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borsari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gul, S.</span></span> <span> </span><span class="NLM_article-title">Accelerating drug discovery efforts for trypanosomatidic infections using an integrated transnational academic drug discovery platform</span>. <i>SLAS Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">346</span>– <span class="NLM_lpage">361</span>, <span class="refDoi"> DOI: 10.1177/2472555218823171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1177%2F2472555218823171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=30784368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktVOjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&pages=346-361&author=C.+B.+Moraesauthor=G.+Wittauthor=M.+Kuzikovauthor=B.+Ellingerauthor=T.+Calogeropoulouauthor=K.+C.+Prousisauthor=S.+Manganiauthor=F.+Di+Pisaauthor=G.+Landiauthor=L.+D.+Iaconoauthor=C.+Pozziauthor=L.+H.+Freitas-Juniorauthor=B.+Dos+Santos+Pascoalinoauthor=C.+P.+Bertolaciniauthor=B.+Behrensauthor=O.+Keminerauthor=J.+Leuauthor=M.+Wolfauthor=J.+Reinshagenauthor=A.+Cordeiro-da-Silvaauthor=N.+Santaremauthor=A.+Venturelliauthor=S.+Wrigleyauthor=D.+Karunakaranauthor=B.+Kebedeauthor=I.+Pohnerauthor=W.+Mullerauthor=J.+Panecka-Hofmanauthor=R.+C.+Wadeauthor=M.+Fenskeauthor=J.+Closauthor=J.+M.+Alundaauthor=M.+J.+Corralauthor=E.+Uliassiauthor=M.+L.+Bolognesiauthor=P.+Lincianoauthor=A.+Quotadamoauthor=S.+Ferrariauthor=M.+Santucciauthor=C.+Borsariauthor=M.+P.+Costiauthor=S.+Gul&title=Accelerating+drug+discovery+efforts+for+trypanosomatidic+infections+using+an+integrated+transnational+academic+drug+discovery+platform&doi=10.1177%2F2472555218823171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform</span></div><div class="casAuthors">Moraes, Carolina B.; Witt, Gesa; Kuzikov, Maria; Ellinger, Bernhard; Calogeropoulou, Theodora; Prousis, Kyriakos C.; Mangani, Stefano; Di Pisa, Flavio; Landi, Giacomo; Iacono, Lucia Dello; Pozzi, Cecilia; Freitas-Junior, Lucio H.; dos Santos Pascoalino, Bruno; Bertolacini, Claudia P.; Behrens, Birte; Keminer, Oliver; Leu, Jennifer; Wolf, Markus; Reinshagen, Jeanette; Cordeiro-da-Silva, Anabela; Santarem, Nuno; Venturelli, Alberto; Wrigley, Stephen; Karunakaran, Deepa; Kebede, Bethlehem; Pohner, Ina; Muller, Wolfgang; Panecka-Hofman, Joanna; Wade, Rebecca C.; Fenske, Martina; Clos, Joachim; Alunda, Jose Maria; Corral, Maria Jesus; Uliassi, Elisa; Bolognesi, Maria Laura; Linciano, Pasquale; Quotadamo, Antonio; Ferrari, Stefania; Santucci, Matteo; Borsari, Chiara; Costi, Maria Paola; Gul, Sheraz</div><div class="citationInfo"><span class="NLM_cas:title">SLAS Discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">346-361</span>CODEN:
                <span class="NLM_cas:coden">SDLIBT</span>;
        ISSN:<span class="NLM_cas:issn">2472-5560</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">According to the World Health Organization, more than 1 billion people are at risk of or are affected by neglected tropical diseases.  Examples of such diseases include trypanosomiasis, which causes sleeping sickness; leishmaniasis; and Chagas disease, all of which are prevalent in Africa, South America, and India.  Our aim within the New Medicines for Trypanosomatidic Infections project was to use (1) synthetic and natural product libraries, (2) screening, and (3) a preclin. absorption, distribution, metab., and excretion-toxicity (ADME-Tox) profiling platform to identify compds. that can enter the trypanosomatidic drug discovery value chain.  The synthetic compd. libraries originated from multiple scaffolds with known antiparasitic activity and natural products from the Hypha Discovery MycoDiverse natural products library.  Our focus was first to employ target-based screening to identify inhibitors of the protozoan Trypanosoma brucei pteridine reductase 1 (TbPTR1) and second to use a Trypanosoma brucei phenotypic assay that made use of the T. brucei brucei parasite to identify compds. that inhibited cell growth and caused death.  Some of the compds. underwent structure-activity relationship expansion and, when appropriate, were evaluated in a preclin. ADME-Tox assay panel.  This preclin. platform has led to the identification of lead-like compds. as well as validated hits in the trypanosomatidic drug discovery value chain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0xfcsY_u7srVg90H21EOLACvtfcHk0lh87C0iFZy55A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktVOjtLs%253D&md5=20a4cc188eb6ccd8ba97141846873324</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1177%2F2472555218823171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2472555218823171%26sid%3Dliteratum%253Aachs%26aulast%3DMoraes%26aufirst%3DC.%2BB.%26aulast%3DWitt%26aufirst%3DG.%26aulast%3DKuzikov%26aufirst%3DM.%26aulast%3DEllinger%26aufirst%3DB.%26aulast%3DCalogeropoulou%26aufirst%3DT.%26aulast%3DProusis%26aufirst%3DK.%2BC.%26aulast%3DMangani%26aufirst%3DS.%26aulast%3DDi%2BPisa%26aufirst%3DF.%26aulast%3DLandi%26aufirst%3DG.%26aulast%3DIacono%26aufirst%3DL.%2BD.%26aulast%3DPozzi%26aufirst%3DC.%26aulast%3DFreitas-Junior%26aufirst%3DL.%2BH.%26aulast%3DDos%2BSantos%2BPascoalino%26aufirst%3DB.%26aulast%3DBertolacini%26aufirst%3DC.%2BP.%26aulast%3DBehrens%26aufirst%3DB.%26aulast%3DKeminer%26aufirst%3DO.%26aulast%3DLeu%26aufirst%3DJ.%26aulast%3DWolf%26aufirst%3DM.%26aulast%3DReinshagen%26aufirst%3DJ.%26aulast%3DCordeiro-da-Silva%26aufirst%3DA.%26aulast%3DSantarem%26aufirst%3DN.%26aulast%3DVenturelli%26aufirst%3DA.%26aulast%3DWrigley%26aufirst%3DS.%26aulast%3DKarunakaran%26aufirst%3DD.%26aulast%3DKebede%26aufirst%3DB.%26aulast%3DPohner%26aufirst%3DI.%26aulast%3DMuller%26aufirst%3DW.%26aulast%3DPanecka-Hofman%26aufirst%3DJ.%26aulast%3DWade%26aufirst%3DR.%2BC.%26aulast%3DFenske%26aufirst%3DM.%26aulast%3DClos%26aufirst%3DJ.%26aulast%3DAlunda%26aufirst%3DJ.%2BM.%26aulast%3DCorral%26aufirst%3DM.%2BJ.%26aulast%3DUliassi%26aufirst%3DE.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DLinciano%26aufirst%3DP.%26aulast%3DQuotadamo%26aufirst%3DA.%26aulast%3DFerrari%26aufirst%3DS.%26aulast%3DSantucci%26aufirst%3DM.%26aulast%3DBorsari%26aufirst%3DC.%26aulast%3DCosti%26aufirst%3DM.%2BP.%26aulast%3DGul%26aufirst%3DS.%26atitle%3DAccelerating%2520drug%2520discovery%2520efforts%2520for%2520trypanosomatidic%2520infections%2520using%2520an%2520integrated%2520transnational%2520academic%2520drug%2520discovery%2520platform%26jtitle%3DSLAS%2520Discovery%26date%3D2019%26volume%3D24%26spage%3D346%26epage%3D361%26doi%3D10.1177%2F2472555218823171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">P-glycoprotein mediated efflux limits the transport of the novel anti-Parkinson’s disease candidate drug FLZ across the physiological and PD pathological in vitro BBB models</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e102442</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0102442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1371%2Fjournal.pone.0102442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=25036090" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=Q.+Liuauthor=J.+Houauthor=X.+Chenauthor=G.+Liuauthor=D.+Zhangauthor=H.+Sunauthor=J.+Zhang&title=P-glycoprotein+mediated+efflux+limits+the+transport+of+the+novel+anti-Parkinson%E2%80%99s+disease+candidate+drug+FLZ+across+the+physiological+and+PD+pathological+in+vitro+BBB+models&doi=10.1371%2Fjournal.pone.0102442"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0102442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0102442%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DP-glycoprotein%2520mediated%2520efflux%2520limits%2520the%2520transport%2520of%2520the%2520novel%2520anti-Parkinson%25E2%2580%2599s%2520disease%2520candidate%2520drug%2520FLZ%2520across%2520the%2520physiological%2520and%2520PD%2520pathological%2520in%2520vitro%2520BBB%2520models%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0102442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bicker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortuna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcao, A.</span></span> <span> </span><span class="NLM_article-title">Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review</span>. <i>Eur. J. Pharm. Biopharm.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">432</span>, <span class="refDoi"> DOI: 10.1016/j.ejpb.2014.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1016%2Fj.ejpb.2014.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=24686194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtlWgu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2014&pages=409-432&author=J.+Bickerauthor=G.+Alvesauthor=A.+Fortunaauthor=A.+Falcao&title=Blood-brain+barrier+models+and+their+relevance+for+a+successful+development+of+CNS+drug+delivery+systems%3A+a+review&doi=10.1016%2Fj.ejpb.2014.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: A review</span></div><div class="casAuthors">Bicker, Joana; Alves, Gilberto; Fortuna, Ana; Falcao, Amilcar</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-432</span>CODEN:
                <span class="NLM_cas:coden">EJPBEL</span>;
        ISSN:<span class="NLM_cas:issn">0939-6411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  During the research and development of new drugs directed at the central nervous system, there is a considerable attrition rate caused by their hampered access to the brain by the blood-brain barrier.  Throughout the years, several in vitro models have been developed in an attempt to mimic crit. functionalities of the blood-brain barrier and reliably predict the permeability of drug candidates.  However, the current challenge lies in developing a model that retains fundamental blood-brain barrier characteristics and simultaneously remains compatible with the high throughput demands of pharmaceutical industries.  This review firstly describes the roles of all elements of the neurovascular unit and their influence on drug brain penetration.  In vitro models, including non-cell based and cell-based models, and in vivo models are herein presented, with a particular emphasis on their methodol. aspects.  Lastly, their contribution to the improvement of brain drug delivery strategies and drug transport across the blood-brain barrier is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph-OEiYO0znrVg90H21EOLACvtfcHk0lh87C0iFZy55A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtlWgu7Y%253D&md5=73c2d2182182626c039ccb469b65eec4</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpb.2014.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpb.2014.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DBicker%26aufirst%3DJ.%26aulast%3DAlves%26aufirst%3DG.%26aulast%3DFortuna%26aufirst%3DA.%26aulast%3DFalcao%26aufirst%3DA.%26atitle%3DBlood-brain%2520barrier%2520models%2520and%2520their%2520relevance%2520for%2520a%2520successful%2520development%2520of%2520CNS%2520drug%2520delivery%2520systems%253A%2520a%2520review%26jtitle%3DEur.%2520J.%2520Pharm.%2520Biopharm.%26date%3D2014%26volume%3D87%26spage%3D409%26epage%3D432%26doi%3D10.1016%2Fj.ejpb.2014.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartz, A. M.</span></span> <span> </span><span class="NLM_article-title">Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">196</span>– <span class="NLM_lpage">209</span>, <span class="refDoi"> DOI: 10.1124/pr.107.07109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1124%2Fpr.107.07109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=18560012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitlWlsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=196-209&author=D.+S.+Millerauthor=B.+Bauerauthor=A.+M.+Hartz&title=Modulation+of+P-glycoprotein+at+the+blood-brain+barrier%3A+opportunities+to+improve+central+nervous+system+pharmacotherapy&doi=10.1124%2Fpr.107.07109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy</span></div><div class="casAuthors">Miller, David S.; Bauer, Bjorn; Hartz, Anika M. S.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">196-209</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Pharmacotherapy of central nervous system (CNS) disorders (e.g., neurodegenerative diseases, epilepsy, brain cancer, and neuro-AIDS) is limited by the blood-brain barrier.  P-glycoprotein, an ATP-driven, drug efflux transporter, is a crit. element of that barrier.  High level of expression, luminal membrane location, multispecificity, and high transport potency make P-glycoprotein a selective gatekeeper of the blood-brain barrier and thus a primary obstacle to drug delivery into the brain.  As such, P-glycoprotein limits entry into the CNS for a large no. of prescribed drugs, contributes to the poor success rate of CNS drug candidates, and probably contributes to patient-to-patient variability in response to CNS pharmacotherapy.  Modulating P-glycoprotein could therefore improve drug delivery into the brain.  Here we review the current understanding of signaling mechanisms responsible for the modulation of P-glycoprotein activity/expression at the blood-brain barrier with an emphasis on recent studies from our labs.  Using intact brain capillaries from rats and mice, we have identified multiple extracellular and intracellular signals that regulate this transporter; several signaling pathways have been mapped.  Three pathways are triggered by elements of the brain's innate immune response, one by glutamate, one by xenobiotic-nuclear receptor (pregnane X receptor) interactions, and one by elevated β-amyloid levels.  Signaling is complex, with several pathways sharing common signaling elements [tumor necrosis factor (TNF) receptor 1, endothelin (ET) B receptor, protein kinase C, and nitric-oxide synthase], suggesting a regulatory network.  Several pathways include autocrine/paracrine elements, involving release of the proinflammatory cytokine, TNF-α, and the polypeptide hormone, ET-1.  Finally, several steps in signaling are potential therapeutic targets that could be used to modulate P-glycoprotein activity in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoHVx_SSsfFLVg90H21EOLACvtfcHk0lhOhQAVNiXNSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitlWlsrs%253D&md5=b82ef70a8d7d087c7216ec52b30282fc</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1124%2Fpr.107.07109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.107.07109%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DD.%2BS.%26aulast%3DBauer%26aufirst%3DB.%26aulast%3DHartz%26aufirst%3DA.%2BM.%26atitle%3DModulation%2520of%2520P-glycoprotein%2520at%2520the%2520blood-brain%2520barrier%253A%2520opportunities%2520to%2520improve%2520central%2520nervous%2520system%2520pharmacotherapy%26jtitle%3DPharmacol.%2520Rev.%26date%3D2008%26volume%3D60%26spage%3D196%26epage%3D209%26doi%3D10.1124%2Fpr.107.07109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gameiro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha-Pereira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastos, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remiao, F.</span></span> <span> </span><span class="NLM_article-title">Cellular models and in vitro assays for the screening of modulators of P-gp, MRP1 and BCRP</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">600</span>, <span class="refDoi"> DOI: 10.3390/molecules22040600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.3390%2Fmolecules22040600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVyls7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=600&author=M.+Gameiroauthor=R.+Silvaauthor=C.+Rocha-Pereiraauthor=H.+Carmoauthor=F.+Carvalhoauthor=M.+L.+Bastosauthor=F.+Remiao&title=Cellular+models+and+in+vitro+assays+for+the+screening+of+modulators+of+P-gp%2C+MRP1+and+BCRP&doi=10.3390%2Fmolecules22040600"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular models and in vitro assays for the screening of modulators of P-gp, MRP1 and BCRP</span></div><div class="casAuthors">Gameiro, Mariline; Silva, Renata; Rocha-Pereira, Carolina; Carmo, Helena; Carvalho, Felix; Bastos, Maria de Lourdes; Remiao, Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">600/1-600/48</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">ATP (ATP)-binding cassette (ABC) transporters are highly expressed in tumor cells, as well as in organs involved in absorption and secretion processes, mediating the ATP-dependent efflux of compds., both endogenous substances and xenobiotics, including drugs.  Their expression and activity levels are modulated by the presence of inhibitors, inducers and/or activators.  In vitro, ex vivo and in vivo studies with both known and newly synthesized P-glycoprotein (P-gp) inducers and/or activators have shown the usefulness of these transport mechanisms in reducing the systemic exposure and specific tissue access of potentially harmful compds.  This article focuses on the main ABC transporters involved in multidrug resistance [P-gp, multidrug resistance-assocd. protein 1 (MRP1) and breast cancer resistance protein (BCRP)] expressed in tissues of toxicol. relevance, such as the blood-brain barrier, cardiovascular system, liver, kidney and intestine.  Moreover, it provides a review of the available cellular models, in vitro and ex vivo assays for the screening and selection of safe and specific inducers and activators of these membrane transporters.  The available cellular models and in vitro assays have been proposed as high throughput and low-cost alternatives to excessive animal testing, allowing the evaluation of a large no. of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn1D36bj5L3rVg90H21EOLACvtfcHk0lhOhQAVNiXNSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVyls7jN&md5=b974657a22d9086985179fc3e2bc811b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22040600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22040600%26sid%3Dliteratum%253Aachs%26aulast%3DGameiro%26aufirst%3DM.%26aulast%3DSilva%26aufirst%3DR.%26aulast%3DRocha-Pereira%26aufirst%3DC.%26aulast%3DCarmo%26aufirst%3DH.%26aulast%3DCarvalho%26aufirst%3DF.%26aulast%3DBastos%26aufirst%3DM.%2BL.%26aulast%3DRemiao%26aufirst%3DF.%26atitle%3DCellular%2520models%2520and%2520in%2520vitro%2520assays%2520for%2520the%2520screening%2520of%2520modulators%2520of%2520P-gp%252C%2520MRP1%2520and%2520BCRP%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D600%26doi%3D10.3390%2Fmolecules22040600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCaffrey, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staatz, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Covarrubias, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finch, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demarco, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laracuente, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronaldson, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, T. P.</span></span> <span> </span><span class="NLM_article-title">P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">962</span>– <span class="NLM_lpage">975</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2012.07831.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.1111%2Fj.1471-4159.2012.07831.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=22716933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Wrtr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2012&pages=962-975&author=G.+McCaffreyauthor=W.+D.+Staatzauthor=L.+Sanchez-Covarrubiasauthor=J.+D.+Finchauthor=K.+Demarcoauthor=M.+L.+Laracuenteauthor=P.+T.+Ronaldsonauthor=T.+P.+Davis&title=P-glycoprotein+trafficking+at+the+blood-brain+barrier+altered+by+peripheral+inflammatory+hyperalgesia&doi=10.1111%2Fj.1471-4159.2012.07831.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia</span></div><div class="casAuthors">McCaffrey, Gwen; Staatz, William D.; Sanchez-Covarrubias, Lucy; Finch, Jessica D.; DeMarco, Kristen; Laracuente, Mei-Li; Ronaldson, Patrick T.; Davis, Thomas P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">5&6</span>),
    <span class="NLM_cas:pages">962-975</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">P-glycoprotein (ABCB1/MDR1, EC 3.6.3.44), the major efflux transporter at the blood-brain barrier (BBB), is a formidable obstacle to CNS pharmacotherapy.  Understanding the mechanism(s) for increased P-glycoprotein activity at the BBB during peripheral inflammatory pain is crit. in the development of novel strategies to overcome the significant decreases in CNS analgesic drug delivery.  In this study, we employed the λ-carrageenan pain model (using female Sprague-Dawley rats), combined with confocal microscopy and subcellular fractionation of cerebral microvessels, to det. if increased P-glycoprotein function, following the onset of peripheral inflammatory pain, is assocd. with a change in P-glycoprotein trafficking which leads to pain-induced effects on analgesic drug delivery.  Injection of λ-carrageenan into the rat hind paw induced a localized, inflammatory pain (hyperalgesia) and simultaneously, at the BBB, a rapid change in colocalization of P-glycoprotein with caveolin-1, a key scaffolding/trafficking protein.  Subcellular fractionation of isolated cerebral microvessels revealed that the bulk of P-glycoprotein constitutively traffics to membrane domains contg. high mol. wt., disulfide-bonded P-glycoprotein-contg. structures that cofractionate with membrane domains enriched with monomeric and high mol. wt., disulfide-bonded, caveolin-1-contg. structures.  Peripheral inflammatory pain promoted a dynamic redistribution between membrane domains of P-glycoprotein and caveolin-1.  Disassembly of high mol. wt. P-glycoprotein-contg. structures within microvascular endothelial luminal membrane domains was accompanied by an increase in ATPase activity, suggesting a potential for functionally active P-glycoprotein.  These results are the first observation that peripheral inflammatory pain leads to specific structural changes in P-glycoprotein responsible for controlling analgesic drug delivery to the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnxy5wlcfYjrVg90H21EOLACvtfcHk0lhWPkWX8Edo9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Wrtr%252FP&md5=2fcfe248612d860f74354c3b9709d833</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2012.07831.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2012.07831.x%26sid%3Dliteratum%253Aachs%26aulast%3DMcCaffrey%26aufirst%3DG.%26aulast%3DStaatz%26aufirst%3DW.%2BD.%26aulast%3DSanchez-Covarrubias%26aufirst%3DL.%26aulast%3DFinch%26aufirst%3DJ.%2BD.%26aulast%3DDemarco%26aufirst%3DK.%26aulast%3DLaracuente%26aufirst%3DM.%2BL.%26aulast%3DRonaldson%26aufirst%3DP.%2BT.%26aulast%3DDavis%26aufirst%3DT.%2BP.%26atitle%3DP-glycoprotein%2520trafficking%2520at%2520the%2520blood-brain%2520barrier%2520altered%2520by%2520peripheral%2520inflammatory%2520hyperalgesia%26jtitle%3DJ.%2520Neurochem.%26date%3D2012%26volume%3D122%26spage%3D962%26epage%3D975%26doi%3D10.1111%2Fj.1471-4159.2012.07831.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reichert, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Freitas, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampaio-Silva, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rokita-Rosa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bydlowski, S. P.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis mechanisms involved in neurodegenerative diseases</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">8765</span>, <span class="refDoi"> DOI: 10.3390/ijms21228765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=10.3390%2Fijms21228765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFyhtbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=8765&author=C.+O.+Reichertauthor=F.+A.+de+Freitasauthor=J.+Sampaio-Silvaauthor=L.+Rokita-Rosaauthor=P.+L.+Barrosauthor=D.+Levyauthor=S.+P.+Bydlowski&title=Ferroptosis+mechanisms+involved+in+neurodegenerative+diseases&doi=10.3390%2Fijms21228765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis mechanisms involved in neurodegenerative diseases</span></div><div class="casAuthors">Reichert, Cadiele Oliana; de Freitas, Fabio Alessandro; Sampaio-Silva, Juliana; Rokita-Rosa, Leonardo; de Lima Barros, Priscila; Levy, Debora; Bydlowski, Sergio Paulo</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8765</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Ferroptosis is a type of cell death that was described less than a decade ago.  It is caused by the excess of free intracellular iron that leads to lipid (hydro) peroxidn.  Iron is essential as a redox metal in several physiol. functions.  The brain is one of the organs known to be affected by iron homeostatic balance disruption.  Since the 1960s, increased concn. of iron in the central nervous system has been assocd. with oxidative stress, oxidn. of proteins and lipids, and cell death.  Here, we review the main mechanisms involved in the process of ferroptosis such as lipid peroxidn., glutathione peroxidase 4 enzyme activity, and iron metab.  Moreover, the assocn. of ferroptosis with the pathophysiol. of some neurodegenerative diseases, namely Alzheimer's, Parkinson's, and Huntington's diseases, has also been addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt86wEDzzmMLVg90H21EOLACvtfcHk0lhWPkWX8Edo9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFyhtbnK&md5=34c5488fb87a100c6453bb8d023a886d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.3390%2Fijms21228765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms21228765%26sid%3Dliteratum%253Aachs%26aulast%3DReichert%26aufirst%3DC.%2BO.%26aulast%3Dde%2BFreitas%26aufirst%3DF.%2BA.%26aulast%3DSampaio-Silva%26aufirst%3DJ.%26aulast%3DRokita-Rosa%26aufirst%3DL.%26aulast%3DBarros%26aufirst%3DP.%2BL.%26aulast%3DLevy%26aufirst%3DD.%26aulast%3DBydlowski%26aufirst%3DS.%2BP.%26atitle%3DFerroptosis%2520mechanisms%2520involved%2520in%2520neurodegenerative%2520diseases%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2020%26volume%3D21%26spage%3D8765%26doi%3D10.3390%2Fijms21228765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i48"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00510">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_47123"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00510?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00510</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_001.csv">CSV</a>)</p></li><li><p class="inline">PDB files of homology (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_002.zip">ZIP</a>)</p></li><li><p class="inline">Enzymatic assays, <i>in vitro</i> toxicology, computational studies, supplementary tables, and figures (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_003.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_001.csv">jm1c00510_si_001.csv (1.64 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_002.zip">jm1c00510_si_002.zip (937.18 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00510/suppl_file/jm1c00510_si_003.pdf">jm1c00510_si_003.pdf (2.22 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00510&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00510%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00510" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679955109f882362","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
